JPH05213852A - Azoxy group-containing compound - Google Patents
Azoxy group-containing compoundInfo
- Publication number
- JPH05213852A JPH05213852A JP24029491A JP24029491A JPH05213852A JP H05213852 A JPH05213852 A JP H05213852A JP 24029491 A JP24029491 A JP 24029491A JP 24029491 A JP24029491 A JP 24029491A JP H05213852 A JPH05213852 A JP H05213852A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- reaction
- azoxy
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は新規なアゾキシ基含有化
合物に関し、さらに詳細には、抗真菌性化合物及びこの
ものを有効成分とする抗真菌剤に関する。TECHNICAL FIELD The present invention relates to a novel azoxy group-containing compound, and more particularly to an antifungal compound and an antifungal agent containing this compound as an active ingredient.
【0002】[0002]
【従来の技術及びその問題点】本発明者らは先に、岡山
県真庭群の土壌から分離したストレプトミセスs.p.
KC−7367(FERM BP−1277)が、真菌
に対して強力な抗菌力を示す物質を生産することを見出
し、更にその培養液から2種の抗真菌性物質KA−73
67A(マニワマイシンA)及びKA−7367B(マ
ニワマイシンB)を単離、同定した(特開平1−624
8号参照)。前記の抗真菌性物質KA−7367A及び
KA−7367Bは下記の式で表される。2. Description of the Related Art The present inventors have previously found that Streptomyces s. p.
It was found that KC-7367 (FERM BP-1277) produces a substance exhibiting a strong antibacterial activity against fungi, and further two antifungal substances KA-73 were produced from the culture solution.
67A (Maniwamycin A) and KA-7366B (Maniwamycin B) were isolated and identified (JP-A-1-624).
(See No. 8). The antifungal substances KA-7366A and KA-7366B are represented by the following formula.
【化2】 X= −CO− :KA−7367A X= −CH (OH) − :KA−7367B[Chemical 2] X = -CO-: KA-7366A X = -CH (OH)-: KA-7366B
【0003】さらに本発明者らはKA−7367Aを原
料として、このものの2位のカルボニル基をイミノ化し
て得られる2−イミノ化合物が優れた抗真菌活性を示す
ことを確認し、特許出願した(PCT/JP89/01
082)。しかしながら、これらの化合物は優れた抗真
菌活性及び安定性を示すが、これを皮膚真菌症例えば汗
疱状白癬の治療に適用するためには、より優れた抗白癬
活性を有する化合物が必要である。また、より優れた抗
真菌剤を得るためには各種誘導体を合成する必要がある
が、発酵法によって製造されるKA−7367を原料と
して合成することは、原料の生産性及び誘導体の種類に
制限があるという欠点がある。Further, the present inventors have confirmed that a 2-imino compound obtained by iminating the carbonyl group at the 2-position of KA-7367A as a raw material exhibits excellent antifungal activity, and applied for a patent ( PCT / JP89 / 01
082). However, although these compounds show excellent antifungal activity and stability, in order to apply them to the treatment of dermatomycosis such as tinea pedis, compounds with better anti-tinetosis activity are needed. .. Further, in order to obtain a better antifungal agent, it is necessary to synthesize various derivatives. However, synthesizing KA-7366 produced by a fermentation method as a raw material is limited to the productivity of the raw material and the kind of the derivative. There is a drawback that there is.
【0004】[0004]
【問題点を解決するための手段】本発明者らは、前記の
問題点を解決すべく、有機合成法によるKA−7367
Aの有機合成法を完成し、更にその類縁体を合成し、こ
れらが抗真菌剤として、有用であることを見出し、本発
明を完成した。本発明は、一般式[Means for Solving the Problems] In order to solve the above-mentioned problems, the inventors of the present invention used the organic synthesis method KA-7367.
The organic synthesis method of A was completed, and its analogs were further synthesized. They found that they were useful as antifungal agents, and completed the present invention. The present invention has the general formula
【化3】 〔式中、R1 及びR2 は同一又は異なって水素原子、低
級アルキル基、低級アルケニル基、低級アルキニル基
(ハロゲン原子で置換されていてもよい)、低級アルコ
キシ基、低級アケニルオキシ基、低級アルキニルオキシ
基(ハロゲン原子で置換されていてもよい)、アリール
基又はアラルキル基(アリール基及びアラルキル基は1
乃至2個のハロゲン原子、低級アルキル基、低級アルコ
キキシ基、ハロゲン化低級アルキニル基又はハロゲン化
低級アルキニルオキシ基で置換されていてもよい)を、
R3 は水素原子、低級アルキル基(カルボキシル基で置
換されていてもよい)、低級アルキニル基(ハロゲン原
子で置換されていてもよい)、低級アルキニルオキシ基
(ハロゲン原子で置換されていてもよい)、ベンゾイル
基(ハロゲン化低級アルキニルオキシ基で置換されてい
てもよい)を示すが、R1 がn−ブチル基を示す場合は
R3 はハロゲン化低級アルキニル基又はハロゲン化アル
キニルオキシ基で置換されたベンゾイル基を示す〕で表
されるアゾキシ基含有化合物である。[Chemical 3] [Wherein R 1 and R 2 are the same or different and each is a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower alkynyl group (which may be substituted with a halogen atom), a lower alkoxy group, a lower alkenyloxy group, a lower alkynyl group. An oxy group (which may be substituted with a halogen atom), an aryl group or an aralkyl group (the aryl group and the aralkyl group are 1
To two halogen atoms, a lower alkyl group, a lower alkoxy group, a halogenated lower alkynyl group or a halogenated lower alkynyloxy group),
R 3 is a hydrogen atom, a lower alkyl group (which may be substituted with a carboxyl group), a lower alkynyl group (which may be substituted with a halogen atom), a lower alkynyloxy group (which may be substituted with a halogen atom) ), A benzoyl group (which may be substituted with a halogenated lower alkynyloxy group), but when R 1 represents an n-butyl group, R 3 is substituted with a halogenated lower alkynyl group or a halogenated alkynyloxy group. Represents a benzoyl group represented by the formula [1].
【0005】式Iの化合物の各置換基のための低級アル
キル基、低級アルケニル基及び低級アルキニル基として
は直鎖状もしくは分枝鎖状の炭素数1乃至8のものが好
ましい。ハロゲン原子としてはフッ素原子、塩素原子、
沃素原子などが好ましい。式Iの化合物には、オキシム
水酸基に関するアンチ−異性体及びシン−異性体が存在
するが、何れも抗真菌活性を有し、本発明の範囲に属す
る。The lower alkyl group, lower alkenyl group and lower alkynyl group for each substituent of the compound of formula I are preferably linear or branched ones having 1 to 8 carbon atoms. As a halogen atom, a fluorine atom, a chlorine atom,
Iodine atom and the like are preferable. There are anti-isomers and syn-isomers of the oxime hydroxyl group in the compound of formula I, both of which have antifungal activity and belong to the scope of the present invention.
【0006】本発明の化合物(I)は一般式The compound (I) of the present invention has the general formula
【化4】 (式中、R1 及びR2 は前記の意味を有し、nは2又は
3を示す)で表される化合物に酸を作用させて、一般式[Chemical 4] (In the formula, R 1 and R 2 have the above-mentioned meanings, and n is 2 or 3.) An acid is allowed to act on the compound represented by the general formula
【化5】 (式中の各記号は前記の意味を有する)で表される化合
物を得、次いでこの化合物に一般式 H2 N−OR3 (IV) (式中、R3 は前記の意味を有する)で表される化合物
を反応させることによって製造できる。式 IIIの化合物
は、一般式[Chemical 5] A compound of the general formula H 2 N—OR 3 (IV), in which R 3 has the abovementioned meaning, is obtained. It can be produced by reacting the represented compound. The compound of formula III has the general formula
【化6】 (式中の各記号は前記の意味を有する)で表される化合
物を脱水して炭素−炭素二重結合を導入することによっ
て製造できる。[Chemical 6] It can be produced by dehydrating a compound represented by the formula (each symbol in the formula has the above meaning) to introduce a carbon-carbon double bond.
【0007】式Vの化合物は、一般式The compound of formula V has the general formula
【化7】 (式中の記号は前記の意味を有する)で表される化合物
を、一般式[Chemical 7] (Wherein the symbols in the formula have the above meanings), a compound represented by the general formula
【化8】 (式中の各記号は前記の意味を有する)で表されるケト
ンまたはアルデヒドと反応させることによって製造でき
る。[Chemical 8] It can be produced by reacting with a ketone or aldehyde represented by the formula (each symbol in the formula has the above meaning).
【0008】この反応を式で示すと次のとおりである。The reaction is represented by the following formula.
【化9】 [Chemical 9]
【0009】化合物(VI)を化合物(VII)と反応させる
と化合物(V)が得られる。本反応は、強塩基を用いて
化合物(VI)のアゾキシ基に結合するメチル基の炭素原
子を活性化したのちに行うことが好ましい。塩基として
は、例えばリチウムジイソプロピルアミド、リチウムヘ
キサメチルジシラジド、ナトリウムヒドリドなどが挙げ
られる。例えば塩基としてリチウムジイソプロピルアミ
ドを用いる場合には、化合物(VI)と、好ましくは新た
に調製した塩基を溶媒中で−70℃〜+50℃で数分間
ないし数時間反応させて化合物(VI)のメチル基の炭素
原子を活性化させ、この反応液に化合物(VII)を化合物
(VI)に対して1〜5モル加え、好ましくは同温度で数
分間ないし数時間反応させる。溶媒としては、例えばメ
タノール、エタノール、イソプロパノール等のアルコー
ル;クロロホルム、塩化メチレン等のハロゲン化炭化水
素;ベンゼン、トルエン、キシレン、シクロヘキサン等
の炭化水素;エーテル、ジオキサン、テトラヒドロフラ
ン等のエーテルなどが挙げられる。The compound (VI) is obtained by reacting the compound (VI) with the compound (VII). This reaction is preferably carried out after activating the carbon atom of the methyl group bonded to the azoxy group of compound (VI) using a strong base. Examples of the base include lithium diisopropylamide, lithium hexamethyldisilazide, sodium hydride and the like. For example, when lithium diisopropylamide is used as the base, the compound (VI) is reacted with the newly prepared base in a solvent at −70 ° C. to + 50 ° C. for several minutes to several hours to react with the methyl of the compound (VI). The carbon atom of the group is activated, and 1 to 5 mol of the compound (VII) is added to the reaction solution, and the reaction is preferably carried out at the same temperature for several minutes to several hours. Examples of the solvent include alcohols such as methanol, ethanol and isopropanol; halogenated hydrocarbons such as chloroform and methylene chloride; hydrocarbons such as benzene, toluene, xylene and cyclohexane; ethers such as ether, dioxane and tetrahydrofuran.
【0010】こうして得られた化合物(V)を脱水する
と、炭素−炭素二重結合が導入されて化合物(III)が得
られる。脱水方法としては、例えば(a)化合物(V)
の水酸基をスルホニル化したのち脱スルホン酸する方
法、(b)化合物(V)の水酸基をハロゲン原子で置き
換えたのち脱ハロゲン化水素する方法などが挙げられ
る。方法(a)におけるスルホニル化としては、メタン
スルホニル化、p−トルエンスルホニル化等が好まし
い。例えばメタンスルホニル化を行うには、メタンスル
ホン酸の反応性誘導体、例えば塩化メタンスルホン酸と
化合物(V)を溶媒中、好ましくは触媒の存在下で、−
20℃〜+100℃で1〜50時間反応させることが好
ましい。When the compound (V) thus obtained is dehydrated, a carbon-carbon double bond is introduced to obtain a compound (III). Examples of the dehydration method include (a) compound (V)
Examples of the method include sulfonylating the hydroxyl group of (1) and then desulfonic acid, and (b) replacing the hydroxyl group of the compound (V) with a halogen atom and then dehydrohalogenating. As the sulfonylation in the method (a), methanesulfonylation, p-toluenesulfonylation and the like are preferable. For example, to perform methanesulfonylation, a reactive derivative of methanesulfonic acid, such as methanesulfonic acid chloride and compound (V), in a solvent, preferably in the presence of a catalyst,
The reaction is preferably performed at 20 ° C to + 100 ° C for 1 to 50 hours.
【0011】触媒としては、塩基性触媒例えば、ピリジ
ン、トリエチルアミン、ナトリウムヒドリドなどが好ま
しい。溶媒としては前記のものを使用することができる
が、前記の触媒を過剰に用いて溶媒とすることもでき
る。得られたスルホニル化合物は常法によって処理した
のち、精製することなく次の脱スルホン酸反応を行うこ
とが工業的に有利である。脱スルホン酸反応は、スルホ
ニル化合物と脱水剤とを溶媒中で−20℃〜+100℃
で1〜50時間反応させることによって行うことが好ま
しい。脱水剤としては、1,8−ジアザビシクロ〔5.
4.0〕−7−ウンデセン、トリエチルアミン、ピリジ
ンなどが挙げられる。溶媒としては前記のものを使用で
きる。As the catalyst, basic catalysts such as pyridine, triethylamine and sodium hydride are preferable. Although the above-mentioned solvent can be used as the solvent, it is also possible to use the above-mentioned catalyst in excess as the solvent. It is industrially advantageous to treat the obtained sulfonyl compound by the conventional method and then to carry out the subsequent desulfonic acid reaction without purification. For the desulfonic acid reaction, a sulfonyl compound and a dehydrating agent are used in a solvent at −20 ° C. to + 100 ° C.
It is preferable to carry out the reaction for 1 to 50 hours. As the dehydrating agent, 1,8-diazabicyclo [5.
4.0] -7-undecene, triethylamine, pyridine and the like. As the solvent, those mentioned above can be used.
【0012】方法(b)におけるハロゲン原子として
は、塩素、臭素、沃素などが用いられ、塩素が特に好ま
しい。ハロゲン化剤としては、ハロゲン化チオニル、オ
キシハロゲン化リンなどが挙げられる。反応は化合物
(V)とハロゲン化剤とを好ましくは触媒の存在下に、
溶媒中で−20℃〜+50℃で数分間ないし数時間行う
ことが好ましい。得られるハロゲン化合物は、常法によ
って処理したのち、精製することなく次の脱ハロゲン化
水素反応を行うことが工業的に有利である。脱ハロゲン
化水素反応は、得られるハロゲン化合物と脱水剤とを溶
媒中で−20℃〜+100℃で1〜50時間反応させる
ことによって行うことが好ましい。脱水剤及び溶媒とし
ては前記のものを使用できる。As the halogen atom in the method (b), chlorine, bromine, iodine and the like are used, and chlorine is particularly preferable. Examples of the halogenating agent include thionyl halide and phosphorus oxyhalide. In the reaction, compound (V) and a halogenating agent are preferably added in the presence of a catalyst,
It is preferable to carry out in a solvent at −20 ° C. to + 50 ° C. for several minutes to several hours. It is industrially advantageous to treat the resulting halogen compound by a conventional method and then carry out the subsequent dehydrohalogenation reaction without purification. The dehydrohalogenation reaction is preferably carried out by reacting the obtained halogen compound and a dehydrating agent in a solvent at -20 ° C to + 100 ° C for 1 to 50 hours. The above-mentioned can be used as the dehydrating agent and the solvent.
【0013】こうして得られた化合物(III)に酸を作用
させることによって目的化合物(II)がえられる。酸と
しては、例えば塩酸、硫酸等の無機酸;酢酸、p−トル
エンスルホン酸等の有機酸;塩化第二鉄−シリカゲル等
のルイス酸;アンバ−リスト15等の陽イオン交換樹脂
などが挙げられる。反応化合物(III)と酸とを溶媒中で
−20℃〜+100℃で数分間ないし数時間反応させる
ことによって行うことが好ましい。溶媒としては前記の
ものの他、アセトン、テトラヒドロフランなども使用で
きる。By reacting the compound (III) thus obtained with an acid, the target compound (II) can be obtained. Examples of the acid include inorganic acids such as hydrochloric acid and sulfuric acid; organic acids such as acetic acid and p-toluenesulfonic acid; Lewis acids such as ferric chloride-silica gel; cation exchange resins such as Amberlyst 15. .. It is preferable to carry out the reaction by reacting the reaction compound (III) with an acid in a solvent at −20 ° C. to + 100 ° C. for several minutes to several hours. Besides the above-mentioned solvents, acetone, tetrahydrofuran, etc. can be used as the solvent.
【0014】こうして得られた化合物(II)に化合物
(IV)又はその塩を作用させると目的化合物(I)が得
られる。この反応は、通常、適当な溶媒中で且つ適宜塩
基の存在下に、約−10℃ないし溶媒の還流温度、好ま
しくは約5℃ないし約100℃の温度において行うこと
ができる。ここで使用しうる溶媒としては、例えば、メ
タノール、エタノール、イソプロパノール等のアルコー
ル;クロロホルム、塩化メチレン等のハロゲン化炭化水
素;ベンゼン、トルエン、キシレン、シクロヘキサン等
の炭化水素;エーテル、ジオキサン、テトラヒドロフラ
ン等のエーテルなどが挙げられる。When the compound (II) thus obtained is reacted with the compound (IV) or a salt thereof, the target compound (I) is obtained. This reaction can usually be carried out in a suitable solvent and in the presence of a base, at a temperature of about -10 ° C to the reflux temperature of the solvent, preferably about 5 ° C to about 100 ° C. Examples of the solvent that can be used here include alcohols such as methanol, ethanol and isopropanol; halogenated hydrocarbons such as chloroform and methylene chloride; hydrocarbons such as benzene, toluene, xylene and cyclohexane; ethers, dioxane, tetrahydrofuran and the like. Examples include ether.
【0015】また、必要に応じて使用しうる塩基として
は、例えば、水酸化ナトリウム、水酸化カリウム、炭酸
ナトリウム、炭酸カリウム等の無機塩基;トリエチルア
ミン、ピリジン、4−メチルアミノピリジン等の有機塩
基などが挙げられる。これらの塩基は一般に、化合物
(II)1モル当り0.1〜100当量、特に1〜10当
量の範囲内で使用することができる。この反応の原料で
ある化合物(II)は、前工程終了後に精製することなく
本反応に用いることができる。式中のR1 もしくはR2
又はそれらの置換基が基−A−CH2 −C≡C−Xであ
る化合物を製造する場合には、前記の何れの工程でもハ
ロゲン化を行うことができるが、脱水工程〔V→III 〕
を終了した段階で沃素化することが特に好ましい。Examples of the base that can be used as necessary include inorganic bases such as sodium hydroxide, potassium hydroxide, sodium carbonate and potassium carbonate; organic bases such as triethylamine, pyridine and 4-methylaminopyridine. Is mentioned. These bases can be used generally in the range of 0.1 to 100 equivalents, particularly 1 to 10 equivalents per mol of the compound (II). The compound (II), which is the starting material for this reaction, can be used in this reaction without purification after the completion of the previous step. R 1 or R 2 in the formula
Alternatively, in the case of producing a compound in which those substituents are the group —A—CH 2 —C≡C—X, halogenation can be carried out in any of the above steps, but the dehydration step [V → III]
It is particularly preferable that the iodination is carried out at the stage of completing the above.
【0016】目的化合物の精製は通常の方法で行うこと
ができるが、カラムクロマトグラフィー法、再結晶法、
凍結乾燥法などが好ましい。原料化合物(VI)は、例え
ば、アラニンをクロル蟻酸エチルを用いてエチルカルバ
メートとしたのち、メチルリチウムを用いてアルキル化
を行ってケトンとし、このケトンをケタールで保護した
のち、Mossらの方法〔J. Org .Chem. 31(1966)
1082〕に従ってニトロソ化して次式The target compound can be purified by a usual method, but it may be purified by column chromatography, recrystallization,
A freeze-drying method or the like is preferable. The starting compound (VI) is, for example, alanine converted into ethyl carbamate using ethyl chloroformate, alkylated with methyllithium to give a ketone, and the ketone is protected with a ketal, followed by the method of Moss et al. J. Org. Chem. 31 (1966)
1082] and nitrosated according to the following formula
【化10】 (式中nは前記の意味を有する)で表される化合物を得
たのち、カリウムt−ブチラートを反応させてジアゾテ
ートを製造し、このものに一般式 CH3 −Y (式中Yはハロゲン原子を示す)で表される化合物を反
応させることによって製造できる。[Chemical 10] After obtaining a compound represented by the formula (n has the above meaning), potassium t-butyrate is reacted to produce diazotate, and this compound is represented by the general formula CH 3 —Y (wherein Y is a halogen atom). The compound represented by 1) is reacted.
【0017】本発明の化合物(I)は優れた抗真菌活性
を有しており、例えば、カンジタ、クリプトコッカス、
アスペルギルス、トリコフィトンなどのヒトを含む温血
動物に感染性の真菌類;ピリキュリア、ポッリティス、
サッカロミセス、セプトリアなどの農園芸作物や果樹な
どに感染性の真菌類に対して優れた抗菌活性を発揮す
る。The compound (I) of the present invention has excellent antifungal activity. For example, candita, cryptococcus,
Fungi infecting warm-blooded animals including humans such as Aspergillus and Trichophyton; Pyricularia, Poritis,
It exhibits excellent antibacterial activity against fungi that are infectious to agricultural and horticultural crops such as Saccharomyces and Septoria and fruit trees.
【0018】後記の実施例で製造される本発明化合物
(I)の代表的真菌に対する最小阻止濃度(μg/m
l)の測定結果を表1〜3に示す。最小阻止濃度はサブ
ローデキストロース培地を用い、寒天平板希釈法によっ
て求めた。The minimum inhibitory concentration (μg / m) of the compound (I) of the present invention produced in the examples described below against typical fungi
The measurement results of l) are shown in Tables 1 to 3. The minimum inhibitory concentration was determined by the agar plate dilution method using Sabouraud dextrose medium.
【0019】[0019]
【表1】 [Table 1]
【表2】 [Table 2]
【表3】 * C.a.: カンジダ・アルビカンス T.m.: トリコフィートン・メンタグロファイテス T.r.: トリコフィートン・ルブラム[Table 3] * C. a. : Candida albicans T. m. : Trichofton Mentaglofites T. r. : Trichofton Rubram
【0020】前記のように本発明の化合物は、ヒトを含
む温血動物に感染性の真菌類、農園芸作物や果樹に感染
性の真菌類に対して優れた抗菌活性を有しており、医
薬、獣医薬用及び農園芸用の抗真菌剤として有用であ
る。As described above, the compounds of the present invention have excellent antibacterial activity against fungi infecting warm-blooded animals including humans, fungi infecting agricultural and horticultural crops and fruit trees, It is useful as an antifungal agent for medicine, veterinary medicine, and agriculture and horticulture.
【0021】本発明の化合物を抗真菌剤として用いる場
合には、それぞれの用途に適した形態に製剤化して用い
ることができる。例えば、本発明の化合物を医薬又は獣
医薬(動物薬)として用いる場合には、本発明の化合物
又はその塩に賦形剤、結合剤、崩壊剤、被覆剤、乳化
剤、懸濁化剤、溶剤、安定化剤、吸収助剤、軟膏基剤等
の補助剤を適宜添加し、常法により経口投与用、注射投
与用、直腸内投与用、外用などの剤形に製剤化すること
ができる。When the compound of the present invention is used as an antifungal agent, it can be used by formulating it into a form suitable for each use. For example, when the compound of the present invention is used as a medicine or veterinary medicine (animal drug), an excipient, a binder, a disintegrating agent, a coating agent, an emulsifying agent, a suspending agent, a solvent is added to the compound of the present invention or a salt thereof. , A stabilizer, an absorption aid, an ointment base and the like can be appropriately added, and the drug can be formulated into a dosage form for oral administration, injection administration, rectal administration, external use and the like by a conventional method.
【0022】経口投与用の製剤としては、顆粒、錠剤、
糖衣錠、カプセル剤、丸剤、液剤、乳剤、懸濁剤等、注
射投与用の製剤としては静脈内注射、筋肉内注射、皮下
注射、点滴注射用の製剤等、直腸内投与用の製剤として
は坐薬、軟カプセル等が挙げられる。外用剤としては、
軟膏剤、ローション剤、リニメント剤、クリーム等が好
ましい。その他、点眼薬、点耳液等の剤形にすることも
できる。Preparations for oral administration include granules, tablets,
Dragees, capsules, pills, liquids, emulsions, suspensions, etc., such as injection preparations for intravenous injection, intramuscular injection, subcutaneous injection, drip injection, etc., for rectal preparations Examples include suppositories and soft capsules. As an external preparation,
Ointments, lotions, liniments, creams and the like are preferable. In addition, it may be in the form of eye drops, ear drops or the like.
【0023】農園芸用の抗真菌剤として用いる場合は、
常法に従い液剤、乳濁剤、顆粒剤、粉剤、ダスト剤、ペ
ースト剤等の剤形にすることができる。本発明の化合物
をヒトを含む温血動物に投与する場合の投与量は、投与
すべき動物の種類、症状の軽重、体重、性別、措置する
医師の判断等に応じて広い範囲に亘って変えることがで
きるが、通常は1日当り約0.1〜約500mg/kg
体重であり、1日1回又は数回に分けて投与することが
できる。また、農園芸用に使用する場合、本発明の化合
物は土壌処理用、茎葉処理用などとして、真菌類の生息
区域に施用することができ、その施用量は通常約0.0
05〜約5kg/haである。When used as an antifungal agent for agriculture and horticulture,
According to a conventional method, a liquid preparation, an emulsion preparation, a granule preparation, a powder preparation, a dust preparation, a paste preparation and the like can be prepared. When the compound of the present invention is administered to warm-blooded animals including humans, the dose varies over a wide range depending on the type of animal to be administered, the severity of symptoms, body weight, sex, judgment of the doctor to take measures, etc. Usually, about 0.1 to about 500 mg / kg per day
It is the body weight and can be administered once or divided into several times a day. When used for agricultural and horticultural use, the compound of the present invention can be applied to a fungal habitat for soil treatment, foliage treatment, etc., and its application amount is usually about 0.0
05 to about 5 kg / ha.
【0024】参考例 3−(メチル−ONN−アゾキシ)−2,2−プロピレ
ンジオキシブタン〔化合物(VI)〕の製造: (a)L−アラニン45g及び炭酸ナトリウム127g
を水400mlに溶解し、氷冷下にクロル蟻酸エチル6
4mlを滴下したのち、室温で30分間攪拌した。反応
液に35%塩酸を加えて酸性にし、ダイヤイオンHP−
20のカラム(6.5×60cm)に吸着させ、水洗後
70%メタノールで溶出した。溶出液を減圧下に濃縮
し、油状物として、N−エトキシカルボニルアラニン6
9g(収率96%)を得た。Reference Example Production of 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane [compound (VI)]: (a) L-alanine 45 g and sodium carbonate 127 g
Is dissolved in 400 ml of water, and ethyl chloroformate 6 is added under ice cooling.
After dropping 4 ml, the mixture was stirred at room temperature for 30 minutes. 35% hydrochloric acid was added to the reaction solution to acidify it, and DIAION HP-
It was adsorbed on 20 columns (6.5 × 60 cm), washed with water and eluted with 70% methanol. The eluate was concentrated under reduced pressure to give N-ethoxycarbonylalanine 6 as an oil.
9 g (yield 96%) was obtained.
【0025】1H−NMR値:δ CDCl3 ,ppm 1.26(3H,t,J=7Hz)、1.46(3H,
d,J=7Hz)、4.15(2H,q,J=7H
z)、4.40(1H,m)、5.28(1H,br,
d,J=7Hz)、7.35(1H,br.s)、IR
値:νmax,cm-1 1719,1697 1 H-NMR value: δ CDCl 3 , ppm 1.26 (3H, t, J = 7 Hz), 1.46 (3H,
d, J = 7 Hz), 4.15 (2H, q, J = 7H)
z), 4.40 (1H, m), 5.28 (1H, br,
d, J = 7 Hz), 7.35 (1H, br.s), IR
Value: νmax, cm -1 1719, 1697
【0026】(b)前記(a)で得られたN−エトキシ
カルボニルアラニン3gを窒素雰囲気下にテトラヒドロ
フラン60mlに溶解し、−78℃で激しく攪拌しなが
ら1.19Nメチルリチウムエーテル溶液48mlを3
0分間で加えた。更に同温度で40分間攪拌したのち、
室温で1時間攪拌した。反応液を冷10%リン酸水に注
加し、酢酸エチルで抽出した。抽出液を飽和炭酸水素ナ
トリウム水溶液、次いで水で洗浄したのち乾燥し、減圧
下で濃縮した。残渣をシリカゲルカラムクロマトグラフ
ィー〔溶媒:クロロホルム−n−ヘキサン(5:1)で
精製して、3−エトキシカルボニルアミノ−2−オクソ
ブタン1.8g(収率60%)を得た。(B) 3 g of N-ethoxycarbonylalanine obtained in (a) above was dissolved in 60 ml of tetrahydrofuran under a nitrogen atmosphere, and 3 ml of 48 ml of 1.19N methyllithium ether solution was stirred with vigorous stirring at -78 ° C.
Added in 0 minutes. After stirring for 40 minutes at the same temperature,
The mixture was stirred at room temperature for 1 hour. The reaction solution was poured into cold 10% aqueous phosphoric acid and extracted with ethyl acetate. The extract was washed with saturated aqueous sodium hydrogen carbonate solution and then with water, dried, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography [solvent: chloroform-n-hexane (5: 1) to obtain 1.8 g of 3-ethoxycarbonylamino-2-oxobutane (yield 60%).
【0027】1H−NMR値:δ CDCl3 ,ppm 1.24(3H,t,J=7.0Hz)、1.38(3
H,d,J=7.0Hz)、2.20(3H,s)、
4.12(2H,q,J=7.0Hz)、4.37(1
H,br.d,J=7.0Hz)、4.44(1H,b
r.s)、IR値:νmax,CHCl3 ,cm-1 1706,1500 1 H-NMR value: δ CDCl 3 , ppm 1.24 (3 H, t, J = 7.0 Hz), 1.38 (3
H, d, J = 7.0 Hz), 2.20 (3 H, s),
4.12 (2H, q, J = 7.0Hz), 4.37 (1
H, br. d, J = 7.0 Hz), 4.44 (1H, b
r. s), IR value: νmax, CHCl 3 , cm -1 1706, 1500
【0028】(c)前記(b)で得られたケトン体6.
34g及びp−トルエンスルホン酸のピリジン塩500
mgをベンゼン280mlに溶解し、1,3−プロパン
ジオール22mlを加え、4時間加熱還流した。反応液
を放冷したのち、飽和炭酸水素ナトリウム水溶液を加え
て有機層を分取し、水層をベンゼンで抽出した。有機層
を合わせて減圧下に濃縮し、残渣をシリカゲルカラムク
ロマトグラフィー〔溶媒:エーテル−n−ヘキサン
(1:3)で精製して、3−エトキシカルボニルアミノ
−2,2−プロピレンオキシブタン8.25g(収率9
5%)を得た。(C) Ketone body obtained in (b) above.
34 g and pyridine salt of p-toluenesulfonic acid 500
mg was dissolved in 280 ml of benzene, 22 ml of 1,3-propanediol was added, and the mixture was heated under reflux for 4 hours. The reaction solution was allowed to cool, saturated aqueous sodium hydrogen carbonate solution was added, the organic layer was separated, and the aqueous layer was extracted with benzene. The organic layers were combined and concentrated under reduced pressure, and the residue was purified by silica gel column chromatography [solvent: ether-n-hexane (1: 3) to give 3-ethoxycarbonylamino-2,2-propyleneoxybutane 8. 25 g (yield 9
5%) was obtained.
【0029】1H−NMR値:δ CDCl3 ,ppm 1.17(3H,d,J=7.0Hz)、1.24(3
H,t,J=7.0Hz)、1.37〜1.50(1
H,m)、1.42(3H,s)、1.80〜2.02
(1H,m)、3.76〜4.06(5H,m)、4.
11(2H,q,J=7.0Hz)、4.90(1H,
br.s)、IR値:νmax,CHCl3 ,cm-1 1701,1507 1 H-NMR value: δ CDCl 3 , ppm 1.17 (3 H, d, J = 7.0 Hz), 1.24 (3
H, t, J = 7.0 Hz), 1.37 to 1.50 (1
H, m), 1.42 (3H, s), 1.80 to 2.02
(1H, m), 3.76 to 4.06 (5H, m), 4.
11 (2H, q, J = 7.0Hz), 4.90 (1H,
br. s), IR value: νmax, CHCl 3 , cm −1 1701,1507
【0030】(d)前記(c)で得られた化合物4.4
9gを窒素雰囲気下に無水エーテル30mlに溶解し、
炭酸水素ナトリウム8.7gを加え、この溶液を−25
℃に冷却し、四酸化二窒素3.3mlの無水エーテル溶
液9.6mlを滴下し、同温度で3.5時間攪拌した。
反応液を冷飽和炭酸水素ナトリウム水溶液に注加し、冷
エーテルで抽出した。エーテル層を乾燥し、減圧下30
℃以下で濃縮したのち、共沸で水を除去した。カリウム
t−ブトキシド4.64gをジメチルホルムアミド20
mlに懸濁させ、窒素雰囲気下が−30℃に冷却した。
これに、先に調製したN−ニトロソ化合物のジメチルホ
ルムアミド溶液6mlを滴下し、−30℃で2.5時間
攪拌した。(D) Compound 4.4 obtained in the above (c)
9 g was dissolved in 30 ml of anhydrous ether under a nitrogen atmosphere,
8.7 g of sodium hydrogen carbonate was added, and the solution was -25
The mixture was cooled to ° C, 9.6 ml of anhydrous ether solution of 3.3 ml of dinitrogen tetraoxide was added dropwise, and the mixture was stirred at the same temperature for 3.5 hours.
The reaction mixture was poured into cold saturated aqueous sodium hydrogen carbonate solution and extracted with cold ether. The ether layer is dried and dried under reduced pressure 30
After concentrating at ℃ or less, water was removed azeotropically. 4.64 g of potassium t-butoxide was added to dimethylformamide 20.
It was suspended in ml and cooled to -30 ° C under a nitrogen atmosphere.
6 ml of the dimethylformamide solution of the N-nitroso compound prepared above was added dropwise thereto, and the mixture was stirred at -30 ° C for 2.5 hours.
【0031】この反応液に沃化メチル6.44mlを滴
下し、室温で一夜攪拌した。反応液を氷水に注加して酢
酸エチルで抽出し、有機層を乾燥後、減圧下に濃縮し
た。残渣をシリカゲルカラムクロマトグラフィー〔溶
媒:酢酸エチル−n−ヘキサン(1:3)で精製した。
得られた残渣をピリジン3mlに溶解し、無水酢酸1.
5mlを加えて室温で1時間攪拌した。反応液を水に注
加して酢酸エチルで抽出し、有機層を飽和炭酸水素ナト
リウムで乾燥したのち減圧下で濃縮した。残渣をシリカ
ゲルカラムクロマトグラフィー〔溶媒:酢酸エチル−n
−ヘキサン(1:3)で精製して目的物1.49g(収
率38%)を得た。Methyl iodide (6.44 ml) was added dropwise to this reaction solution, and the mixture was stirred overnight at room temperature. The reaction solution was poured into ice water and extracted with ethyl acetate. The organic layer was dried and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography [solvent: ethyl acetate-n-hexane (1: 3).
The obtained residue was dissolved in 3 ml of pyridine, and acetic anhydride 1.
5 ml was added and the mixture was stirred at room temperature for 1 hour. The reaction mixture was poured into water and extracted with ethyl acetate, the organic layer was dried over saturated sodium hydrogen carbonate and then concentrated under reduced pressure. The residue was subjected to silica gel column chromatography [solvent: ethyl acetate-n
The product was purified with -hexane (1: 3) to obtain 1.49 g of the desired product (yield 38%).
【0032】1H−NMR値:δ CDCl3 ,ppm 1.13(3H,d,J=7.0Hz)、1.45(3
H,s)、1.59〜1.92(2H,m)、3.85
(4H,m)、4.10(3H,s)、4.49(1
H,q,J=7Hz)、IR値:νmax,CHC
l3 ,cm-1 1503,1424,1370,1330 1 H-NMR value: δ CDCl 3 , ppm 1.13 (3 H, d, J = 7.0 Hz), 1.45 (3
H, s), 1.59 to 1.92 (2H, m), 3.85
(4H, m), 4.10 (3H, s), 4.49 (1
H, q, J = 7 Hz), IR value: νmax, CHC
l 3 , cm -1 1503, 1424, 1370, 1330
【0033】実施例1 2−ヒドロキシイミノ−3−〔2−(4−(3−ヨード
プロパルギル)オキシフェニル)−1−プロペニル−O
NN−アゾキシ〕−ブタン〔化合物(I):R1 =4−
(3−ヨードプロパルギル)オキシフエニル基、R2 =
メチル基、R3 =水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)249
mgを窒素雰囲気下にテトラヒドロフラン3mlに溶解
した。この溶液に氷冷下、リチウムジイソプロピルアミ
ド1.7mmolのシクロヘキサン溶液1.15mlを
加えて30分間攪拌した。この溶液に4−プロパルギル
オキシアセトフェノン358mgのテトラヒドロフラン
4ml溶液を加え、更に氷冷下で30分間攪拌した。Example 1 2-Hydroxyimino-3- [2- (4- (3-iodopropargyl) oxyphenyl) -1-propenyl-O
NN-azoxy] -butane [Compound (I): R 1 = 4-
(3-iodopropargyl) oxyphenyl group, R 2 =
Methyl group, R 3 = hydrogen atom]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) 249 obtained in Reference Example
mg was dissolved in 3 ml of tetrahydrofuran under a nitrogen atmosphere. Under ice-cooling, 1.15 ml of a cyclohexane solution of 1.7 mmol of lithium diisopropylamide was added and stirred for 30 minutes. To this solution was added a solution of 358 mg of 4-propargyloxyacetophenone in 4 ml of tetrahydrofuran, and the mixture was further stirred under ice cooling for 30 minutes.
【0034】氷冷下、反応混合物に10%塩化アンモニ
ウム水溶液5mlを加えて5分間攪拌したのち、エーテ
ル50mlで抽出した。抽出液を飽和食塩水で洗浄後、
乾燥して減圧下で濃縮した。得られた油状物650mg
をシリカゲルカラムクロマトグラフィー(溶出液:50
%エーテルヘキサン溶液)で精製して、3−〔2−ヒド
ロキシ−2−(4−プロパルギルオキシフェニル)プロ
ピル−ONN−アゾキシ〕−2,2−プロピレンジオキ
シブタン(V) のジアステレオマー混合物(1:1)を
無色油状物として242mg(収率:51%)を得た。Under ice-cooling, 5 ml of 10% aqueous ammonium chloride solution was added to the reaction mixture, the mixture was stirred for 5 minutes, and then extracted with 50 ml of ether. After washing the extract with saturated saline,
It was dried and concentrated under reduced pressure. 650 mg of the obtained oily substance
Silica gel column chromatography (eluent: 50
% (Hexane solution in ether)) and a diastereomeric mixture of 3- [2-hydroxy-2- (4-propargyloxyphenyl) propyl-ONN-azoxy] -2,2-propylenedioxybutane (V) ( 242 mg (yield: 51%) of 1: 1) was obtained as a colorless oil.
【0035】ジアステレオマー(a)1 H−NMR値:δ CDCl3 ,ppm 7.42(2H,d,J=9Hz)、6.95(2H,
d,J=9Hz)、5.24(1H,br,s)、4.
67(2H,d,J=2Hz)、4.51(1H,d,
J=12Hz)、4.39(1H,d,J=12H
z)、4.35(1H,q,J=7Hz)、3.70〜
3.97(4H,m)、2.51(1H,t,J=2H
z)、1.71〜1.87(1H,m)、1.54(3
H,s)、1.46〜1.59(1H,m)、1.26
(3H,s)、1.07(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3430(br),3290,1505,1225(b
r)Diastereomer (a) 1 H-NMR value: δ CDCl 3 , ppm 7.42 (2H, d, J = 9 Hz), 6.95 (2H,
d, J = 9 Hz), 5.24 (1H, br, s), 4.
67 (2H, d, J = 2Hz), 4.51 (1H, d,
J = 12 Hz), 4.39 (1H, d, J = 12H)
z), 4.35 (1H, q, J = 7 Hz), 3.70-
3.97 (4H, m), 2.51 (1H, t, J = 2H
z), 1.71-1.87 (1H, m), 1.54 (3
H, s), 1.46 to 1.59 (1H, m), 1.26
(3H, s), 1.07 (3H, d, J = 7Hz) IR value: νmax, CHCl 3 , cm -1 3430 (br), 3290, 1505, 1225 (b
r)
【0036】ジアステレオマー(b)1 H−NMR値:δ CDCl3 ,ppm 7.40(2H,d,J=9Hz)、6.93(2H,
d,J=9Hz)、5.24(1H,br,s)、4.
67(2H,d,J=2Hz)、4.57(1H,d,
J=12Hz)、4.43(1H,q,J=7Hz)、
4.40(1H,d,J=12Hz)、3.77〜3.
98(4H,m)、2.50(1H,t,J=2H
z)、1.66〜1.84(1H,m)、1.55〜
1.66(1H,m)、1.54(3H,s)、1.3
6(3H,s)、0.74(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3420(br),3290,1505,1225(b
r)Diastereomer (b) 1 H-NMR value: δ CDCl 3 , ppm 7.40 (2H, d, J = 9 Hz), 6.93 (2H,
d, J = 9 Hz), 5.24 (1H, br, s), 4.
67 (2H, d, J = 2Hz), 4.57 (1H, d,
J = 12 Hz), 4.43 (1H, q, J = 7 Hz),
4.40 (1H, d, J = 12 Hz), 3.77-3.
98 (4H, m), 2.50 (1H, t, J = 2H
z), 1.66 to 1.84 (1H, m), 1.55
1.66 (1H, m), 1.54 (3H, s), 1.3
6 (3H, s), 0.74 (3H, d, J = 7Hz) IR value: νmax, CHCl 3 , cm -1 3420 (br), 3290, 1505, 1225 (b
r)
【0037】(2)前記(1)で得られたヒドロキシ化
合物(V) 155mgをピリジン0.4mlに溶解し、
氷冷下に塩化チオニル0.05mlを加え15分間攪拌
した。次いで1,8−ジアザビシクロ〔5.4.0〕−
7−ウンデセン0.6mlを加え、更に氷冷下に1.5
時間攪拌した。反応液にエーテル50ml及び1N塩酸
5mlを加え、エーテル層を分取し、これを飽和食塩水
5ml、飽和炭酸水素ナトリウム水溶液5ml、次いで
飽和食塩水5mlで順次洗浄したのち、乾燥して減圧下
に濃縮した。得られた油状物170mgをシリカゲルカ
ラムクロマトグラフィー(溶媒:ベンゼン)で精製して
3−〔2−(4−プロパルギルオキシフェニル)−1−
プロペニル−ONN−アゾキシ〕−2,2−プロピレン
ジオキシブタン(III ′)を無色油状物として150m
g(収率:71%)得た。(2) 155 mg of the hydroxy compound (V) obtained in (1) above was dissolved in 0.4 ml of pyridine,
Under ice-cooling, 0.05 ml of thionyl chloride was added and stirred for 15 minutes. Then 1,8-diazabicyclo [5.4.0]-
0.6 ml of 7-undecene was added, and the mixture was further cooled to 1.5 on ice.
Stir for hours. 50 ml of ether and 5 ml of 1N hydrochloric acid were added to the reaction solution, and the ether layer was separated and washed successively with 5 ml of saturated saline solution, 5 ml of saturated aqueous sodium hydrogencarbonate solution and then 5 ml of saturated saline solution, dried and concentrated under reduced pressure. Concentrated. 170 mg of the obtained oily substance was purified by silica gel column chromatography (solvent: benzene) to give 3- [2- (4-propargyloxyphenyl) -1-.
150 m of propenyl-ONN-azoxy] -2,2-propylenedioxybutane (III ') as colorless oil
g (yield: 71%) was obtained.
【0038】1H−NMR値:δ CDCl3 ,ppm 7.33(2H,d,J=9Hz)、7.19(1H,
q,J=1Hz)、6.91(2H,d,J=9H
z)、4.66(1H,q,J=7Hz)、4.65
(2H,d,J=2Hz)、3.86〜3.93(4
H,m)、2.47(1H,t,J=2Hz)、2.3
8(3H,d,J=1Hz)、1.67〜1.81(1
H,m)、1.52〜1.64(1H,m)、1.43
(3H,s)、1.15(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3290,1505,1225(br) 1 H-NMR value: δ CDCl 3 , ppm 7.33 (2H, d, J = 9 Hz), 7.19 (1H,
q, J = 1 Hz), 6.91 (2H, d, J = 9H
z), 4.66 (1H, q, J = 7Hz), 4.65
(2H, d, J = 2Hz), 3.86 to 3.93 (4
H, m), 2.47 (1H, t, J = 2Hz), 2.3
8 (3H, d, J = 1 Hz), 1.67 to 1.81 (1
H, m), 1.52 to 1.64 (1H, m), 1.43
(3H, s), 1.15 (3H, d, J = 7Hz) IR value: νmax, CHCl 3 , cm -1 3290, 1505, 1225 (br)
【0039】(3)前記(2)で得られたプロパルギ化
合物(III ′)63mgをメタノール1.5mlに溶解
し、氷冷下10M水酸化ナトリウム水溶液0.07ml
及び沃素100mgを加え、反応化合物が均一になった
のち、室温で15分間攪拌した。反応混合物にエーテル
50ml及び1Mチオ硫酸ナトリウム水溶液5mlを加
え、エーテル層を分取し、これを飽和食塩水5mlで洗
浄して乾燥したのち減圧下で濃縮した。得られた油状物
83mgをシリカゲル分取薄膜クロマトグラフィー〔溶
媒:酢酸エチル−ベンゼン(1:5)〕で分離精製し
て、3−〔2−(4−(3−ヨードプロパルギル)オキ
シフェニル)−1−プロペニル−ONN−アゾキシ〕−
2,2−プロピレンジオキシブタン(III)を無色油状物
として85mg(収率99%)を得た。(3) 63 mg of the propargy compound (III ') obtained in the above (2) was dissolved in 1.5 ml of methanol, and 0.07 ml of 10M aqueous sodium hydroxide solution was cooled with ice.
And 100 mg of iodine were added, and after the reaction compound became uniform, the mixture was stirred at room temperature for 15 minutes. To the reaction mixture, 50 ml of ether and 5 ml of 1M sodium thiosulfate aqueous solution were added, the ether layer was separated, washed with 5 ml of saturated saline solution, dried and then concentrated under reduced pressure. 83 mg of the obtained oily substance was separated and purified by silica gel preparative thin film chromatography [solvent: ethyl acetate-benzene (1: 5)] to give 3- [2- (4- (3-iodopropargyl) oxyphenyl)-. 1-propenyl-ONN-azoxy]-
85 mg (yield 99%) of 2,2-propylenedioxybutane (III) was obtained as a colorless oily substance.
【0040】1H−NMR値:δ CDCl3 ,ppm 7.39(2H,d,J=9Hz)、7.12(1H,
q,J=1Hz)、6.96(2H,d,J=9H
z)、4.85(2H,s)、4.73(1H,q,J
=7Hz)、3.93〜3.99(4H,m)、2.4
5(3H,d,J=1Hz)、1.50(3H,s)、
1.22(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 1505,1225(br) 1 H-NMR value: δ CDCl 3 , ppm 7.39 (2H, d, J = 9 Hz), 7.12 (1H,
q, J = 1 Hz), 6.96 (2H, d, J = 9H)
z), 4.85 (2H, s), 4.73 (1H, q, J
= 7 Hz), 3.93 to 3.99 (4H, m), 2.4
5 (3H, d, J = 1 Hz), 1.50 (3H, s),
1.22 (3H, d, J = 7Hz) IR value: νmax, CHCl 3 , cm -1 1505, 1225 (br)
【0041】(4)前記(3)で得られたプロピレンジ
オキシ化合物(III)61mgをアセトン0.5mlに溶
解し、塩化鉄−シリカゲル(11重量%)115mgを
加えて室温で2時間攪拌した。反応混合物に四塩化炭素
10mlを加えたのち、セライトを用いて吸引ろ過し、
ろ液を減圧下に濃縮した。得られた油状物をシリカゲル
カラムクロマトグラフィー〔溶媒:エーテル−ヘキサン
(1:1)〕で精製して、3−〔2−(4−3−ヨード
プロパルギル)オキシフェニル)−1−プロペニル−O
NN−アゾキシ〕−2−オクソブタン(II) を無色油状
物として43mg(収率79%)を得た。(4) 61 mg of the propylenedioxy compound (III) obtained in (3) above was dissolved in 0.5 ml of acetone, 115 mg of iron chloride-silica gel (11% by weight) was added, and the mixture was stirred at room temperature for 2 hours. .. After adding 10 ml of carbon tetrachloride to the reaction mixture, suction filtration was performed using Celite,
The filtrate was concentrated under reduced pressure. The obtained oily substance was purified by silica gel column chromatography [solvent: ether-hexane (1: 1)] to give 3- [2- (4-3-iodopropargyl) oxyphenyl) -1-propenyl-O.
43 mg (yield 79%) of NN-azoxy] -2-oxobutane (II) was obtained as a colorless oily substance.
【0042】1H−NMR値:δ CDCl3 ,ppm 7.41(2H,d,J=9Hz)、7.19(1H,
q,J=1Hz)、6.98(2H,d,J=9H
z)、4.86(2H,s)、4.62(1H,q,J
=7Hz)、2.50(3H,d,J=1Hz)、2.
23(3H,s)、1.51(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 1715,1505,1220 〔α〕D 23 −21°(C 2.9,クロロホルム) 1 H-NMR value: δ CDCl 3 , ppm 7.41 (2H, d, J = 9 Hz), 7.19 (1H,
q, J = 1 Hz), 6.98 (2H, d, J = 9H
z), 4.86 (2H, s), 4.62 (1H, q, J
= 7 Hz), 2.50 (3H, d, J = 1 Hz), 2.
23 (3H, s), 1.51 (3H, d, J = 7Hz) IR value: νmax, CHCl 3 , cm −1 1715, 1505, 1220 [α] D 23 −21 ° (C 2.9, chloroform). )
【0043】(5)前記(4)で得られたオクソ化合物
(II) 33.2mgをメタノール0.3mlに溶解し、
ヒドロキシルアミン塩酸塩11.1mg及びピリジン
0.02mlを加えて室温で10分間攪拌した。反応混
合物にエーテル25ml及び水5mlを加え、エーテル
層を分取し、これを飽和食塩水で洗浄したのち乾燥して
減圧下に濃縮した。得られた油状物37mgをシリカゲ
ル分取薄膜クロマトグラフィー〔溶媒:酢酸エチル−ベ
ンゼン(1:3)〕で精製して、目的物(I)のオキシ
ム水酸基に関するアンチ−及びシン−異性体をそれぞれ
無色油状物として11.7mg(収率51%)及び9.
2mg(収率27%)得た。(5) 33.2 mg of the oxo compound (II) obtained in (4) above was dissolved in 0.3 ml of methanol,
11.1 mg of hydroxylamine hydrochloride and 0.02 ml of pyridine were added, and the mixture was stirred at room temperature for 10 minutes. 25 ml of ether and 5 ml of water were added to the reaction mixture, and the ether layer was separated, washed with saturated brine, dried and concentrated under reduced pressure. 37 mg of the obtained oily substance was purified by preparative thin-layer chromatography on silica gel [solvent: ethyl acetate-benzene (1: 3)] to obtain colorless anti- and syn-isomers of the oxime hydroxyl group of the target product (I). 11.7 mg (51% yield) as an oil and 9.
2 mg (yield 27%) was obtained.
【0044】(a)アンチ−異性体1 H−NMR値:δ CDCl3 ,ppm 7.40(2H,d,J=9Hz)、7.12(1H,
s)、6.97(2H,q,J=9Hz)、4.85
(2H,s)、4.82(1H,q,J=7Hz)、
2.48(3H,s)、1.97(3H,s)、1.4
2(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3550,3270(br),1605,1505,1
220(br) 〔α〕D 23 +17°(C 2.5,クロロホルム)(A) Anti-isomer 1 H-NMR value: δ CDCl 3 , ppm 7.40 (2H, d, J = 9 Hz), 7.12 (1H,
s), 6.97 (2H, q, J = 9Hz), 4.85
(2H, s), 4.82 (1H, q, J = 7Hz),
2.48 (3H, s), 1.97 (3H, s), 1.4
2 (3H, d, J = 7 Hz) IR value: νmax, CHCl 3 , cm -1 3550, 3270 (br), 1605, 1505, 1
220 (br) [α] D 23 + 17 ° (C 2.5, chloroform)
【0045】(b)シン−異性体1 H−NMR値:δ CDCl3 ,ppm 7.41(2H,d,J=9Hz)、7.16(1H,
q,J=1Hz)、6.97(2H,d,J=9H
z)、5.40(1H,q,J=7Hz)、4.86
(2H,s)、2.51(3H,d,J=1Hz)、
1.81(3H,s)、1.45(3H,d,J=7H
z) IR値:νmax,CHCl3 ,cm-1 3560,3240(br),1605,1505,1
225(br) 〔α〕D 23 +84°(C 1.0,クロロホルム)(B) Syn-isomer 1 H-NMR value: δ CDCl 3 , ppm 7.41 (2H, d, J = 9 Hz), 7.16 (1H,
q, J = 1 Hz), 6.97 (2H, d, J = 9H
z), 5.40 (1H, q, J = 7Hz), 4.86
(2H, s), 2.51 (3H, d, J = 1Hz),
1.81 (3H, s), 1.45 (3H, d, J = 7H
z) IR value: νmax, CHCl 3 , cm -1 3560, 3240 (br), 1605, 1505, 1
225 (br) [α] D 23 + 84 ° (C 1.0, chloroform)
【0046】実施例2 2−ヒドロキシイミノ−3−〔2−(2−(3−ヨード
プロパルギル)オキシフェニル)−1−プロペニル−O
NN−アゾキシ〕−ブタン〔化合物(I):R1 =2−
(3−ヨードプロパルギル)オキシフエニル基、R2 =
メチル基、R3=水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)及び2
−プロパルギルオキシアセトフェノンを用い、実施例1
(1)と同様に反応処理して、3−〔2−ヒドロキシ−
2−(2−プロパルギルオキシフェニル)−プロピル−
ONN−アゾキシ〕−2,2−プロピレンジオキシブタ
ン(V) のジアステレオマーの混合物(1:1)を得
た。Example 2 2-Hydroxyimino-3- [2- (2- (3-iodopropargyl) oxyphenyl) -1-propenyl-O
NN-azoxy] -butane [Compound (I): R 1 = 2-
(3-iodopropargyl) oxyphenyl group, R 2 =
Methyl group, R 3 = hydrogen atom]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) and 2 obtained in Reference Example
Example 1 using propargyloxyacetophenone
Reaction treatment is carried out in the same manner as in (1), and 3- [2-hydroxy-
2- (2-propargyloxyphenyl) -propyl-
A mixture of diastereomers of ONN-azoxy] -2,2-propylenedioxybutane (V) (1: 1) was obtained.
【0047】ジアステレオマー(a)(無色油状物)1 H−NMR値:δ CDCl3 ,ppm 7.70(1H,dd,J=8,2Hz)、7.23
(1H,td,J=8,2Hz)、6.99(1H,
t,J=8Hz)、6.94(1H,d,J=8H
z)、5.39(1H,s)、5.15(1H,d,J
=12Hz)、4.75(2H,d,J=2Hz)、
4.45(1H,d,J=12Hz)、4.41(1
H,q,J=7Hz)、3.77〜3.88(2H,
m)、3.48〜3.57(1H,m)、3.32〜
3.42(1H,m)、2.54(1H,t,J=2H
z)、1.59〜1.70(2H,m)、1.61(3
H,s)、1.23(3H,s)、0.96(3H,
d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3430(br),3290,1485,1225(b
r)Diastereomer (a) (colorless oil) 1 H-NMR value: δ CDCl 3 , ppm 7.70 (1 H, dd, J = 8, 2 Hz), 7.23
(1H, td, J = 8, 2Hz), 6.99 (1H,
t, J = 8 Hz), 6.94 (1H, d, J = 8H)
z), 5.39 (1H, s), 5.15 (1H, d, J
= 12 Hz), 4.75 (2H, d, J = 2 Hz),
4.45 (1H, d, J = 12Hz), 4.41 (1
H, q, J = 7 Hz), 3.77 to 3.88 (2H,
m), 3.48 to 3.57 (1H, m), 3.32 to
3.42 (1H, m), 2.54 (1H, t, J = 2H
z), 1.59 to 1.70 (2H, m), 1.61 (3
H, s), 1.23 (3H, s), 0.96 (3H,
d, J = 7 Hz) IR value: νmax, CHCl 3 , cm -1 3430 (br), 3290, 1485, 1225 (b
r)
【0048】ジアステレオマー(b) 無色プリズム状晶(m.p. 127.0〜130.5
℃)1 H−NMR値:δ CDCl3 ,ppm 7.66(1H,dd,J=8,2Hz)、7.24
(1H,td,J=8,2Hz)、6.98(1H,
t,J=8Hz)、6.94(1H,d,J=8H
z)、5.28(1H,s)、5.23(1H,d,J
=11Hz)、4.73(2H,d,J=2Hz)、
4.35(1H,d,J=11Hz)、4.36(1
H,q,J=7Hz)、3.74〜3.91(4H,
m)、2.54(1H,t,J=2Hz)、1.58〜
1.72(2H,m,Hm)、1.63(3H,s)、
1.33(3H,s)、0.44(3H,d,J=7H
z) IR値:νmax,CHCl3 ,cm-1 3440(br),3270,1485,1385,1
240,1090Diastereomer (b) Colorless prismatic crystals (mp 127.0-130.5)
C) 1 H-NMR value: δ CDCl 3 , ppm 7.66 (1 H, dd, J = 8, 2 Hz), 7.24
(1H, td, J = 8, 2Hz), 6.98 (1H,
t, J = 8 Hz), 6.94 (1H, d, J = 8H)
z), 5.28 (1H, s), 5.23 (1H, d, J
= 11 Hz), 4.73 (2H, d, J = 2 Hz),
4.35 (1H, d, J = 11Hz), 4.36 (1
H, q, J = 7 Hz), 3.74 to 3.91 (4H,
m), 2.54 (1H, t, J = 2Hz), 1.58-
1.72 (2H, m, Hm), 1.63 (3H, s),
1.33 (3H, s), 0.44 (3H, d, J = 7H
z) IR value: νmax, CHCl 3 , cm -1 3440 (br), 3270, 1485, 1385, 1
240, 1090
【0049】(2)前記(1)で得られたヒドロキシ化
合物(V) を用い、実施例1(2)と同様に反応、処理
して、3−〔2−(2−プロパルギルオキシフェニル)
−1−プロペニル−ONN−アゾキシ)−2,2−プロ
ピレンジオキシブタン(III ′)を無色油状物として得
た。(2) Using the hydroxy compound (V) obtained in (1) above, the reaction and treatment were carried out in the same manner as in Example 1 (2) to give 3- [2- (2-propargyloxyphenyl)].
-1-Propenyl-ONN-azoxy) -2,2-propylenedioxybutane (III ') was obtained as a colorless oil.
【0050】1H−NMR値:δ CDCl3 ,ppm 7.32(1H,ddd,J=8,7,2Hz)、7.
21(1H,dd,J=7,2Hz)、7.04(1
H,d,J=8Hz)、6.99(1H,t,J=7H
z)、6.94(1H,q,J=1Hz)、4.74
(1H,q,J=7Hz)、4.73(2H,d,J=
2Hz)、3.93〜3.99(4H,m)、2.25
(1H,t,J=2Hz)、2.43(3H,d,J=
1Hz)、1.60〜1.87(2H,m)、1.50
(3H,s)、1.22(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3290,1485,1450 1 H-NMR value: δ CDCl 3 , ppm 7.32 (1H, ddd, J = 8, 7, 2 Hz), 7.
21 (1H, dd, J = 7, 2 Hz), 7.04 (1
H, d, J = 8Hz, 6.99 (1H, t, J = 7H
z), 6.94 (1H, q, J = 1 Hz), 4.74
(1H, q, J = 7Hz), 4.73 (2H, d, J =
2Hz), 3.93 to 3.99 (4H, m), 2.25
(1H, t, J = 2Hz), 2.43 (3H, d, J =
1 Hz), 1.60 to 1.87 (2H, m), 1.50
(3H, s), 1.22 (3H, d, J = 7Hz) IR value: νmax, CHCl 3 , cm -1 3290, 1485, 1450
【0051】(3)前記(2)で得られたプロパルギ化
合物(III ′)を用い、実施例1(3)と同様に反応処
理して、3−〔2−(2−(3−ヨードプロパルギル)
オキシフェニル)−1−プロペニル−ONN−アゾキ
シ〕−2,2−プロピレンジオキシブタン(III)を無色
油状物として得た。(3) 3- (2- (2- (3-iodopropargyl) )
Oxyphenyl) -1-propenyl-ONN-azoxy] -2,2-propylenedioxybutane (III) was obtained as a colorless oil.
【0052】1H−NMR値:δ CDCl3 ,ppm 7.33(1H,t,J=7Hz)、7.21(1H,
d,J=7Hz)、7.03(1H,d,J=7H
z)、6.99(1H,t,J=7Hz)、6.94
(1H,s)、4.86(2H,s)、4.74(1
H,q,J=7Hz)、3.93〜3.99(4H,
m)、2.42(3H,s)、1.60〜1.88(2
H,m)、1.50(3H,s)、1.22(3H,
d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 1485,1450 1 H-NMR value: δ CDCl 3 , ppm 7.33 (1H, t, J = 7 Hz), 7.21 (1H,
d, J = 7 Hz), 7.03 (1H, d, J = 7H
z), 6.99 (1H, t, J = 7Hz), 6.94
(1H, s), 4.86 (2H, s), 4.74 (1
H, q, J = 7 Hz), 3.93 to 3.99 (4H,
m), 2.42 (3H, s), 1.60 to 1.88 (2
H, m), 1.50 (3H, s), 1.22 (3H,
d, J = 7 Hz) IR value: νmax, CHCl 3 , cm −1 1485, 1450
【0053】(4)前記(3)で得られたプロピレンジ
オキシ化合物(III)を用い、実施例1(4)と同様に反
応、処理して、3−〔2−(2−(3−ヨードプロパル
ギル)オキシフェニル)−1−プロペニル−ONN−ア
ゾキシ〕−2−オクソブタン(II)を無色油状物として
得た。(4) Using the propylenedioxy compound (III) obtained in (3) above, the reaction and treatment were carried out in the same manner as in Example 1 (4) to give 3- [2- (2- (3- Iodopropargyl) oxyphenyl) -1-propenyl-ONN-azoxy] -2-oxobutane (II) was obtained as a colorless oil.
【0054】1H−NMR値:δ CDCl3 ,ppm 7.35(1H,ddd,J=8,7,2Hz)、7.
21(1H,dd,J=7,2Hz)、7.04(1
H,d,J=8Hz)、7.01(1H,t,J=7H
z)、7.01(1H,q,J=1Hz)、4.87
(2H,s)、4.61(1H,q,J=7Hz)、
2.45(3H,d,J=1Hz)、2.23(3H,
s)、1.50(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 1715,1485,1450 〔α〕D 23 −37°(C 3.5,クロロホルム) 1 H-NMR value: δ CDCl 3 , ppm 7.35 (1 H, ddd, J = 8, 7, 2 Hz), 7.
21 (1H, dd, J = 7, 2 Hz), 7.04 (1
H, d, J = 8 Hz, 7.01 (1H, t, J = 7H
z), 7.01 (1H, q, J = 1 Hz), 4.87
(2H, s), 4.61 (1H, q, J = 7Hz),
2.45 (3H, d, J = 1 Hz), 2.23 (3H,
s), 1.50 (3 H, d, J = 7 Hz) IR value: νmax, CHCl 3 , cm −1 1715, 1485, 1450 [α] D 23 −37 ° (C 3.5, chloroform).
【0055】(5)前記(4)で得られたオクソ化合物
(II) を用い、実施例1(5)と同様に反応、処理し
て、目的物(I)のオキシム水酸基に関するアンチ−及
びシン−異性体をそれぞれ無色油状物として得た。(5) Using the oxo compound (II) obtained in (4) above, the reaction and treatment were carried out in the same manner as in Example 1 (5) to obtain the anti- and syn-oxy groups related to the oxime hydroxyl group of the desired product (I). -Each isomer was obtained as a colorless oil.
【0056】アンチ−異性体1 H−NMR値:δ CDCl3 ,ppm 7.33(1H,ddd,J=8,7,2Hz)、7.
20(1H,dd,J=7,2Hz)、7.03(1
H,d,J=8Hz)、7.00(1H,t,J=7H
z)、6.94(1H,q,J=1Hz)、4.86
(2H,s)、4.83(1H,q,J=7Hz)、
2.43(3H,d,J=1Hz)、1.98(3H,
s)、1.41(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3550,3260(br),1485,1445 〔α〕D 23 +8.0°(C 0.56,クロロホル
ム)Anti-isomer 1 H-NMR value: δ CDCl 3 , ppm 7.33 (1 H, ddd, J = 8, 7, 2 Hz), 7.
20 (1H, dd, J = 7, 2Hz), 7.03 (1
H, d, J = 8 Hz), 7.00 (1H, t, J = 7H
z), 6.94 (1H, q, J = 1 Hz), 4.86
(2H, s), 4.83 (1H, q, J = 7Hz),
2.43 (3H, d, J = 1 Hz), 1.98 (3H,
s), 1.41 (3 H, d, J = 7 Hz) IR value: νmax, CHCl 3 , cm −1 3550, 3260 (br), 1485, 1445 [α] D 23 + 8.0 ° (C 0.56) , Chloroform)
【0057】シン−異性体1 H−NMR値:δ CDCl3 ,ppm 7.34(1H,ddd,J=8,7,2Hz)、7.
21(1H,dd,J=7,2Hz)、7.04(1
H,d,J=8Hz)、7.01(1H,t,J=7H
z)、6.97(1H,q,J=1Hz)、5.42
(1H,q,J=7Hz)、4.87(2H,s)、
2.46(3H,d,J=1Hz)、1.83(3H,
s)、1.48(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3560,3240(br),1485,1450 〔α〕D 23 +36°(C 0.25,クロロホルム)Syn-isomer 1 H-NMR value: δ CDCl 3 , ppm 7.34 (1 H, ddd, J = 8, 7, 2 Hz), 7.
21 (1H, dd, J = 7, 2 Hz), 7.04 (1
H, d, J = 8 Hz, 7.01 (1H, t, J = 7H
z), 6.97 (1H, q, J = 1 Hz), 5.42
(1H, q, J = 7Hz), 4.87 (2H, s),
2.46 (3H, d, J = 1 Hz), 1.83 (3H,
s), 1.48 (3 H, d, J = 7 Hz) IR value: νmax, CHCl 3 , cm −1 3560, 3240 (br), 1485, 1450 [α] D 23 + 36 ° (C 0.25, chloroform) )
【0058】実施例3 2−ヒドロキシイミノ−3−〔2−(3−(3−ヨード
プロパルギル)オキシフェニル)−1−プロペニル−O
NN−アゾキシ〕−ブタン〔化合物(I):R1 =3−
(3−ヨードプロパルギル)オキシフエニル基、R2 =
メチル基、R3=水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)及び3
−プロパルギルオキシアセトフェノンを用い、実施例1
(1)と同様に反応、処理して、3−〔2−ヒドロキシ
−2−(3−プロパルギルオキシフェニル)プロピル−
ONN−アゾキシ〕−2,2−プロピレンジオキシブタ
ン(V) のジアステレオマーの混合物(1:1)を油状
物として得た。Example 3 2-Hydroxyimino-3- [2- (3- (3-iodopropargyl) oxyphenyl) -1-propenyl-O
NN-azoxy] -butane [Compound (I): R 1 = 3-
(3-iodopropargyl) oxyphenyl group, R 2 =
Methyl group, R 3 = hydrogen atom]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) and 3 obtained in Reference Example
Example 1 using propargyloxyacetophenone
Reaction and treatment are carried out in the same manner as in (1) to give 3- [2-hydroxy-2- (3-propargyloxyphenyl) propyl-
A mixture of diastereomers of ONN-azoxy] -2,2-propylenedioxybutane (V) (1: 1) was obtained as an oil.
【0059】ジアステレオマー(a)1 H−NMR値:δ CDCl3 ,ppm 7.26(1H,t,J=8Hz)、7.16(1H,
br,s)、7.08(1H,d,J=8Hz)、6.
87(1H,dd,J=8,3Hz)、5.28(1
H,br,s)、4.69(2H,d,J=2Hz)、
4.54(1H,d,J=13Hz)、4.41(1
H,d,J=13Hz)、4.36(1H,q,J=7
Hz)、3.69〜3.97(4H,m)、2.52
(1H,t,J=2Hz)、1.71〜1.86(1
H,m)、1.55(3H,s)、1.48〜1.59
(1H,m)、1.26(3H,s)、1.06(3
H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3430(br),3290,1600,1500,1
230(br)Diastereomer (a) 1 H-NMR value: δ CDCl 3 , ppm 7.26 (1 H, t, J = 8 Hz), 7.16 (1 H,
br, s), 7.08 (1H, d, J = 8 Hz), 6.
87 (1H, dd, J = 8, 3Hz), 5.28 (1
H, br, s), 4.69 (2H, d, J = 2Hz),
4.54 (1H, d, J = 13Hz), 4.41 (1
H, d, J = 13 Hz), 4.36 (1H, q, J = 7)
Hz), 3.69 to 3.97 (4H, m), 2.52
(1H, t, J = 2Hz), 1.71-1.86 (1
H, m), 1.55 (3H, s), 1.48 to 1.59
(1H, m), 1.26 (3H, s), 1.06 (3
H, d, J = 7 Hz) IR value: νmax, CHCl 3 , cm -1 3430 (br), 3290, 1600, 1500, 1
230 (br)
【0060】ジアステレオマー(b)1 H−NMR値:δ CDCl3 ,ppm 7.25(1H,t,J=8Hz)、7.14(1H,
t,J=2Hz)、7.06(1H,br,d,J=8
Hz)、6.87(1H,dd,J=8,2Hz)、
5.29(1H,br,s)、4.69(2H,d,J
=2Hz)、4.59(1H,d,J=12Hz)、
4.42(1H,d,J=12Hz)、4.42(1
H,q,J=7Hz)、3.77〜3.96(4H,
m)、2.52(1H,t,J=2Hz)、1.68〜
1.82(1H,m)、1.58〜1.66(1H,
m)、1.55(3H,s)、1.36(3H,s)、
0.74(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3420(br),3290,1600,1500,1
225(br)Diastereomer (b) 1 H-NMR value: δ CDCl 3 , ppm 7.25 (1H, t, J = 8 Hz), 7.14 (1H,
t, J = 2 Hz), 7.06 (1H, br, d, J = 8)
Hz), 6.87 (1H, dd, J = 8, 2Hz),
5.29 (1H, br, s), 4.69 (2H, d, J
= 2 Hz), 4.59 (1H, d, J = 12 Hz),
4.42 (1H, d, J = 12Hz), 4.42 (1
H, q, J = 7 Hz), 3.77 to 3.96 (4H,
m), 2.52 (1H, t, J = 2Hz), 1.68 ~
1.82 (1H, m), 1.58 to 1.66 (1H,
m), 1.55 (3H, s), 1.36 (3H, s),
0.74 (3H, d, J = 7Hz) IR value: νmax, CHCl 3 , cm -1 3420 (br), 3290, 1600, 1500, 1
225 (br)
【0061】(2)前記(1)で得られたヒドロキシ化
合物(V) を用い、実施例1(2)と同様に反応、処理
して、3−〔2−(3−プロパルギルオキシフェニル)
−1−プロペニル−ONN−アゾキシ)−2,2−プロ
ピレンジオキシブタン(III ′)を無色油状物として得
た。(2) Using the hydroxy compound (V) obtained in (1) above, reacting and treating in the same manner as in Example 1 (2) to give 3- [2- (3-propargyloxyphenyl)].
-1-Propenyl-ONN-azoxy) -2,2-propylenedioxybutane (III ') was obtained as a colorless oil.
【0062】1H−NMR値:δ CDCl3 ,ppm 7.31(1H,t,J=8Hz)、7.12(1H,
q,J=1Hz)、7.06(1H,br.d,J=8
Hz)、7.03(1H,t,J=2Hz)、6.98
(1H,dd,J=8,2Hz)、4.72(1H,
d,J=2Hz)4.72(1H,q,J=7Hz)、
3.93〜4.00(4H,m)、2.52(1H,
t,J=2Hz)、2.45(3H,d,J=1H
z)、1.74〜1.89(1H,m)、1.60〜
1.71(1H,m)、1.51(3H,s)、1.2
2(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3290,1570,1480,1220(br) 1 H-NMR value: δ CDCl 3 , ppm 7.31 (1H, t, J = 8 Hz), 7.12 (1H,
q, J = 1 Hz), 7.06 (1H, br.d, J = 8
Hz), 7.03 (1H, t, J = 2Hz), 6.98
(1H, dd, J = 8, 2Hz), 4.72 (1H,
d, J = 2 Hz) 4.72 (1H, q, J = 7 Hz),
3.93 to 4.00 (4H, m), 2.52 (1H,
t, J = 2 Hz), 2.45 (3H, d, J = 1H)
z), 1.74-1.89 (1H, m), 1.60
1.71 (1H, m), 1.51 (3H, s), 1.2
2 (3H, d, J = 7Hz) IR value: νmax, CHCl 3 , cm -1 3290, 1570, 1480, 1220 (br)
【0063】(3)前記(2)で得られたプロパルギ化
合物(III ′)を用い、実施例1(3)と同様に反応、
処理して、3−〔2−(3−(3−ヨードプロパルギ
ル)オキシフェニル)−1−プロペニル−ONN−アゾ
キシ〕−2,2−プロピレンジオキシブタン(III)を無
色油状物として得た。(3) Using the propargy compound (III ') obtained in (2) above, a reaction was carried out in the same manner as in Example 1 (3),
This was treated to give 3- [2- (3- (3-iodopropargyl) oxyphenyl) -1-propenyl-ONN-azoxy] -2,2-propylenedioxybutane (III) as a colorless oil.
【0064】1H−NMR値:δ CDCl3 ,ppm 7.31(1H,t,J=8Hz)、7.12(1H,
q,J=1Hz)、7.07(1H,br.d,J=8
Hz)、7.01(1H,t,J=2Hz)、6.96
(1H,dd,J=8,2Hz)、4.85(2H,
s)、4.73(1H,q,J=7Hz)、3.93〜
3.99(4H,m)、2.45(3H,d,J=1H
z)、1.74〜1.89(1H,m)、1.61〜
1.71(1H,m)、1.51(3H,s)、1.2
2(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 1575,1480,1215(br) 1 H-NMR value: δ CDCl 3 , ppm 7.31 (1H, t, J = 8 Hz), 7.12 (1H,
q, J = 1 Hz), 7.07 (1H, br.d, J = 8)
Hz), 7.01 (1H, t, J = 2 Hz), 6.96
(1H, dd, J = 8, 2Hz), 4.85 (2H,
s), 4.73 (1H, q, J = 7Hz), 3.93-
3.99 (4H, m), 2.45 (3H, d, J = 1H
z), 1.74-1.89 (1H, m), 1.61-
1.71 (1H, m), 1.51 (3H, s), 1.2
2 (3H, d, J = 7 Hz) IR value: νmax, CHCl 3 , cm −1 1575, 1480, 1215 (br)
【0065】(4)前記(3)で得られたプロピレンジ
オキシ化合物(III)を用い、実施例1(4)と同様に反
応、処理して、3−〔2−(3−(3−ヨードプロパル
ギル)オキシフェニル)−1−プロペニル−ONN−ア
ゾキシ〕−2−オクソブタン(II)を油状物として得
た。(4) Using the propylenedioxy compound (III) obtained in (3) above, the reaction and treatment were carried out in the same manner as in Example 1 (4) to give 3- [2- (3- (3- Iodopropargyl) oxyphenyl) -1-propenyl-ONN-azoxy] -2-oxobutane (II) was obtained as an oil.
【0066】1H−NMR値:δ CDCl3 ,ppm 7.33(1H,t,J=8Hz)、7.18(1H,
q,J=1Hz)、7.08(1H,br.d,J=8
Hz)、7.02(1H,t,J=2Hz)、6.99
(1H,dd,J=8,2Hz)、4.85(2H,
s)、4.62(1H,q,J=7Hz)、2.50
(3H,d,J=1Hz)、2.24(3H,s)、
1.52(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 1715,1595,1440(br),1285 〔α〕D 23 −30°(C 1.7,クロロホルム) 1 H-NMR value: δ CDCl 3 , ppm 7.33 (1 H, t, J = 8 Hz), 7.18 (1 H,
q, J = 1 Hz), 7.08 (1H, br.d, J = 8
Hz), 7.02 (1H, t, J = 2Hz), 6.99
(1H, dd, J = 8, 2Hz), 4.85 (2H,
s), 4.62 (1H, q, J = 7Hz), 2.50
(3H, d, J = 1 Hz), 2.24 (3H, s),
1.52 (3 H, d, J = 7 Hz) IR value: νmax, CHCl 3 , cm −1 1715, 1595, 1440 (br), 1285 [α] D 23 −30 ° (C 1.7, chloroform)
【0067】(5)前記(4)で得られたオクソ化合物
(II) を用い、実施例1(5)と同様に反応、処理し
て、目的物(I)のオキシム水酸基に関するアンチ−及
びシン−異性体をそれぞれ無色油状物として得た。(5) Using the oxo compound (II) obtained in (4) above, the reaction and treatment were carried out in the same manner as in Example 1 (5) to obtain the anti- and syn-compounds relating to the oxime hydroxyl group of the desired product (I). -Each isomer was obtained as a colorless oil.
【0068】アンチ−異性体1 H−NMR値:δ CDCl3 ,ppm 7.32(1H,t,J=8Hz)、7.12(1H,
br.s)、7.06(1H,d,J=8Hz)、7.
01(1H,br.s)、6.97(1H,d,J=8
Hz)、4.85(2H,s)、4.83(1H,q,
J=7Hz)、2.47(3H,s)、1.98(2
H,s)、1.42(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3550,3270(br),1695,1465,1
285 〔α〕D 23 +7.1°(C 0.68,クロロホル
ム)Anti-isomer 1 H-NMR value: δ CDCl 3 , ppm 7.32 (1 H, t, J = 8 Hz), 7.12 (1 H,
br. s), 7.06 (1H, d, J = 8 Hz), 7.
01 (1H, br.s), 6.97 (1H, d, J = 8)
Hz), 4.85 (2H, s), 4.83 (1H, q,
J = 7 Hz), 2.47 (3H, s), 1.98 (2
H, s), 1.42 (3H, d, J = 7 Hz) IR value: νmax, CHCl 3 , cm -1 3550, 3270 (br), 1695, 1465, 1
285 [α] D 23 + 7.1 ° (C 0.68, chloroform)
【0069】シン−異性体1 H−NMR値:δ CDCl3 ,ppm 7.33(1H,t,J=8Hz)、7.16(1H,
q,J=1Hz)、7.08(1H,br.d,J=8
Hz)、7.02(1H,t,J=2Hz)、6.98
(1H,dd,J=8,2Hz)、5.41(1H,
q,J=7Hz)、4.86(2H,s)、2.51
(3H,d,J=1Hz)、1.83(3H,s)、
1.46(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3560,3240(br),1600,1460,1
285 〔α〕D 23 +67°(C 0.19,クロロホルム)Syn-isomer 1 H-NMR value: δ CDCl 3 , ppm 7.33 (1H, t, J = 8 Hz), 7.16 (1H,
q, J = 1 Hz), 7.08 (1H, br.d, J = 8
Hz), 7.02 (1H, t, J = 2 Hz), 6.98
(1H, dd, J = 8, 2Hz), 5.41 (1H,
q, J = 7 Hz), 4.86 (2H, s), 2.51
(3H, d, J = 1 Hz), 1.83 (3H, s),
1.46 (3H, d, J = 7Hz) IR value: νmax, CHCl 3 , cm -1 3560, 3240 (br), 1600, 1460, 1
285 [α] D 23 + 67 ° (C 0.19, chloroform)
【0070】実施例4 2−ヒドロキシイミノ−3−〔4′−(3−ヨードプロ
パルギル)オキシスチリル−ONN−アゾキシ〕−ブタ
ン〔化合物(I):R1 =4−(3−ヨードプロパルギ
ル)オキシフエニル基、R2 =R3 =水素原子〕の製
造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)743
mg及び4−プロパルギルオキシベンズアルデヒド(V
I) 1.08gを用い、実施例1(1)と同様に反応、
処理して、3−〔2−ヒドロキシ−2−(4−プロパル
ギルオキシフェニル)−エチル−ONN−アゾキシ〕−
2,2−プロピレンジオキシブタン(V) のジアステレ
オマーの混合物(4:5)を無色油状物として1.00
g(収率73%)得た。Example 4 2-Hydroxyimino-3- [4 '-(3-iodopropargyl) oxystyryl-ONN-azoxy] -butane [Compound (I): R 1 = 4- (3-iodopropargyl) oxyphenyl] Group, R 2 = R 3 = hydrogen atom]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) 743 obtained in Reference Example
mg and 4-propargyloxybenzaldehyde (V
I) Using 1.08 g, the same reaction as in Example 1 (1),
Treated to give 3- [2-hydroxy-2- (4-propargyloxyphenyl) -ethyl-ONN-azoxy]-
Mixture of diastereomers of 2,2-propylenedioxybutane (V) (4: 5) as a colorless oil 1.00
g (yield 73%) was obtained.
【0071】ジアステレオマー(a)1 H−NMR値:δ CDCl3 ,ppm 7.35(2H,d,J=9Hz)、6.99(2H,
d,J=9Hz)、5.32(1H,br.d,J=8
Hz)、4.70(2H,d,J=2Hz)、4.54
(1H,dd,J=13,2Hz)、4.36(1H,
dd,J=13,8Hz)、4.32(1H,br,
s)、3.91〜4.06(2H,m)、3.86(1
H,q,J=7Hz)、3.74〜3.86(2H,
m)、2.52(1H,t,J=2Hz)、1.87〜
2.06(1H,m)、1.47(3H,s)、1.3
4〜1.44(1H,m)、1.19(3H,d,J=
7Hz) IR値:νmax,CHCl3 ,cm-1 3410(br),3240,1495,1220(b
r),1155Diastereomer (a) 1 H-NMR value: δ CDCl 3 , ppm 7.35 (2H, d, J = 9 Hz), 6.99 (2H,
d, J = 9 Hz), 5.32 (1H, br.d, J = 8)
Hz), 4.70 (2H, d, J = 2Hz), 4.54
(1H, dd, J = 13, 2Hz), 4.36 (1H,
dd, J = 13,8 Hz), 4.32 (1H, br,
s), 3.91 to 4.06 (2H, m), 3.86 (1
H, q, J = 7 Hz), 3.74 to 3.86 (2H,
m), 2.52 (1H, t, J = 2Hz), 1.87-
2.06 (1H, m), 1.47 (3H, s), 1.3
4 to 1.44 (1H, m), 1.19 (3H, d, J =
7 Hz) IR value: νmax, CHCl 3 , cm -1 3410 (br), 3240, 1495, 1220 (b
r), 1155
【0072】ジアステレオマー(b)1 H−NMR値:δ CDCl3 ,ppm 7.36(2H,d,J=9Hz)、6.98(2H,
d,J=9Hz)、5.32(1H,br,d,J=9
Hz)、4.69(2H,d,J=2Hz)、4.51
(1H,dd,J=13,9Hz)、4.48(1H,
br,s)、4.27(1H,dd,J=13,2H
z)、3.92〜4.06(2H,m)、3.96(1
H,q,J=6Hz)、3.77〜3.87(2H,
m)、2.51(1H,t,J=2Hz)、1.89〜
2.07(1H,m)、1.50(3H,s)、1.3
3〜1.45(1H,s)、1.20(3H,d,J=
6Hz) IR値:νmax,CHCl3 ,cm-1 3390(br),3300,1495,1220(b
r),1155Diastereomer (b) 1 H-NMR value: δ CDCl 3 , ppm 7.36 (2H, d, J = 9 Hz), 6.98 (2H,
d, J = 9 Hz), 5.32 (1H, br, d, J = 9)
Hz), 4.69 (2H, d, J = 2Hz), 4.51
(1H, dd, J = 13,9Hz), 4.48 (1H,
br, s), 4.27 (1H, dd, J = 13, 2H
z), 3.92 to 4.06 (2H, m), 3.96 (1
H, q, J = 6 Hz), 3.77 to 3.87 (2H,
m), 2.51 (1H, t, J = 2Hz), 1.89-
2.07 (1H, m), 1.50 (3H, s), 1.3
3 to 1.45 (1H, s), 1.20 (3H, d, J =
6 Hz) IR value: νmax, CHCl 3 , cm -1 3390 (br), 3300, 1495, 1220 (b
r), 1155
【0073】(2)前記(1)で得られたヒドロキシ化
合物(V′)449mgを用い、実施例1(2)と同様
に反応、処理して、3−(4′−プロパルギルオキシス
チリル−ONN−アゾキシ)−2,2−プロピレンジオ
キシブタン(III ′)を無色油状物として239mg
(収率56%)得た。(2) Using 449 mg of the hydroxy compound (V ') obtained in (1) above, the reaction and treatment were carried out in the same manner as in Example 1 (2) to give 3- (4'-propargyloxystyryl-ONN. -Azoxy) -2,2-propylenedioxybutane (III ') as a colorless oil 239 mg
(Yield 56%) was obtained.
【0074】1H−NMR値:δ CDCl3 ,ppm 7.76(1H,d,J=14Hz)、7.57(1
H,d,J=14Hz)、7.45(2H,d,J=9
Hz)、6.99(2H,d,J=9Hz)、4.73
(2H,d,J=2Hz)、4.71(1H,q,J=
7Hz)、3.92〜4.02(4H,m)、2.55
(1H,t,J=2Hz)、1.77〜1.92(1
H,m)、1.61〜1.69(1H,m)、1.51
(3H,s)、1.22(3H,d,J=7Hz)IR
値:νmax,CHCl3 ,cm-1 3290,1605,1510,1450,1230
(br) 1 H-NMR value: δ CDCl 3 , ppm 7.76 (1 H, d, J = 14 Hz), 7.57 (1
H, d, J = 14 Hz), 7.45 (2H, d, J = 9)
Hz), 6.99 (2H, d, J = 9Hz), 4.73
(2H, d, J = 2Hz), 4.71 (1H, q, J =
7 Hz), 3.92 to 4.02 (4H, m), 2.55
(1H, t, J = 2Hz), 1.77 to 1.92 (1
H, m), 1.61 to 1.69 (1H, m), 1.51
(3H, s), 1.22 (3H, d, J = 7Hz) IR
Value: νmax, CHCl 3 , cm -1 3290, 1605, 1510, 1450, 1230
(Br)
【0075】(3)前記(2)で得られたプロパルギ化
合物(III ′)229mgを用い、実施例1(3)と同
様に反応、処理して、3−〔4′−(3−ヨードプロパ
ルギル)オキシスチリル−ONN−アゾキシ〕−2,2
−プロピレンジオキシブタン(III)を無色油状物として
277mg(収率88%)得た。(3) Using 229 mg of the propargy compound (III ') obtained in (2) above, the reaction and treatment were carried out in the same manner as in Example 1 (3) to give 3- [4'-(3-iodopropargyl). ) Oxystyryl-ONN-azoxy] -2,2
277 mg (yield 88%) of propylenedioxybutane (III) was obtained as a colorless oil.
【0076】1H−NMR値:δ CDCl3 ,ppm 7.76(1H,d,J=14Hz)、7.57(1
H,d,J=14Hz)、7.45(2H,d,J=9
Hz)、6.97(2H,d,J=9Hz)、4.86
(2H,s)、4.71(1H,q,J=6Hz)、
3.90〜4.01(4H,m)、1.77〜1.92
(1H,m)、1.57〜1.68(1H,m)、1.
51(3H,s)、1.22(3H,d,J=6Hz) IR値:νmax,CHCl3 ,cm-1 1605,1505,1450,1225(br) 1 H-NMR value: δ CDCl 3 , ppm 7.76 (1 H, d, J = 14 Hz), 7.57 (1
H, d, J = 14 Hz), 7.45 (2H, d, J = 9)
Hz), 6.97 (2H, d, J = 9 Hz), 4.86
(2H, s), 4.71 (1H, q, J = 6Hz),
3.90 to 4.01 (4H, m), 1.77 to 1.92
(1H, m), 1.57 to 1.68 (1H, m), 1.
51 (3H, s), 1.22 (3H, d, J = 6Hz) IR value: νmax, CHCl 3 , cm -1 1605, 1505, 1450, 1225 (br)
【0077】(4)前記(3)で得られたプロピレンジ
オキシ化合物(III)249mgを用い、実施例1(4)
と同様に反応、処理して、3−〔4′−(3−ヨードプ
ロパルギル)オキシスチリル−ONN−アゾキシ〕−2
−オクソブタン(II) の粗油状物225mgを得た。こ
の粗油状物をメタノールより再結晶すると融点86℃
(分解)の微黄色針状晶が得られた。(4) Using 249 mg of the propylenedioxy compound (III) obtained in (3) above, Example 1 (4)
Is reacted and treated in the same manner as in 3- [4 '-(3-iodopropargyl) oxystyryl-ONN-azoxy] -2.
-225 mg of a crude oil of oxobutane (II) was obtained. Recrystallization of this crude oil from methanol gave a melting point of 86 ° C.
Fine yellow needle crystals of (decomposition) were obtained.
【0078】1H−NMR値:δ CDCl3 ,ppm 7.79(1H,d,J=14Hz)、7.58(1
H,d,J=14Hz)、7.47(2H,d,J=9
Hz)、6.99(2H,d,J=9Hz)、4.87
(2H,s)、4.68(1H,q,J=7Hz)、
2.21(3H,s)、1.51(3H,d,J=7H
z) IR値:νmax,CHCl3 ,cm-1 1715,1600,1510,1375,1300,
1250,1170 1 H-NMR value: δ CDCl 3 , ppm 7.79 (1 H, d, J = 14 Hz), 7.58 (1
H, d, J = 14 Hz), 7.47 (2H, d, J = 9)
Hz), 6.99 (2H, d, J = 9Hz), 4.87
(2H, s), 4.68 (1H, q, J = 7Hz),
2.21 (3H, s), 1.51 (3H, d, J = 7H
z) IR value: νmax, CHCl 3 , cm −1 1715, 1600, 1510, 1375, 1300,
1250, 1170
【0079】(5)前記(4)で得られたオクソ化合物
(II) の粗油状物225mgを用い、実施例1(5)と
同様に反応、処理して、目的物(I)のオキシム水酸基
に関するアンチ−及びシン−異性体をそれぞれ無色油状
物として136mg及び52mg得た。(5) Using 225 mg of the crude oil of oxo compound (II) obtained in (4) above, the reaction and treatment were carried out in the same manner as in Example 1 (5) to obtain the oxime hydroxyl group of the desired product (I). The anti- and syn-isomers of were obtained as colorless oils, 136 mg and 52 mg, respectively.
【0080】アンチ−異性体1 H−NMR値:δ CDCl3 ,ppm 7.77(1H,d,J=14Hz)、7.52(1
H,d,J=14Hz)、7.46(2H,d,J=9
Hz)、6.98(2H,d,J=9Hz)、4.87
(1H,q,J=7Hz)、4.86(2H,s)、
1.98(3H,s1.42(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3550,3260(br),1605,1505,1
455,1220(br),1170 〔α〕D 23 +21°(C 1.2,クロロホルム)Anti-isomer 1 H-NMR value: δ CDCl 3 , ppm 7.77 (1 H, d, J = 14 Hz), 7.52 (1
H, d, J = 14 Hz), 7.46 (2H, d, J = 9)
Hz), 6.98 (2H, d, J = 9 Hz), 4.87
(1H, q, J = 7Hz), 4.86 (2H, s),
1.98 (3H, s1.42 (3H, d, J = 7Hz) IR value: νmax, CHCl 3 , cm -1 3550, 3260 (br), 1605, 1505, 1
455, 1220 (br), 1170 [α] D 23 + 21 ° (C 1.2, chloroform)
【0081】シン−異性体1 H−NMR値:δ CDCl3 ,ppm 7.79(1H,d,J=14Hz)、7.53(1
H,d,J=14Hz)、7.47(2H,d,J=9
Hz)、6.98(2H,d,J=9Hz)、5.43
(1H,q,J=7Hz)、4.87(2H,s)、
1.79(3H,s1.46(3H,d,J=7Hz) IR値:νmax,CHCl3 ,cm-1 3550,3260(br),1605,1505,1
455,1220(br),1170 〔α〕D 23 +44°(C 0.63,クロロホルム)Syn-isomer 1 H-NMR value: δ CDCl 3 , ppm 7.79 (1 H, d, J = 14 Hz), 7.53 (1
H, d, J = 14 Hz), 7.47 (2H, d, J = 9)
Hz), 6.98 (2H, d, J = 9 Hz), 5.43
(1H, q, J = 7Hz), 4.87 (2H, s),
1.79 (3H, s1.46 (3H, d, J = 7Hz) IR value: νmax, CHCl 3 , cm -1 3550, 3260 (br), 1605, 1505, 1
455, 1220 (br), 1170 [α] D 23 + 44 ° (C 0.63, chloroform)
【0082】実施例5 3−(2′−クロロスチリル−ONN−アゾキシ)−2
−ヒドロキシイミノ−ブタン〔化合物(I):R1 =2
−クロロフエニル基、R2 =R3 =水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(V)297
mg及びO−クロロベンズアルデヒド(VII )0.36
mlを用い、実施例1(1)と同様に反応、処理して、
3−〔2−クロロフェニル)−2−ヒドロキシエチル−
ONN−アゾキシ〕−2,2−プロピレンジオキシブタ
ン(V) を463mg(収率84%)得た。Example 5 3- (2'-chlorostyryl-ONN-azoxy) -2
-Hydroxyimino-butane [Compound (I): R 1 = 2
-Chlorophenyl group, R 2 = R 3 = hydrogen atom]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (V) 297 obtained in Reference Example
mg and O-chlorobenzaldehyde (VII) 0.36
Using ml, the reaction and treatment were carried out in the same manner as in Example 1 (1),
3- [2-chlorophenyl) -2-hydroxyethyl-
ONN-azoxy] -2,2-propylenedioxybutane (V) (463 mg, yield 84%) was obtained.
【0083】1H−NMR値:δ CDCl3 ,ppm 1.06(3H,d,J=6.34Hz)、1.28
(3H,d,J=6.59Hz)、1.46(3H,
s)、1.48(1H,s)、1.92〜2.05(4
H)、3.76〜4.90(16H)、5.62〜5.
68(2H)、7.24〜7.77(8H) 1 H-NMR value: δ CDCl 3 , ppm 1.06 (3 H, d, J = 6.34 Hz), 1.28
(3H, d, J = 6.59 Hz), 1.46 (3H,
s), 1.48 (1H, s), 1.92 to 2.05 (4
H), 3.76 to 4.90 (16H), 5.62 to 5.
68 (2H), 7.24 to 7.77 (8H)
【0084】(2)前記(1)で得られたヒドロキシ化
合物(IV) 285mgを用い、実施例1(2)と同様に
反応、処理して、3−(2−クロロスチリル−ONN−
アゾキシ)−2,2−プロピレンジオキシブタン(III
)を222mg(収率82.3%)得た。(2) 3- (2-chlorostyryl-ONN-
Azoxy) -2,2-propylenedioxybutane (III
) Was obtained (222 mg, yield 82.3%).
【0085】1H−NMR値:δ CDCl3 ,ppm 1.23(3H,d,J=6.35Hz)、1.51
(3H,s)、1.62〜1.87(2H)、3.94
〜4.01(4H)、4.71(1H,q,J=6.3
5Hz)、7.25〜7.56(4H)、7.94(2
H,q,J=13.67Hz) IR値:νmax,CHCl3 ,cm-1 1460 UV(EtOH,λmax)〔nm〕 276 〔α〕D 23 +34.4°(C 1.0,CHCl3 ) 1 H-NMR value: δ CDCl 3 , ppm 1.23 (3H, d, J = 6.35 Hz), 1.51
(3H, s), 1.62 to 1.87 (2H), 3.94
˜4.01 (4H), 4.71 (1H, q, J = 6.3
5 Hz), 7.25 to 7.56 (4H), 7.94 (2
H, q, J = 13.67 Hz) IR value: νmax, CHCl 3 , cm -1 1460 UV (EtOH, λmax) [nm] 276 [α] D 23 + 34.4 ° (C 1.0, CHCl 3 ).
【0086】(3)前記(2)で得られたプロピレンジ
オキシ化合物(III )32mgを用い、実施例1(4)
と同様に反応、処理して粗製の油状物を得た。この粗製
油状物を精製することなく、実施例1(5)と同様に反
応、処理して目的物(I)をアンチ−及びシン−異性体
の混合物(3:1)として18.3mg(収率66.2
%)得た。(3) Using 1 mg of the propylenedioxy compound (III) obtained in (2) above, Example 1 (4)
Reaction and treatment were carried out in the same manner as above to obtain a crude oily substance. This crude oily substance was reacted and treated in the same manner as in Example 1 (5) without purification to give the target compound (I) as a mixture (3: 1) of anti- and syn-isomers (18.3 mg, yield). Rate 66.2
%)Obtained.
【0087】1H−NMR値:δ CDCl3 ,ppm 1.43(3H,d,J=6.84Hz)、1.47
(3H,d,J=7.33Hz)、1.82(3H,
s)、1.99(3H,s)、4.88(1H,q,J
=6.84Hz)、7.29〜7.63(10H,
s)、8.18〜8.23(2H,s) IR値:νmax,CHCl3 ,cm-1 1458 1 H-NMR value: δ CDCl 3 , ppm 1.43 (3H, d, J = 6.84 Hz), 1.47
(3H, d, J = 7.33Hz), 1.82 (3H,
s), 1.99 (3H, s), 4.88 (1H, q, J
= 6.84 Hz), 7.29 to 7.63 (10H,
s), 8.18 to 8.23 (2H, s) IR value: νmax, CHCl 3 , cm -1 1458.
【0088】実施例6 3−〔2−(2−クロロフェニル)−1−プロペニル−
ONN−アゾキシ〕−2−ヒドロキシイミノ−ブタン
〔化合物(I):R1 =2−クロロフエニル基、R2 =
R3 =水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)320
mg及びO−クロロアセトフェノン0.45mlを用
い、実施例1(1)と同様に反応、処理して、3−〔2
−クロロフェニル)−2−ヒドロキシプロピル−ONN
−アゾキシ〕−2,2−プロピレンジオキシブタン
(V) を194mg(収率33%)得た。Example 6 3- [2- (2-chlorophenyl) -1-propenyl-
ONN-azoxy] -2-hydroxyimino-butane [Compound (I): R 1 = 2-chlorophenyl group, R 2 =
R 3 = hydrogen atom]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) 320 obtained in Reference Example
mg and O-chloroacetophenone 0.45 ml, reacted and treated in the same manner as in Example 1 (1) to give 3- [2
-Chlorophenyl) -2-hydroxypropyl-ONN
194 mg (yield 33%) of -azoxy] -2,2-propylenedioxybutane (V) was obtained.
【0089】1H−NMR値:δ CDCl3 ,ppm 0.46(3H,d,J=6.35Hz)、1.01
(3H,d,J=6.35Hz)、1.17(3H,
s)、1.36(3H,s)、1.71(3H,s)、
1.72(3H,s)、1.45〜1.80(4H)、
3.65〜3.85(8H)、4.25(1H,q,J
=6.35Hz)、4.34(1H,q,J=6.35
Hz)、4.42(1H,d,J=12.21Hz)、
4.53(1H,d,J=12.7Hz)、5.31
(1H,d,J=12.7Hz)、5.43(1H,
d,J=12.2Hz)、5.52(1H,s)、5.
66(1H,s)、7.19〜7.22(6H)、7.
84〜7.90(2H) 1 H-NMR value: δ CDCl 3 , ppm 0.46 (3 H, d, J = 6.35 Hz), 1.01
(3H, d, J = 6.35Hz), 1.17 (3H,
s), 1.36 (3H, s), 1.71 (3H, s),
1.72 (3H, s), 1.45 to 1.80 (4H),
3.65 to 3.85 (8H), 4.25 (1H, q, J
= 6.35 Hz), 4.34 (1H, q, J = 6.35)
Hz), 4.42 (1H, d, J = 12.21 Hz),
4.53 (1H, d, J = 12.7Hz), 5.31
(1H, d, J = 12.7 Hz), 5.43 (1H,
d, J = 12.2 Hz), 5.52 (1H, s), 5.
66 (1H, s), 7.19 to 7.22 (6H), 7.
84 to 7.90 (2H)
【0090】(2)前記(1)で得られたヒドロキシ化
合物(V) 184mgを用い、実施例1(2)と同様に
反応、処理して、3−〔2−(2−クロロフェニル)−
1−プロペニル−ONN−アゾキシ)−2,2−プロピ
レンジオキシブタン(III )を34.9mg(収率20
%)得た。(2) 3- [2- (2-chlorophenyl)-
34.9 mg of 1-propenyl-ONN-azoxy) -2,2-propylenedioxybutane (III) (yield 20
%)Obtained.
【0091】1H−NMR値:δ CDCl3 ,ppm 1.22(3H,d,J=6.35Hz)、1.50
(3H,s)、2.45(3H,d,J=1.95H
z)、3.93〜3.99(4H)、4.71(1H,
q,J=6.35Hz)、6.88(1H,d,J=
1.95Hz)、7.24〜7.42(4H) IR値:νmax,CHCl3 ,cm-1 1470 UV(EtOH,λmax)〔nm〕 233 〔α〕D 23 +26.4°(C 1.0,CHCl3 ) 1 H-NMR value: δ CDCl 3 , ppm 1.22 (3H, d, J = 6.35 Hz), 1.50
(3H, s), 2.45 (3H, d, J = 1.95H
z), 3.93 to 3.99 (4H), 4.71 (1H,
q, J = 6.35 Hz), 6.88 (1H, d, J =
1.95 Hz), 7.24 to 7.42 (4H) IR value: νmax, CHCl 3 , cm -1 1470 UV (EtOH, λmax) [nm] 233 [α] D 23 + 26.4 ° (C 1. 0, CHCl 3 )
【0092】(3)前記(2)で得られたプロピレンジ
オキシ化合物(III )27.4mgを用い、実施例1
(4)と同様に反応、処理して、粗製の油状物(II)を
得た。この粗製油状物を精製することなく、実施例1
(5)と同様に反応、処理して、目的物(I)をアンチ
−及びシン−異性体の混合物(4:1)として18.5
mg(収率77.8%)得た。(3) Example 1 was prepared using 27.4 mg of the propylenedioxy compound (III) obtained in (2) above.
Reaction and treatment were carried out in the same manner as in (4) to obtain a crude oily product (II). This crude oil was purified without purification of Example 1
By reacting and treating in the same manner as in (5), the target product (I) was prepared as a mixture of anti- and syn-isomers (4: 1) at 18.5.
mg (yield 77.8%) was obtained.
【0093】1H−NMR値:δ CDCl3 ,ppm 1.42(3H,d,J=6.35Hz)、1.44
(3H,d,J=6.70Hz)、1.83(3H,
s)、1.98(3H,s)、2.45(3H,d,J
=1.95Hz)、2.48(3H,d,J=1.95
Hz)、4.83(1H,q,J=6.35Hz)、
5.43(1H,q,J=6.70Hz)、6.88
(1H,d,J=1.95Hz)、6.90(1H,
d,J=1.95Hz)、7.25〜7.43(8H) IR値:νmax,CHCl3 ,cm-1 1463 1 H-NMR value: δ CDCl 3 , ppm 1.42 (3H, d, J = 6.35 Hz), 1.44
(3H, d, J = 6.70 Hz), 1.83 (3H,
s), 1.98 (3H, s), 2.45 (3H, d, J
= 1.95 Hz), 2.48 (3H, d, J = 1.95)
Hz), 4.83 (1H, q, J = 6.35Hz),
5.43 (1H, q, J = 6.70 Hz), 6.88
(1H, d, J = 1.95Hz), 6.90 (1H,
d, J = 1.95 Hz), 7.25 to 7.43 (8H) IR value: νmax, CHCl 3 , cm −1 1463
【0094】実施例7 3−〔2−(2,4−ジフルオロフェニル)−1−プロ
ペニル−ONN−アゾキシ〕−2−ヒドロキシイミノブ
タン〔化合物(I):R1 =2−フルオロフエニル基、
R2 =メチル基、R3 =4−フルオロ〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(V)309
mg及び2,4−ジフルオロアセトフェノン0.5ml
を用い、実施例1(1)と同様に反応、処理して、3−
〔2−(2,4−ジフルオロフェニル)−2−ヒドロキ
シプロピル−ONN−アゾキシ〕−2,2−プロピレン
ジオキシブタン(V) を419.4mg(収率74.2
%)得た。Example 7 3- [2- (2,4-difluorophenyl) -1-propenyl-ONN-azoxy] -2-hydroxyiminobutane [Compound (I): R 1 = 2-fluorophenyl group,
Production of R 2 = methyl group, R 3 = 4-fluoro]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (V) 309 obtained in Reference Example
mg and 2,4-difluoroacetophenone 0.5 ml
Was treated and treated in the same manner as in Example 1 (1) to give 3-
[2- (2,4-Difluorophenyl) -2-hydroxypropyl-ONN-azoxy] -2,2-propylenedioxybutane (V) 419.4 mg (yield 74.2)
%)Obtained.
【0095】(2)前記(1)で得られたヒドロキシ化
合物(V) 419mgを用い、実施例1(2)と同様に
反応、処理して、3−〔2−(2,4−ジフルオロフェ
ニル)−1−プロペニル−ONN−アゾキシ〕−2,2
−プロピレンジオキシブタン(III )を65.4mg
(収率16.5%)得た。(2) Using 419 mg of the hydroxy compound (V) obtained in (1) above, the reaction and treatment were carried out in the same manner as in Example 1 (2) to give 3- [2- (2,4-difluorophenyl). ) -1-Propenyl-ONN-azoxy] -2,2
-Propylenedioxybutane (III) 65.4 mg
(Yield 16.5%) was obtained.
【0096】(3)前記(2)で得られたプロピレンジ
オキシ化合物(III )65mgを用い、実施例1(4)
及び(5)と同様に反応、処理して目的物(I)をアン
チ−異性体及びシン−異性体の混合物(2:1)として
38.8mg(収率68.8%)得た。1 H−NMR値:δ CDCl3 ,ppm 1.42(3H,d,J=6.84Hz)、1.45
(3H,d,J=6.84Hz)、1.83(3H,
s)、1.98(3H,s)、2.44(3H,d,J
=1.95Hz)、2.47(3H,d,J=1.95
Hz)、4.83(1H,q,J=6.84Hz)、
5.41(1H,q,J=6.84Hz)、6.87
(1H,d,J=1.95Hz)、6.84〜7.30
(6H,s) IR値:νmax,CHCl3 ,cm-1 1464(3) Using 1 mg of the propylenedioxy compound (III) obtained in (2) above, Example 1 (4)
The reaction and treatment were carried out in the same manner as in (5) and (5) to obtain 38.8 mg (yield 68.8%) of the target product (I) as a mixture (2: 1) of anti-isomer and syn-isomer. 1 H-NMR value: δ CDCl 3 , ppm 1.42 (3H, d, J = 6.84 Hz), 1.45.
(3H, d, J = 6.84Hz), 1.83 (3H,
s), 1.98 (3H, s), 2.44 (3H, d, J
= 1.95 Hz), 2.47 (3H, d, J = 1.95)
Hz), 4.83 (1H, q, J = 6.84Hz),
5.41 (1H, q, J = 6.84Hz), 6.87
(1H, d, J = 1.95 Hz), 6.84 to 7.30
(6H, s) IR value: νmax, CHCl 3 , cm -1 1464
【0097】実施例8 3−(1−ヘキセニル−ONN−アゾキシ)−2−(3
−ヨードプロパルギルオキシイミノ)−ブタン〔化合物
(1):R1 =n−ブチル基、R2 =水素原子、R3 =
3−ヨードプロパルギル基〕の製造: (1)ジイソプロピルアミン0.536mlと1.59
Nのn−ブチルリチウムヘキサン溶液2.39mlか
ら、窒素雰囲気下、氷冷下で調製したリチウムジイソプ
ロピルアミドのテトラヒドロフラン溶液10mlに、参
考例で得られた3−(メチル−ONN−アゾキシ)−
2,2−プロピレンジオキシブタン(VI)549mgの
テトラヒドロフラン2.4mlを滴下した。この溶液に
n−バレルアルデヒド(VII)0.953mlを加え、更
に30分間攪拌した。反応液に飽和塩化アンモニウム水
溶液を加えて酢酸エチルで抽出し、有機層を水洗、乾燥
したのち減圧下で濃縮した。残渣をシリカゲルカラムク
ロマトグラフィー〔溶媒:酢酸エチル−n−ヘキサン
(1:3)〕で精製して、3−(2−ヒドロキシヘキシ
ル−ONN−アゾキシ)−2,2−プロピレンジオキシ
ブタン(V)436mg(収率:54%)を得た。Example 8 3- (1-Hexenyl-ONN-azoxy) -2- (3
-Iodopropargyloxyimino) -butane [Compound (1): R 1 = n-butyl group, R 2 = hydrogen atom, R 3 =
3-iodopropargyl group]: (1) 0.536 ml of diisopropylamine and 1.59
3- (methyl-ONN-azoxy) -obtained in Reference Example was added to 2.39 ml of N-butyllithium hexane solution of N to 10 ml of a tetrahydrofuran solution of lithium diisopropylamide prepared under ice cooling under a nitrogen atmosphere.
2.4 ml of tetrahydrofuran containing 549 mg of 2,2-propylenedioxybutane (VI) was added dropwise. 0.953 ml of n-valeraldehyde (VII) was added to this solution, and the mixture was further stirred for 30 minutes. A saturated aqueous solution of ammonium chloride was added to the reaction solution and the mixture was extracted with ethyl acetate. The organic layer was washed with water, dried and concentrated under reduced pressure. The residue was purified by silica gel column chromatography [solvent: ethyl acetate-n-hexane (1: 3)] to give 3- (2-hydroxyhexyl-ONN-azoxy) -2,2-propylenedioxybutane (V). 436 mg (yield: 54%) was obtained.
【0098】1H−NMR値:δ CDCl3 ,ppm 0.90(3H,br.t,J=8.0Hz)、1.1
6,1.18(計3H,各d,J=7.0Hz)、1.
24〜1.94(6H,m)、1.47(3H,s)、
3.66(1H,br.s)、3.84〜3.98(4
H,m)、4.0〜4.37(3H,m)、4.60
(1H,m) IR値:νmax,CHCl3 ,cm-1 1497,1370 1 H-NMR value: δ CDCl 3 , ppm 0.90 (3 H, br.t, J = 8.0 Hz), 1.1
6, 1.18 (total 3H, each d, J = 7.0Hz), 1.
24-1.94 (6H, m), 1.47 (3H, s),
3.66 (1H, br.s), 3.84 to 3.98 (4
H, m), 4.0 to 4.37 (3H, m), 4.60
(1H, m) IR value: νmax, CHCl 3 , cm -1 1497, 1370
【0099】(2)前記(1)で得られたヒドロキシ化
合物(V)160mgをピリジン1.5mlに溶解し、
氷冷下で塩化メタンスルホニル0.058mlを加え、
室温で一夜攪拌した。反応液を0℃に冷却し、水を一滴
加え、室温で30分間攪拌した。更に、水10mlを加
えて酢酸エチルで抽出した。有機層を0.5N塩酸及び
飽和炭酸水素ナトリウム水溶液で洗浄したのち乾燥し、
減圧下で濃縮して粗製のメタンスルホニル化合物220
mgを得た。このメタンスルホニル化合物をトルエン2
mlに溶解し、氷冷下で1,8−ジアザビシクロ〔5.
4.0〕−7−ウンデセン0.14mlを加え、室温で
一夜攪拌した。反応液に水10mlを加え、酢酸エチル
で抽出した。有機層を0.5N塩酸及び飽和炭酸水素ナ
トリウム水溶液で洗浄し、乾燥したのち減圧下で濃縮し
た。残渣をシリカゲルカラムクロマトグラフィー〔溶
媒:エーテル−n−ヘキサン(1:5)〕で精製して、
3−(1−ヘキセニル−ONN−アゾキシ)−2,2−
プロピレンジオキシブタン(III)133mg(収率89
%)を得た。(2) 160 mg of the hydroxy compound (V) obtained in (1) above was dissolved in 1.5 ml of pyridine,
Add 0.058 ml of methanesulfonyl chloride under ice cooling,
Stir overnight at room temperature. The reaction solution was cooled to 0 ° C., one drop of water was added, and the mixture was stirred at room temperature for 30 minutes. Further, 10 ml of water was added and the mixture was extracted with ethyl acetate. The organic layer was washed with 0.5N hydrochloric acid and a saturated aqueous sodium hydrogen carbonate solution, and then dried,
Crude methanesulfonyl compound 220 concentrated under reduced pressure
mg was obtained. This methanesulfonyl compound was added to toluene 2
It was dissolved in 1 ml of 1,8-diazabicyclo [5.
4.0] -7-Undecene (0.14 ml) was added, and the mixture was stirred at room temperature overnight. 10 ml of water was added to the reaction solution, and the mixture was extracted with ethyl acetate. The organic layer was washed with 0.5N hydrochloric acid and a saturated aqueous sodium hydrogen carbonate solution, dried and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography [solvent: ether-n-hexane (1: 5)],
3- (1-hexenyl-ONN-azoxy) -2,2-
133 mg of propylenedioxybutane (III) (yield 89
%) Was obtained.
【0100】1H−NMR値:δ CDCl3 ,ppm 0.90(3H,t,J=7.0Hz)、1.18(3
H,d,J=7.0Hz)、1.22〜1.53(4
H,m)、1.46(3H,s)、1.56〜1.68
(1H,m)、1.72〜1.90(1H,m)、2.
12〜2.26(2H,m)、3.86〜4.02(4
H,m)、4.64(1H,q,J=7.0Hz)、
6.98(2H,m) IR値:νmax,CHCl3 ,cm-1 1405,1380,1316,964 1 H-NMR value: δ CDCl 3 , ppm 0.90 (3 H, t, J = 7.0 Hz), 1.18 (3
H, d, J = 7.0 Hz), 1.22 to 1.53 (4
H, m), 1.46 (3H, s), 1.56 to 1.68
(1H, m), 1.72-1.90 (1H, m), 2.
12 to 2.26 (2H, m), 3.86 to 4.02 (4
H, m), 4.64 (1H, q, J = 7.0 Hz),
6.98 (2H, m) IR value: νmax, CHCl 3 , cm -1 1405, 1380, 1316, 964
【0101】(3)前記(2)で得られたプロピレンジ
オキシ化合物(III)80mgをアセトン3mlに溶解
し、塩化第二鉄−シリカゲル40mgを加え、室温で1
時間攪拌した。反応液をセライトを用いて濾過し、濾液
に水10mlを加えて酢酸エチルで抽出した。有機層を
水及び飽和食塩水で洗浄し、乾燥したのち減圧下で濃縮
した。残渣をシリカゲルカラムクロマトグラフィー〔溶
媒:エーテル−n−ヘキサン(1:5)〕で精製して、
3−(1−ヘキセニル−ONN−アゾキシ)−2−オク
ソブタン〔(II):KA−7367A〕31mg(収率
50%)を得た。(3) 80 mg of the propylenedioxy compound (III) obtained in (2) above was dissolved in 3 ml of acetone, 40 mg of ferric chloride-silica gel was added, and the mixture was stirred at room temperature for 1 hour.
Stir for hours. The reaction mixture was filtered through Celite, 10 ml of water was added to the filtrate, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried and concentrated under reduced pressure. The residue was purified by silica gel column chromatography [solvent: ether-n-hexane (1: 5)],
31 mg (yield 50%) of 3- (1-hexenyl-ONN-azoxy) -2-oxobutane [(II): KA-767A] was obtained.
【0102】比旋光度:〔α〕D 22 −160°(c
1.0、CHCl3 )1 H−NMR値:δ CDCl3 ,ppm 0.89(3H,t,J=7.0Hz)、1.27〜
1.48(4H,m)、1.37(3H,d,J=7.
5Hz)、1.22〜1.53(4H,m)、2.10
(3H,s)、2.22(2H,brq,J=7.5H
z)、4.52(1H,q,J=7.5Hz)、6.9
0(1H,dt,J=14.0Hz,7.5Hz)、
7.23(1H,dd,J=14.0Hz,1.0H
z) IR値:νmax,CHCl3 ,cm-1 1717,1463Specific rotation: [α] D 22 −160 ° (c
1.0, CHCl 3 ) 1 H-NMR value: δ CDCl 3 , ppm 0.89 (3H, t, J = 7.0 Hz), 1.27 to.
1.48 (4H, m), 1.37 (3H, d, J = 7.
5Hz), 1.22 to 1.53 (4H, m), 2.10
(3H, s), 2.22 (2H, brq, J = 7.5H
z), 4.52 (1H, q, J = 7.5 Hz), 6.9.
0 (1H, dt, J = 14.0Hz, 7.5Hz),
7.23 (1H, dd, J = 14.0Hz, 1.0H
z) IR value: νmax, CHCl 3 , cm −1 1717, 1463
【0103】(4)N−(3−ヨードプロパルギルオキ
シ)フタルイミド(IV′)50mgをエタノール0.8
mlに溶かし、ヒドラジン1水和物7.7mgを加え、
0℃で40分間攪拌した。反応後、生じた不溶物を濾去
し、濾液に前記(3)で得られたオクソ化合物(II)2
8.5mgを加えて室温で4時間攪拌した。反応後、水
で希釈し、酢酸エチルで抽出した。抽出液を飽和硫酸水
素カリウム溶液、飽和食塩水で洗浄し、芒硝で乾燥した
後、減圧下で濃縮した。残渣をプレパラティブ薄層クロ
マトグラフィー(酢酸エチル−ヘキサン)により精製
し、目的物(I)のアンチ−異性体とシン−異性体混合
物39.2mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.36(3H,d,4−CH3 )、1.92(3H,
s,1−CH3 )、4.79(2H,s,OCH2 )、
4.80(1H,q,3−CH−)、6.95(2H,
s,オレフイン性H)(4) 50 mg of N- (3-iodopropargyloxy) phthalimide (IV ') was added to 0.8 of ethanol.
Dissolve in ml, add 7.7 mg of hydrazine monohydrate,
The mixture was stirred at 0 ° C for 40 minutes. After the reaction, the resulting insoluble matter was filtered off, and the oxo compound (II) 2 obtained in (3) above was added to the filtrate.
8.5 mg was added, and the mixture was stirred at room temperature for 4 hours. After the reaction, the mixture was diluted with water and extracted with ethyl acetate. The extract was washed with saturated potassium hydrogen sulfate solution and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by preparative thin layer chromatography (ethyl acetate-hexane) to obtain 39.2 mg of a mixture of anti-isomer and syn-isomer of the target product (I). 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.36 (3H, d, 4-CH 3 ), 1.92 (3H,
s, 1-CH 3), 4.79 (2H, s, OCH 2),
4.80 (1H, q, 3-CH-), 6.95 (2H,
s, olefinic H)
【0104】実施例9 3−(スチリル−ONN−アゾキシ)−2−ヒドロキシ
イミノ−ブタン〔化合物(I):R1 =フエニル基、R
2 =R3 =水素原子〕の製造: (1)参考例で得られた化合物(VI)481mgをテト
ラヒドロフラン14mlに溶かし、−35℃に冷却した
後、リチウムジイソプロピルアミド2.2ml(1.5
Mヘキサン溶液)を加え、30分間攪拌した。次いで、
ベンズアルデヒド0.52mlを加えて、さらに40分
間攪拌した。反応後、飽和塩化アンモニウム溶液14m
lを加え、反応液を酢酸エチルで抽出した。酢酸エチル
層を水、飽和食塩水で洗浄し、乾燥後、減圧下濃縮し
た。残渣をシリカゲルのカラムクロマトグラフィー(酢
酸エチル−ヘキサン)で精製して、3−(2−ヒドロキ
シ−2−フエニルエチル−ONN−アゾキシ)−2,2
−プロピレンジオキシブタン(V)のジアステレオマー
の混合物476.5mg(収率63.3%)を得た。Example 9 3- (Styryl-ONN-azoxy) -2-hydroxyimino-butane [Compound (I): R 1 = phenyl group, R
2 = R 3 = hydrogen atom]: (1) 481 mg of the compound (VI) obtained in Reference Example was dissolved in 14 ml of tetrahydrofuran and cooled to −35 ° C., and then 2.2 ml of lithium diisopropylamide (1.5
M hexane solution) was added and stirred for 30 minutes. Then
0.52 ml of benzaldehyde was added, and the mixture was further stirred for 40 minutes. After the reaction, saturated ammonium chloride solution 14m
1 was added and the reaction solution was extracted with ethyl acetate. The ethyl acetate layer was washed with water and saturated brine, dried and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate-hexane) to give 3- (2-hydroxy-2-phenylethyl-ONN-azoxy) -2,2.
-476.5 mg (yield 63.3%) of a mixture of diastereomers of propylenedioxybutane (V) was obtained.
【0105】1H−NMR値:δ CDCl3 ,TM
S,ppm 1.18,1.22(3H,d,4−CH3 )、1.4
8,1.52(3H,s,1−CH3 )、1.98(2
H,m)、3.91(4H,m)、4.44(3H,
m)、5.38(1H,m)、7.40(5H,m,芳
香核H) 1 H-NMR value: δ CDCl 3 , TM
S, ppm 1.18,1.22 (3H, d , 4-CH 3), 1.4
8,1.52 (3H, s, 1- CH 3), 1.98 (2
H, m), 3.91 (4H, m), 4.44 (3H,
m), 5.38 (1H, m), 7.40 (5H, m, aromatic nucleus H)
【0106】(2)前記(1)で得られたヒドロキシ化
合物(V)476.5mgをトルエン11mlに溶か
し、氷冷下、1,8−ジアザビシクロ〔5.4.0〕−
7−ウンデセン0.73mlとメタンスルホニルクロリ
ド0.25mlを 順次滴下した。滴下後、室温で4時
間攪拌し、反応後、水−酢酸エチルで希釈し、酢酸エチ
ルで抽出した。酢酸エチル層を飽和硫酸水素カリウム溶
液、水、飽和炭酸水素ナトリウム溶液、水、飽和食塩水
で順次洗浄し、芒硝で乾燥後、減圧下濃縮した。残渣を
シリカゲルのカラムクロマトグラフィー(酢酸エチル−
ヘキサン)で精製して、3−(スチリル−ONN−アゾ
キシ)−2,2,−プロピレンジオキシブタン(III)3
44mg(収率76.9%)を得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.23(3H,d,4−CH3 )、1.51(3H,
s,1−CH3 )、1.73(2H,m)、3.97
(4H,m)、4.71(1H,q,3−CH−)、
7.45(5H,m,芳香核H)、7.73(2H,a
bq,オレフイン性H)(2) 476.5 mg of the hydroxy compound (V) obtained in (1) above was dissolved in 11 ml of toluene, and 1,8-diazabicyclo [5.4.0] -under ice cooling.
0.73 ml of 7-undecene and 0.25 ml of methanesulfonyl chloride were sequentially added dropwise. After the dropping, the mixture was stirred at room temperature for 4 hours, reacted, diluted with water-ethyl acetate, and extracted with ethyl acetate. The ethyl acetate layer was washed successively with saturated potassium hydrogensulfate solution, water, saturated sodium hydrogencarbonate solution, water and saturated brine, dried over sodium sulfate and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (ethyl acetate-
Hexane) to give 3- (styryl-ONN-azoxy) -2,2, -propylenedioxybutane (III) 3.
44 mg (yield 76.9%) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.23 (3H, d, 4-CH 3 ), 1.51 (3H,
s, 1-CH 3), 1.73 (2H, m), 3.97
(4H, m), 4.71 (1H, q, 3-CH-),
7.45 (5H, m, aromatic nucleus H), 7.73 (2H, a
bq, olefinic H)
【0107】(3)前記(2)で得られたプロピレンジ
オキシ化合物(III)30mgをアセトン2mlに溶か
し、塩化第二鉄−シリカゲル60mgを加えて、室温で
1時間攪拌する。反応後、シリカゲルを除き、ジエチル
エーテルで希釈してエーテル層を水、飽和食塩水で洗浄
し、芒硝で乾燥した後、減圧下で濃縮する。残渣をメタ
ノール1mlに溶かし、ヒドロキシルアミン塩酸塩1
1.5mg(1.5当量)、ピリジン0.05mlを加
えて、室温で30分間攪拌する。反応後、溶媒を減圧下
で濃縮し、シリカゲルの薄層クロマトグラフィーで精製
して、目的物(I)のアンチ−異性体とシン−異性体の
混合物20mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.42,1.46(3H,d,4−CH3 )、1.8
1,1.99(3H,s,1−CH3 )、4.88,
5.46(1H,q,3−CH−)、7.37〜7.5
8(5H,m,芳香核H)、7.60,7.02(1
H,d,1′=CH−)、7.83(1H,d,2′−
CH=)、8.10(1H,brs,OH) 1 H−NMR値:δ CDCl3 ,TMS,ppm(チ
ヤート上で判別可能) アンチ−異性体 1.42(3H,d,4−CH3 )、1.96(3H,
s,1−CH3 )、4.80(2H,s,−CH
2 −)、4.87(1H,q,−CH−)、7.45
(5H,m,芳香核H)、7.69(2H,abq,オ
レフイン性H)、シン−異性体 1.44(3H,d,4−CH3 )、1.83(3H,
s,1−CH3 )、4.79(2H,s,−CH
2 −)、5.35(1H,q,−CH−)、7.45
(5H,m,芳香核H)、7.69(2H,abq,オ
レフイン性H)(3) Propylene di obtained in (2) above
Dissolve 30 mg of oxy compound (III) in 2 ml of acetone
Then, add 60 mg of ferric chloride-silica gel and at room temperature.
Stir for 1 hour. After the reaction, remove silica gel and remove diethyl ether.
Dilute with ether and wash the ether layer with water and saturated saline.
Then, the extract is dried over sodium sulfate and concentrated under reduced pressure. The residue is meta
Dissolve in 1 ml of knoll, hydroxylamine hydrochloride 1
1.5 mg (1.5 equivalents) and 0.05 ml of pyridine were added.
Then, stir for 30 minutes at room temperature. After the reaction, remove the solvent under reduced pressure
Concentrate with and purify by silica gel thin-layer chromatography.
To obtain the anti-isomer and syn-isomer of the target compound (I).
20 mg of a mixture was obtained.1 H-NMR value: δ CDCl3, TMS, ppm 1.42, 1.46 (3H, d, 4-CH3) 1.8
1,1.99 (3H, s, 1-CH3), 4.88,
5.46 (1H, q, 3-CH-), 7.37 to 7.5
8 (5H, m, aromatic nucleus H), 7.60, 7.02 (1
H, d, 1 '= CH-), 7.83 (1H, d, 2'-
CH =), 8.10 (1H, brs, OH) 1 H-NMR value: δ CDCl3, TMS, ppm (
Anti-isomer 1.42 (3H, d, 4-CH)3), 1.96 (3H,
s, 1-CH3), 4.80 (2H, s, -CH
2-), 4.87 (1H, q, -CH-), 7.45
(5H, m, aromatic nucleus H), 7.69 (2H, abq, oh
Refining H), syn-isomer 1.44 (3H, d, 4-CH3), 1.83 (3H,
s, 1-CH3), 4.79 (2H, s, -CH
2-), 5.35 (1H, q, -CH-), 7.45
(5H, m, aromatic nucleus H), 7.69 (2H, abq, oh
Refinability H)
【0108】実施例10 3−(2′−クロロスチリル−ONN−アゾキシ)−2
−(3−ヨードプロパルギルオキシイミノ)−ブタン
〔化合物(I):R1 =2−クロロフエニル基、R2 =
水素原子、R3 =3−ヨードプロパルギル基〕の製造:
実施例5で得られた3−(2′−クロロスチリル−ON
N−アゾキシ)−2−ヒドロキシイミノ−ブタン(I)
74.3mgをジメチルホルムアミド0.7mlに溶か
し、炭酸カリウム192mg、ヨウ化カリウム230m
gおよびヨードプロパルギルブロミド340mgを加え
て、室温で1夜攪拌した。反応後、水に希釈し、酢酸エ
チルで抽出した。酢酸エチル層は飽和硫酸水素カリウム
溶液、飽和食塩水で洗浄し、芒硝で乾燥した後、減圧下
で濃縮した。残渣320mgをプレパラティブ薄層クロ
マトグラフィー(酢酸エチル−ヘキサン)で精製し、目
的物(I)6.6mg(収率5.5%)を得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.43(3H,d,4−CH3 )、1.97(3H,
s,1−CH3 )、4.80(2H,s,−CH
2 −)、4.88(1H,q,−CH−)、7.43
(4H,m,芳香核H)、7.89(2H,abq,オ
レフイ性H)Example 10 3- (2'-chlorostyryl-ONN-azoxy) -2
-(3-Iodopropargyloxyimino) -butane [Compound (I): R 1 = 2-chlorophenyl group, R 2 =
Production of hydrogen atom, R 3 = 3-iodopropargyl group]:
3- (2'-chlorostyryl-ON obtained in Example 5
N-azoxy) -2-hydroxyimino-butane (I)
74.3 mg was dissolved in dimethylformamide 0.7 ml, potassium carbonate 192 mg, potassium iodide 230 m
g and 340 mg of iodopropargyl bromide were added, and the mixture was stirred at room temperature overnight. After the reaction, the mixture was diluted with water and extracted with ethyl acetate. The ethyl acetate layer was washed with saturated potassium hydrogensulfate solution and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. 320 mg of the residue was purified by preparative thin layer chromatography (ethyl acetate-hexane) to obtain 6.6 mg of the desired product (I) (yield 5.5%). 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.43 (3H, d, 4-CH 3 ), 1.97 (3H,
s, 1-CH 3), 4.80 (2H, s, -CH
2- ), 4.88 (1H, q, -CH-), 7.43
(4H, m, aromatic nucleus H), 7.89 (2H, abq, oleophytic H)
【0109】実施例11 3−〔2−(2−クロロフエニル)−1−プロペニル−
ONN−アゾキシ〕−2−プロパルギルオキシイミノ−
ブタン〔化合物(I):R1 =2−クロロフエニル基、
R2 =メチル基、R3 =プロパルギル基〕の製造:実施
例6で得られた3−〔2−(2−クロロフエニル)−1
−プロペニル−ONN−アゾキシ〕−2−ヒドロキシイ
ミノ−ブタン(I)24.4mgをジメチルホルムアミ
ド0.2mlに溶かし、プロパルギルブロミド0.08
ml、炭酸カリウム60.8mg、ヨウ化カリウム7
1.8mgを加えて室温で13時間攪拌した。反応後、
水を加えジエチルエーテルで抽出した。エーテル層は飽
和塩化アンモニウム溶液、飽和食塩水で洗浄し、芒硝で
乾燥後、減圧下で濃縮した。残渣39mgをプレパラテ
ィブ薄層クロマトグラフィーにより精製し、置換オキシ
ムのアンチ−異性体11.1mgとシン−異性体5.8
mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm アンチ−異性体 1.41(3H,d,4−CH3 )、1.97(3H,
s,1−CH3 )、2.45(3H,d,3′−C
H3 )、2.45(1H,t,アセチレン性H)、4.
67(2H,d,−CH2 −)、4.84(1H,q,
3−CH−)、6.86(1H,q,1′−H)、7.
20〜7.33(3H,m)、7.39〜7.44(1
H,m) シン−異性体 1.43(3H,d,4−CH3 )、1.87(3H,
s,1−CH3 )、2.45(3H,d,3′−C
H3 )、2.47(1H,t,アセチレン性H)、4.
66(2H,d,−CH2 −)、5.33(1H,q,
3−CH−)、6.89(1H,q,1′−H)、7.
21〜7.33(3H,m)、7.39〜7.45(1
H,m)Example 11 3- [2- (2-chlorophenyl) -1-propenyl-
ONN-azoxy] -2-propargyloxyimino-
Butane [compound (I): R 1 = 2-chlorophenyl group,
R 2 = methyl group, R 3 = propargyl group]: 3- [2- (2-chlorophenyl) -1 obtained in Example 6
-Propenyl-ONN-azoxy] -2-hydroxyimino-butane (I) (24.4 mg) was dissolved in dimethylformamide (0.2 ml) to give propargyl bromide (0.08).
ml, potassium carbonate 60.8 mg, potassium iodide 7
1.8 mg was added and the mixture was stirred at room temperature for 13 hours. After the reaction
Water was added and the mixture was extracted with diethyl ether. The ether layer was washed with a saturated ammonium chloride solution and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. 39 mg of the residue were purified by preparative thin layer chromatography, 11.1 mg of the anti-isomer of the substituted oxime and 5.8 of the syn-isomer.
mg was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm anti-isomer 1.41 (3H, d, 4-CH 3 ), 1.97 (3H,
s, 1-CH 3), 2.45 (3H, d, 3'-C
H 3), 2.45 (1H, t, acetylenic H), 4.
67 (2H, d, -CH 2 -), 4.84 (1H, q,
3-CH-), 6.86 (1H, q, 1'-H), 7.
20 to 7.33 (3H, m), 7.39 to 7.44 (1
H, m) syn - isomer 1.43 (3H, d, 4- CH 3), 1.87 (3H,
s, 1-CH 3), 2.45 (3H, d, 3'-C
H 3 ), 2.47 (1H, t, acetylenic H), 4.
66 (2H, d, -CH 2 -), 5.33 (1H, q,
3-CH-), 6.89 (1H, q, 1'-H), 7.
21-7.33 (3H, m), 7.39-7.45 (1
H, m)
【0110】実施例12 3−〔2−(2−クロロフエニル)−1−プロペニル−
ONN−アゾキシ〕−2−(3−ヨードプロパルギルオ
キシイミノ)−ブタン〔化合物(I):R1 =2−クロ
ロフエニル基、R2 =メチル基、R3 =3−ヨードプロ
パルギル基〕の製造: (1)アンチ−異性体 実施例11で得られた3−〔2−(2−クロロフエニ
ル)−1−プロペニル−ONN−アゾキシ〕−2−プロ
パルギルオキシイミノ−ブタン(I)のアンチ−異性体
11.1mgをメタノール0.3mlに溶かし、氷冷攪
拌下、10規定水酸化ナトリウム溶液0.01ml、ヨ
ウ素21.8mgを順次加えた。1時間反応後、ジエチ
ルエーテルと1Mチオ硫酸ナトリウムを加え、ジエチル
エーテルで抽出した。エーテル層は飽和塩化アンモニウ
ム溶液、飽和食塩水で洗浄し、芒硝で乾燥後、減圧下で
濃縮した。残渣16mgをプレパラティブ薄層クロマト
グラフィー(アセトン−ベンゼン)により精製し、目的
物のアンチ−異性体13.4mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.41(3H,d,4−CH3 )、1.96(3H,
s,1−CH3 )、2.45(3H,d,3′−C
H3 )、4.80(2H,s,OCH2 )、4.82
(1H,q,3−CH−)、6.86(1H,q,1′
−CH)、7.17〜7.44(4H,m)Example 12 3- [2- (2-chlorophenyl) -1-propenyl-
Production of ONN-azoxy] -2- (3-iodopropargyloxyimino) -butane [Compound (I): R 1 = 2-chlorophenyl group, R 2 = methyl group, R 3 = 3-iodopropargyl group]: 1) Anti-isomer 11. The anti-isomer of 3- [2- (2-chlorophenyl) -1-propenyl-ONN-azoxy] -2-propargyloxyimino-butane (I) obtained in Example 11. 1 mg was dissolved in 0.3 ml of methanol, and 0.01 N of 10N sodium hydroxide solution and 21.8 mg of iodine were sequentially added while stirring with ice cooling. After reacting for 1 hour, diethyl ether and 1M sodium thiosulfate were added, and the mixture was extracted with diethyl ether. The ether layer was washed with a saturated ammonium chloride solution and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. The residue (16 mg) was purified by preparative thin layer chromatography (acetone-benzene) to obtain the target anti-isomer (13.4 mg). 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.41 (3H, d, 4-CH 3 ), 1.96 (3H,
s, 1-CH 3), 2.45 (3H, d, 3'-C
H 3), 4.80 (2H, s, OCH 2), 4.82
(1H, q, 3-CH-), 6.86 (1H, q, 1 '
-CH), 7.17 to 7.44 (4H, m)
【0111】(2)シン−異性体 実施例11で得られた化合物(I)のシン−異性体5.
8mgをメタノール0.2mlに溶かし、氷冷攪拌下、
10規定水酸化ナトリウム溶液0.005ml、ヨウ素
14.8mgを順次加えた。1時間反応後、ジエチルエ
ーテルと1Mチオ硫酸ナトリウムを加え、ジエチルエー
テルにより抽出した。エーテル層は飽和塩化アンモニウ
ム溶液、飽和食塩水で洗浄し、芒硝で乾燥後、減圧下で
濃縮した。残渣8mgをプレパラティブ薄層クロマトグ
ラフィー(アセトン−ベンゼン)により精製し、目的物
のシン−異性体13.4mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.42(3H,d,4−CH3 )、1.86(3H,
s,1−CH3 )、2.47(3H,d,3′−C
H3 )、4.98(2H,s,OCH2 )、5.32
(1H,q,3−CH−)、6.89(1H,q,1′
−CH−)、7.18〜7.45(4H,m)(2) Syn-isomer 5. Syn-isomer of compound (I) obtained in Example 11.
8 mg was dissolved in 0.2 ml of methanol and stirred under ice cooling.
0.005 ml of a 10 N sodium hydroxide solution and 14.8 mg of iodine were sequentially added. After reacting for 1 hour, diethyl ether and 1M sodium thiosulfate were added, and the mixture was extracted with diethyl ether. The ether layer was washed with a saturated ammonium chloride solution and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. The residue (8 mg) was purified by preparative thin layer chromatography (acetone-benzene) to obtain the target syn-isomer (13.4 mg). 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.42 (3H, d, 4-CH 3 ), 1.86 (3H,
s, 1-CH 3), 2.47 (3H, d, 3'-C
H 3 ), 4.98 (2H, s, OCH 2 ), 5.32
(1H, q, 3-CH-), 6.89 (1H, q, 1 '
-CH-), 7.18 to 7.45 (4H, m)
【0112】実施例13 3−〔2−(4−(3−ヨードプロパルギル)オキシフ
エニル)−1−プロペニル−ONN−アゾキシ〕−2−
メトキシイミノ−ブタン〔化合物(I):R1=4−
(3−ヨードプロパルギル)オキシフエニル基、R2 =
R3 =メチル基〕の製造:実施例1(4)で得られた3
−〔2−(4−(3−ヨードプロパルギル)オキシフエ
ニル)−1−プロペニル−ONN−アゾキシ〕−2−オ
クソブタン(II)46mgをメタノール1mlに溶か
し、O−メチルヒドロキシルアミン塩酸塩8mgを加
え、室温で攪拌下ピリジン0.1mlを滴下した。10
分間攪拌した後、溶媒の一部を減圧下で濃縮し、プレパ
ラティブ薄層クロマトグラフィーにかけ、目的物のアン
チ−メチルオキシム23mgを得た。旋光度+22.9
(c1,CHCl3 )。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.41(3H,d,4−CH3 )、1.93(3H,
s,1−CH3 )、2.47(3H,d,3′−C
H3 )、3.86(3H,s,OCH3 )、4.80
(1H,q,3−CH−)、4.85(2H,s,OC
H2 )、6.97(2H,m,芳香核H)、7.11
(1H,m,1′−CH)、7.40(2H,m,芳香
核H)Example 13 3- [2- (4- (3-Iodopropargyl) oxyphenyl) -1-propenyl-ONN-azoxy] -2-
Methoxyimino-butane [Compound (I): R 1 = 4-
(3-iodopropargyl) oxyphenyl group, R 2 =
R 3 = methyl group]: 3 obtained in Example 1 (4)
46 mg of-[2- (4- (3-iodopropargyl) oxyphenyl) -1-propenyl-ONN-azoxy] -2-oxobutane (II) was dissolved in 1 ml of methanol, 8 mg of O-methylhydroxylamine hydrochloride was added, and the mixture was stirred at room temperature. With stirring, 0.1 ml of pyridine was added dropwise. 10
After stirring for a minute, part of the solvent was concentrated under reduced pressure and subjected to preparative thin-layer chromatography to obtain 23 mg of the target anti-methyloxime. Optical rotation +22.9
(C1, CHCl 3). 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.41 (3H, d, 4-CH 3 ), 1.93 (3H,
s, 1-CH 3), 2.47 (3H, d, 3'-C
H 3 ), 3.86 (3H, s, OCH 3 ), 4.80
(1H, q, 3-CH-), 4.85 (2H, s, OC
H 2 ), 6.97 (2H, m, aromatic nucleus H), 7.11
(1H, m, 1'-CH), 7.40 (2H, m, aromatic nucleus H)
【0113】実施例14 3−〔4′−(3−ヨードプロパルギル)オキシスチリ
ル−ONN−アゾキシ〕−2−メトキシイミノ−ブタン
〔化合物(I):R1 =4−(3−ヨードプロパルギ
ル)オキシフエニル基、R2 =水素原子、R3 =メチル
基〕の製造:実施例4(4)で得られた3−〔4′−
(3−ヨードプロパルギル)オキシスチリル−ONN−
アゾキシ〕−2−オクソブタン(II)193mgをメタ
ノール4mlとジメチルホルムアミド1mlの混合液に
溶かし、O−メチルヒドロキシルアミン塩酸塩61m
g、ピリジン0.06mlを加え、室温で75分間攪拌
した。反応後、水に希釈し、酢酸エチルで抽出した。抽
出液を飽和硫酸水素カリウム溶液、飽和食塩水で洗浄
し、芒硝で乾燥後、減圧下で濃縮した。残渣をプレパラ
ティブ薄層クロマトグラフィーにより精製し、目的物
(I)のアンチ−異性体122.9mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.41(3H,d,4−CH3 )、1.92(3H,
s,1−CH3 )、3.86(3H,s,O−C
H3 )、4.86(2H,s,−CH2 −)、4.86
(1H,q,−CH−)、7.22(4H,abq,芳
香核H)、7.64(2H,abq,オレフイン性H)Example 14 3- [4 '-(3-Iodopropargyl) oxystyryl-ONN-azoxy] -2-methoxyimino-butane [Compound (I): R 1 = 4- (3-iodopropargyl) oxyphenyl] Group, R 2 = hydrogen atom, R 3 = methyl group]: 3- [4′-obtained in Example 4 (4)
(3-Iodopropargyl) oxystyryl-ONN-
Azoxy] -2-oxobutane (II) (193 mg) was dissolved in a mixed solution of methanol (4 ml) and dimethylformamide (1 ml) to give O-methylhydroxylamine hydrochloride (61 m).
g and 0.06 ml of pyridine were added, and the mixture was stirred at room temperature for 75 minutes. After the reaction, the mixture was diluted with water and extracted with ethyl acetate. The extract was washed with saturated potassium hydrogen sulfate solution and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by preparative thin layer chromatography to obtain 122.9 mg of the anti-isomer of the desired product (I). 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.41 (3H, d, 4-CH 3 ), 1.92 (3H,
s, 1-CH 3), 3.86 (3H, s, O-C
H 3), 4.86 (2H, s, -CH 2 -), 4.86
(1H, q, -CH-), 7.22 (4H, abq, aromatic nucleus H), 7.64 (2H, abq, olefinic H)
【0114】実施例15 2−カルボキシルメトキシイミノ−3−〔4′−(3−
ヨードプロパルギル)オキシスチリル−ONN−アゾキ
シ〕−ブタン〔化合物(I):R1 =4−(3−プロパ
ルギル)オキシフエニル基、R2 =水素原子、R3 =カ
ルボキシルメチル基〕の製造:実施例4(4)で得られ
た3−〔4′−(3−ヨードプロパルギル)オキシスチ
リル−ONN−アゾキシ〕−2−オクソブタン20mg
をメタノール−ジメチルホルムアミド(5:1)0.2
mlに溶かし、室温で攪拌下、ピリジン0.01mlと
O−カルボキシメチルヒドロキシルアミン塩酸塩14m
gを加えた。30分間反応後、ジエチルエーテルで希釈
し、エーテル層を1規定塩酸、水、飽和食塩水で順次洗
浄した。エーテル層は芒硝で乾燥後、減圧下で濃縮し
た。残渣をプレパラティブ薄層クロマトグラフィーによ
り精製し、目的物(I)(アンチ−異性体:シン−異性
体 3:1の混合物)19mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.41,1.50(3H,d,4−CH3 )、1.7
9,2.01(3H,s,1−CH3 )、4.64(2
H,s,OCH2 CO)、4.86(2H,s,OCH
2 C)、6.98,7.46(each 2H,d,芳
香核H)、7.51,7.77(each 1H,d,
オレフイン性H)Example 15 2-Carboxymethoxyimino-3- [4 '-(3-
Production of iodopropargyl) oxystyryl-ONN-azoxy] -butane [Compound (I): R 1 = 4- (3-propargyl) oxyphenyl group, R 2 = hydrogen atom, R 3 = carboxylmethyl group]: Example 4 20 mg of 3- [4 '-(3-iodopropargyl) oxystyryl-ONN-azoxy] -2-oxobutane obtained in (4)
Methanol-dimethylformamide (5: 1) 0.2
0.01 ml of pyridine and 14 m of O-carboxymethylhydroxylamine hydrochloride under stirring at room temperature.
g was added. After reacting for 30 minutes, the mixture was diluted with diethyl ether, and the ether layer was washed successively with 1N hydrochloric acid, water and saturated brine. The ether layer was dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by preparative thin layer chromatography to obtain 19 mg of the desired product (I) (anti-isomer: syn-isomer 3: 1 mixture). 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.41, 1.50 (3 H, d, 4-CH 3 ), 1.7
9,2.01 (3H, s, 1- CH 3), 4.64 (2
H, s, OCH 2 CO), 4.86 (2H, s, OCH
2 C), 6.98, 7.46 (each 2H, d, aromatic nucleus H), 7.51, 7.77 (each 1H, d,
Olefinity H)
【0115】実施例16 3−(6−ヨード−1−ヘキセン−5−イル−ONN−
アゾキシ)−2−ヒドロキシイミノブタン〔化合物
(I):R1 =4−ヨード−3−ブチニル基、R2=R
3 =H〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)200
mgを無水テトラヒドロフラン2mlに溶かし、−40
℃に冷却した。これにリチウムジイソプロピルアミド
(1.55Mヘキサン溶液)0.9mlを滴下し、20
分間攪拌した。これに5−ヨード−4−ペンチナール2
90mgの無水テトラヒドロフラン2ml溶液を徐々に
滴下した。30分間攪拌した後、氷冷下、飽和塩化アン
モニウム溶液を加えて反応を停止した。反応液をジエチ
ルエーテルで抽出し、エーテル層を水、飽和食塩水で洗
浄し、芒硝で乾燥後、減圧下で濃縮した。残渣をシリカ
ゲルのカラムクロマトグラフィーで精製し、3−(2−
ヒドロキシ−6−ヨード−5−ヘキシニル−ONN−ア
ゾキシ)−2,2−プロピレンジオキシブタン(V)3
00mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.25,1.28(3H,d,4−CH3 )、1.5
0,1.53(3H,s,1−CH3 )Example 16 3- (6-Iodo-1-hexen-5-yl-ONN-
Azoxy) -2-hydroxyiminobutane [compound (I): R 1 = 4-iodo-3-butynyl group, R 2 = R
3 = H]: (1) 3- (Methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) 200 obtained in Reference Example
Dissolve mg in 2 ml anhydrous tetrahydrofuran, -40
Cooled to ° C. 0.9 ml of lithium diisopropylamide (1.55M hexane solution) was added dropwise to this, and 20
Stir for minutes. 5-iodo-4-pentinal 2
A solution of 90 mg of anhydrous tetrahydrofuran in 2 ml was gradually added dropwise. After stirring for 30 minutes, the reaction was stopped by adding a saturated ammonium chloride solution under ice cooling. The reaction mixture was extracted with diethyl ether, the ether layer was washed with water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- (2-
Hydroxy-6-iodo-5-hexynyl-ONN-azoxy) -2,2-propylenedioxybutane (V) 3
Obtained 00 mg. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.25, 1.28 (3H, d, 4-CH 3 ), 1.5
0,1.53 (3H, s, 1- CH 3)
【0116】(2)前記(1)で得たヒドロキシ化合物
(V)270mgを無水テトラヒドロフラン1mlに溶
かし、氷冷下、トリエチルアミン0.16mlとメタン
スルホニウムクロリド0.08mlを加え、20分間攪
拌した。反応後、反応液に飽和炭酸水素ナトリウム溶液
を加え、ジエチルエーテルで抽出した。エーテル層を1
規定塩酸、水、飽和炭酸水素ナトリウム溶液、飽和食塩
水で洗浄し、芒硝で乾燥後、減圧下で濃縮した。得られ
た油状物を無水テトラヒドロフラン1mlに溶かし、氷
冷下、1,8−ジアザビシクロ〔5.4.0〕−7−ウ
ンデセン0.5mlを加え、1時間攪拌した。反応後、
反応液に水を加え、ジエチルエーテルで抽出した。エー
テル層を1規定塩酸、水、飽和食塩水で洗浄し、芒硝で
乾燥後、減圧下で濃縮した。残渣をシリカゲルのカラム
クロマトグラフィーで精製し、3−(6−ヨード−1−
ヘキセン−5−イル−ONN−アゾキシ)−2,2−プ
ロピレンジオキシブタン(III)63mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.17(3H,d,4−CH3 )、1.47(3H,
s,1−CH3 )、1.57〜1.66(1H,m)、
1.74〜1.89(1H,m)、2.38〜2.48
(2H,m)、2.55(2H,dt,3′−CH
2 −)、3.88〜3.99(4H,m)、4.65
(1H,q)、6.92〜7.08(2H,m)(2) 270 mg of the hydroxy compound (V) obtained in (1) above was dissolved in 1 ml of anhydrous tetrahydrofuran, 0.16 ml of triethylamine and 0.08 ml of methanesulfonium chloride were added under ice cooling, and the mixture was stirred for 20 minutes. After the reaction, saturated sodium hydrogen carbonate solution was added to the reaction solution, and the mixture was extracted with diethyl ether. 1 ether layer
The extract was washed with normal hydrochloric acid, water, saturated sodium hydrogen carbonate solution and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The obtained oily substance was dissolved in 1 ml of anhydrous tetrahydrofuran, 0.5 ml of 1,8-diazabicyclo [5.4.0] -7-undecene was added under ice cooling, and the mixture was stirred for 1 hour. After the reaction
Water was added to the reaction solution, and the mixture was extracted with diethyl ether. The ether layer was washed with 1N hydrochloric acid, water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- (6-iodo-1-
63 mg of hexen-5-yl-ONN-azoxy) -2,2-propylenedioxybutane (III) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.17 (3H, d, 4-CH 3 ), 1.47 (3H,
s, 1-CH 3), 1.57~1.66 (1H, m),
1.74-1.89 (1H, m), 2.38-2.48
(2H, m), 2.55 (2H, dt, 3'-CH
2- ), 3.88 to 3.99 (4H, m), 4.65
(1H, q), 6.92 to 7.08 (2H, m)
【0117】(3)前記(2)で得られたプロピレンジ
オキシ体(III)10mgをアセトニトリル0.5mlに
溶かし、氷冷下塩化第二鉄−シリカゲル26mgを加え
て、室温で20分間攪拌した。反応後、反応液からシリ
カゲルを濾去し、ジエチルエーテルで希釈した。エーテ
ル層は飽和炭酸水素ナトリウム、飽和塩化アンモニウム
溶液、飽和食塩水で精製し、芒硝で乾燥後、減圧下で濃
縮した。残渣をシリカゲルのカラムクロマトグラフィー
で精製し、3−(6−ヨード−1−ヘキセン−5−イル
−ONN−アゾキシ)−2−オクソブタン(II)8mg
を得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.47(3H,d,4−CH3 )、2.19(3H,
s,1−CH3 )、2.44〜2.50(2H,m)、
2.54〜2.60(2H,dt)、4.61(1H,
q)、7.02〜7.06(2H,m)(3) 10 mg of the propylenedioxy derivative (III) obtained in (2) above was dissolved in 0.5 ml of acetonitrile, and 26 mg of ferric chloride-silica gel was added under ice cooling, and the mixture was stirred at room temperature for 20 minutes. . After the reaction, silica gel was filtered off from the reaction solution and diluted with diethyl ether. The ether layer was purified with saturated sodium hydrogen carbonate, a saturated ammonium chloride solution, and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel, 3- (6-iodo-1-hexen-5-yl-ONN-azoxy) -2-oxobutane (II) 8 mg.
Got 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.47 (3H, d, 4-CH 3 ), 2.19 (3H,
s, 1-CH 3), 2.44~2.50 (2H, m),
2.54 to 2.60 (2H, dt), 4.61 (1H,
q), 7.02 to 7.06 (2H, m)
【0118】(4)前記(3)で得られたオクソ化合物
21mgをジメチルホルムアミド−メタノール(1:
5)0.5mlに溶かし、室温でヒドロキシルアミン塩
酸塩11mg、ビリジン0.015mlを加えて、30
分間攪拌した。反応後、反応液をジエチルエーテルで希
釈し、エーテル層は0.5規定塩酸、飽和炭酸水素ナト
リウム溶液、飽和塩化アンモニウム溶液、飽和食塩水で
洗浄し、芒硝で乾燥後、減圧下で濃縮した。残渣をシリ
カゲルのカラムクロマトグラフィーで精製し、目的物
(I)のアンチ−異性体9mg及びシン−異性体2mg
を得た。1 H−NMR値:δ CDCl3 ,TMS,ppm アンチ−異性体 1.38(3H,d,4−CH3 )、1.95(3H,
s,1−CH3 )、2.41〜2.47(2H,m)、
2.53〜2.62(2H,dt)、4.79(1H,
q)、7.00〜7.03(2H,m) シン−異性体 1.42(3H,d,4−CH3 )、1.77(3H,
s,1−CH3 )、2.42〜2.48(2H,m)、
2.54〜2.62(2H,dt)、5.37(1H,
q)、7.01〜7.04(2H,m)(4) 21 mg of the oxo compound obtained in (3) above was added to dimethylformamide-methanol (1:
5) Dissolve in 0.5 ml, add 11 mg of hydroxylamine hydrochloride and 0.015 ml of pyridine at room temperature,
Stir for minutes. After the reaction, the reaction solution was diluted with diethyl ether, and the ether layer was washed with 0.5N hydrochloric acid, a saturated sodium hydrogen carbonate solution, a saturated ammonium chloride solution, and a saturated saline solution, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain 9 mg of anti-isomer and 2 mg of syn-isomer of the target product (I).
Got 1 H-NMR value: δ CDCl 3 , TMS, ppm anti-isomer 1.38 (3H, d, 4-CH 3 ), 1.95 (3H,
s, 1-CH 3), 2.41~2.47 (2H, m),
2.53 to 2.62 (2H, dt), 4.79 (1H,
q), 7.00~7.03 (2H, m ) syn - isomer 1.42 (3H, d, 4- CH 3), 1.77 (3H,
s, 1-CH 3), 2.42~2.48 (2H, m),
2.54 to 2.62 (2H, dt), 5.37 (1H,
q), 7.01 to 7.04 (2H, m)
【0119】実施例17 2−ヒドロキシイミノ−3−〔4′−(4−ヨード−3
−ブチニル)スチリル−ONN−アゾキシ〕−ブタン
〔化合物(I):R1 =4−(4−ヨード−3−ブチニ
ル)フエニル基、R2 =R3 =水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)60m
gを無水テトラヒドロフラン0.7mlに溶かし、−4
0℃に冷却した。これにリチウムジイソプロピルアミド
(1.56Mヘキサン溶液)0.26mlを滴下し、2
0分間攪拌した。これにp−(3−ブチニル)ベンズア
ルデヒド50mgの無水テトラヒドロフラン0.5ml
の溶液を徐々に滴下した。30分間攪拌した後、氷冷
下、飽和塩化アンモニウム溶液を加えて反応を停止し
た。反応液をジエチルエーテルで抽出し、エーテル層を
水、飽和食塩水で洗浄し、芒硝で乾燥後、減圧下で濃縮
した。残渣をシリカゲルのカラムクロマトグラフィーに
かけて精製し、3−〔2−ヒドロキシ−2−(4′−
(3−ブチニル)フエニル)−エチル−ONN−アゾキ
シ〕−2,2−プロピレンジオキシブタン(V′)35
mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.10,1.16(3H,d,4−CH3 )、1.4
3,1.44(3H,s,1−CH3 )、1.57〜
1.68(1H,m)、1.80〜1.85(1H,
m)、1.97(1H,t)、2.47(2H,d
t)、2.84(2H,t)、3.88〜3.97(4
H,m)、4.35〜4.40(2H,m)、4.56
〜4.61(1H,m)、5.23〜5.35(1H,
m)、7.25〜7.38(4H,m)Example 17 2-Hydroxyimino-3- [4 '-(4-iodo-3)
-Butynyl) styryl-ONN-azoxy] -butane [Compound (I): R 1 = 4- (4-iodo-3-butynyl) phenyl group, R 2 = R 3 = hydrogen atom]: (1) Reference 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) obtained in the example 60 m
g was dissolved in anhydrous tetrahydrofuran 0.7 ml, -4
Cooled to 0 ° C. 0.26 ml of lithium diisopropylamide (1.56M hexane solution) was added dropwise to this, and 2
Stir for 0 minutes. To this, p- (3-butynyl) benzaldehyde 50 mg anhydrous tetrahydrofuran 0.5 ml
The above solution was gradually added dropwise. After stirring for 30 minutes, the reaction was stopped by adding a saturated ammonium chloride solution under ice cooling. The reaction mixture was extracted with diethyl ether, the ether layer was washed with water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- [2-hydroxy-2- (4'-
(3-Butynyl) phenyl) -ethyl-ONN-azoxy] -2,2-propylenedioxybutane (V ') 35
mg was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.10, 1.16 (3H, d, 4-CH 3 ), 1.4
3,1.44 (3H, s, 1- CH 3), 1.57~
1.68 (1H, m), 1.80 to 1.85 (1H,
m), 1.97 (1H, t), 2.47 (2H, d)
t), 2.84 (2H, t), 3.88 to 3.97 (4
H, m), 4.35 to 4.40 (2H, m), 4.56
-4.61 (1H, m), 5.23-5.35 (1H,
m), 7.25 to 7.38 (4H, m)
【0120】(2)前記(1)で得られたヒドロキシ化
合物(V′)35mgを無水テトラヒドロフラン0.2
mlに溶かし、氷冷下、トリエチルアミン0.11ml
とメタンスルホニルクロリド0.06mlを加え、45
分間攪拌した。反応後、反応液に飽和炭酸水素ナトリウ
ム溶液を加え、ジエチルエーテルで抽出した。エーテル
層を1規定塩酸、水、飽和炭酸水素ナトリウム溶液、飽
和食塩水で洗浄し、芒硝で乾燥後、減圧下で濃縮した。
得られた油状物を無水テトラヒドロフラン0.2mlに
溶かし、氷冷下、1,8−ジアザビシクロ〔5.4.
0〕−7−ウンデセン0.076mlを加え、10分間
攪拌した。反応後、反応液に水を加え、ジエチルエーテ
ルで抽出した。エーテル層を1規定塩酸、水、飽和食塩
水で洗浄し、芒硝で乾燥後、減圧下で濃縮した。残渣を
シリカゲルのカラムクロマトグラフィーにかけて精製
し、3−〔4′−(3−ブチニル)スチリル−ONN−
アゾキシ〕−2,2−プロピレンジオキシブタン(III
′) 18mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.22(3H,d,4−CH3 )、1.51(3H,
s,1−CH3 )、1.56〜1.66(1H,m)、
1.82〜1.87(1H,m)、1.99(1H,
t,)、2.50(2H,dt,3′−CH2 −)、
2.86(1H,t)、3.93〜4.01(4H,
m)、4.72(1H,q)、7.26(2H,d)、
7.43(2H,d)、7.63(1H,d)、7.7
8(1H,d)(2) 35 mg of the hydroxy compound (V ') obtained in the above (1) was added to anhydrous tetrahydrofuran 0.2
Dissolve in ml and under ice cooling, triethylamine 0.11 ml
And 0.06 ml of methanesulfonyl chloride,
Stir for minutes. After the reaction, saturated sodium hydrogen carbonate solution was added to the reaction solution, and the mixture was extracted with diethyl ether. The ether layer was washed with 1N hydrochloric acid, water, saturated sodium hydrogen carbonate solution and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure.
The obtained oily substance was dissolved in 0.2 ml of anhydrous tetrahydrofuran, and 1,8-diazabicyclo [5.4.
0] -7-Undecene (0.076 ml) was added, and the mixture was stirred for 10 minutes. After the reaction, water was added to the reaction solution and the mixture was extracted with diethyl ether. The ether layer was washed with 1N hydrochloric acid, water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- [4 '-(3-butynyl) styryl-ONN-
Azoxy] -2,2-propylenedioxybutane (III
′) 18 mg was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.22 (3H, d, 4-CH 3 ), 1.51 (3H,
s, 1-CH 3), 1.56~1.66 (1H, m),
1.82 to 1.87 (1H, m), 1.99 (1H,
t,), 2.50 (2H, dt, 3'-CH 2 -),
2.86 (1H, t), 3.93 to 4.01 (4H,
m), 4.72 (1H, q), 7.26 (2H, d),
7.43 (2H, d), 7.63 (1H, d), 7.7
8 (1H, d)
【0121】(3)前記(2)で得られたブチニル化合
物(III ′)脱水体18mgをメタノール0.8mlに
溶かし、氷冷下、10規定苛性ソーダ0.02ml、ヨ
ウ素28mgを加えた後、室温に上げ20分間攪拌し
た。反応後、飽和チオ硫酸ナトリウム溶液を加えて、ジ
エチルエーテルで抽出した。エーテル層は1規定塩酸、
飽和炭酸水素ナトリウム溶液、飽和食塩水で洗浄し、芒
硝で乾燥後、減圧下で濃縮した。残渣をシリカゲルのカ
ラムクロマトグラフィーで精製し、3−〔4′−(4−
ヨード−3−ブチニル)スチリル−ONN−アゾキシ〕
−2,2−プロピレンジオキシブタン(III)22mgを
得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.22(3H,d,4−CH3 )、1.51(3H,
s,1−CH3 )、1.56〜1.66(1H,m)、
1.82〜1.87(1H,m)、2.65(2H,
t)、2.85(1H,t)、3.93〜4.01(4
H,m)、4.71(1H,q)、8.23(2H,
d)、7.43(2H,d)、7.63(1H,d)、
7.78(1H,d)(3) 18 mg of the butynyl compound (III ') dehydrated product obtained in the above (2) was dissolved in 0.8 ml of methanol, 102 caustic soda (0.02 ml) and iodine (28 mg) were added under ice cooling, and then room temperature. And stirred for 20 minutes. After the reaction, saturated sodium thiosulfate solution was added, and the mixture was extracted with diethyl ether. The ether layer is 1N hydrochloric acid,
The extract was washed with saturated sodium hydrogen carbonate solution and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- [4 '-(4-
Iodo-3-butynyl) styryl-ONN-azoxy]
22 mg of -2,2-propylenedioxybutane (III) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.22 (3H, d, 4-CH 3 ), 1.51 (3H,
s, 1-CH 3), 1.56~1.66 (1H, m),
1.82 to 1.87 (1H, m), 2.65 (2H,
t), 2.85 (1H, t), 3.93 to 4.01 (4
H, m), 4.71 (1H, q), 8.23 (2H,
d), 7.43 (2H, d), 7.63 (1H, d),
7.78 (1H, d)
【0122】(4)前記(3)で得られたプロピレンジ
オキシ化合物(III)22mgをアセトニトリル0.5m
lに溶かし、氷冷下、塩化第二鉄−シリカゲル47mg
を加えて、室温で1時間攪拌した。反応後、反応液から
シリカゲルを濾去し、ジエチルエーテルで希釈した。エ
ーテル層は飽和炭酸水素ナトリウム、飽和塩化アンモニ
ウム溶液、飽和食塩水で精製し、芒硝で乾燥後、減圧下
で濃縮した。残渣をシリカゲルのカラムクロマトグラフ
ィーで精製し、3−〔4′−(4−ヨード−3−ブチニ
ル)スチリル−ONN−アゾキシ〕−2−オクソブタン
(II)13mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.44(3H,d,4−CH3 )、2.14(3H,
s,1−CH3 )、2.59(2H,t)、2.79
(2H,d)、4.62(1H,q)、7.18(2
H,d)、7.38(2H,d)、7.56(1H,
d)、7.74(1H,d)(4) 22 mg of the propylenedioxy compound (III) obtained in the above (3) was added to 0.5 m of acetonitrile.
Dissolve in 1 and under ice cooling, ferric chloride-silica gel 47 mg
Was added and the mixture was stirred at room temperature for 1 hour. After the reaction, silica gel was filtered off from the reaction solution and diluted with diethyl ether. The ether layer was purified with saturated sodium hydrogen carbonate, a saturated ammonium chloride solution, and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain 13 mg of 3- [4 '-(4-iodo-3-butynyl) styryl-ONN-azoxy] -2-oxobutane (II). 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.44 (3H, d, 4-CH 3 ), 2.14 (3H,
s, 1-CH 3), 2.59 (2H, t), 2.79
(2H, d), 4.62 (1H, q), 7.18 (2
H, d), 7.38 (2H, d), 7.56 (1H,
d), 7.74 (1H, d)
【0123】(5)前記(4)で得られたオクソ化合物
(II)13mgをジメチルホルムアミド−メタノール
(1:5)0.2mlに溶かし、室温でヒドロキシルア
ミン塩酸塩5mg、ピリジン0.007mlを加えて、
30分間攪拌した。反応後、反応液をジエチルエーテル
で希釈し、エーテル層は1規定塩酸、飽和炭酸水素ナト
リウム溶液、飽和塩化アンモニウム溶液、飽和食塩水で
洗浄し、芒硝で乾燥後、減圧下で濃縮した。残渣をシリ
カゲルのカラムクロマトグラフィーで精製し、3−
〔4′−(4−ヨード−3−ブチニル)スチリル−ON
N−アゾキシ〕−2−オクソブタン(II)13mgを得
た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.44(3H,d,4−CH3 )、2.14(3H,
s,1−CH3 )、2.59(2H,t)、2.79
(2H,d)、4.62(1H,q)、7.18(2
H,d)、7.38(2H,d)、7.56(1H,
d)、7.74(1H,d)(5) 13 mg of the oxo compound (II) obtained in (4) above was dissolved in 0.2 ml of dimethylformamide-methanol (1: 5), and 5 mg of hydroxylamine hydrochloride and 0.007 ml of pyridine were added at room temperature. hand,
Stir for 30 minutes. After the reaction, the reaction solution was diluted with diethyl ether, and the ether layer was washed with 1N hydrochloric acid, a saturated sodium hydrogen carbonate solution, a saturated ammonium chloride solution, and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography, 3-
[4 '-(4-iodo-3-butynyl) styryl-ON
13 mg of N-azoxy] -2-oxobutane (II) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.44 (3H, d, 4-CH 3 ), 2.14 (3H,
s, 1-CH 3), 2.59 (2H, t), 2.79
(2H, d), 4.62 (1H, q), 7.18 (2
H, d), 7.38 (2H, d), 7.56 (1H,
d), 7.74 (1H, d)
【0124】(5)前記(4)で得られたオクソ化合物
(II)13mgをジメチルホルムアミド−メタノール
(1:5)0.2mlに溶かし、室温でヒドロキシルア
ミン塩酸塩5mg、ピリジン0.007mlを加えて、
30分間攪拌した。反応後、反応液をジエチルエーテル
で希釈し、エーテル層は1規定塩酸、飽和炭酸水素ナト
リウム溶液、飽和塩化アンモニウム溶液、飽和食塩水で
洗浄し、芒硝で乾燥後、減圧下で濃縮した。残渣をシリ
カゲルのカラムクロマトグラフィーで精製し、目的物
(I)のアンチ−異性体6mg及びシン−異性体3mg
を得た。1 H−NMR値:δ CDCl3 ,TMS,ppm アンチ−異性体 1.35(3H,d,4−CH3 )、1.91(3H,
s,1−CH3 )、2.58(2H,t)、2.78
(2H,t)、4.80(1H,q)、7.17(2
H,d)、7.37(2H,d)、7.51(1H,
d)、7.73(1H,d) シン−異性体 1.46(3H,d,4−CH3 )、1.80(3H,
s,1−CH3 )、2.66(2H,t)、2.86
(2H,t)、5.44(1H,q)、7.25(2
H,d)、7.45(2H,d)、7.59(1H,
d)、7.81(1H,d)(5) 13 mg of the oxo compound (II) obtained in (4) above was dissolved in 0.2 ml of dimethylformamide-methanol (1: 5), and 5 mg of hydroxylamine hydrochloride and 0.007 ml of pyridine were added at room temperature. hand,
Stir for 30 minutes. After the reaction, the reaction solution was diluted with diethyl ether, and the ether layer was washed with 1N hydrochloric acid, a saturated sodium hydrogen carbonate solution, a saturated ammonium chloride solution, and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain 6 mg of anti-isomer and 3 mg of syn-isomer of the target product (I).
Got 1 H-NMR value: δ CDCl 3 , TMS, ppm anti-isomer 1.35 (3H, d, 4-CH 3 ), 1.91 (3H,
s, 1-CH 3), 2.58 (2H, t), 2.78
(2H, t), 4.80 (1H, q), 7.17 (2
H, d), 7.37 (2H, d), 7.51 (1H,
d), 7.73 (1H, d ) syn - isomer 1.46 (3H, d, 4- CH 3), 1.80 (3H,
s, 1-CH 3), 2.66 (2H, t), 2.86
(2H, t), 5.44 (1H, q), 7.25 (2
H, d), 7.45 (2H, d), 7.59 (1H,
d), 7.81 (1H, d)
【0125】実施例18 3−(1,3,5−オクタトリエニル−ONN−アゾキ
シ)−2−ヒドロキシイミノブタン〔化合物(I):R
1 =2,4−ヘキサジエン、R2 =R3 =水素原子〕の
製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン500mgを
テトラヒドロフラン3mlに溶かし、氷冷攪拌下、リチ
ウムジイソプロピルアミド(1.3当量)のヘキサン溶
液を滴下した。30分間攪拌した後、トランス、トラン
ス、2,4−ヘプタジエナール352mgのテトラヒド
ロフラン5ml溶液を滴下し、さらに1時間攪拌した。
飽和塩化アンモニウム溶液10mlを加えて反応を停止
し、ジエチルエーテルで抽出した。エーテル層は水、飽
和食塩水で洗浄し、芒硝で乾燥した後、減圧下で濃縮し
た。残渣をシリカゲルのカラムクロマトグラフィーで精
製し、3−(2−ヒドロキシ−3,5−オクタジエニル
−ONN−アゾキシ)−2,2−プロピレンジオキシブ
タン(V)400mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.00(3H,t,8′−CH3 )、1.13,1.
16(3H,d,4−CH3 )、1.46(3H,s,
1−CH3 )、2.10(2H,m,7′−CH
2 −)、4.10〜4.40(2H,m)、4.52〜
4.70(1H,m,3−CH−)、5.46〜6.4
8(4H,m,オレフイン性H)Example 18 3- (1,3,5-octatrienyl-ONN-azoxy) -2-hydroxyiminobutane [Compound (I): R
1 = 2,4-hexadiene, R 2 = R 3 = hydrogen production atom]: (1) 3 obtained in Reference Example (methyl -ONN- azoxy) -2,2-propylene dioxy butane 500mg tetrahydrofuran It was dissolved in 3 ml, and a hexane solution of lithium diisopropylamide (1.3 equivalents) was added dropwise under stirring with ice cooling. After stirring for 30 minutes, a solution of trans, trans, 352 mg of 2,4-heptadienal in 5 ml of tetrahydrofuran was added dropwise, and the mixture was further stirred for 1 hour.
The reaction was stopped by adding 10 ml of a saturated ammonium chloride solution, and the mixture was extracted with diethyl ether. The ether layer was washed with water and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain 400 mg of 3- (2-hydroxy-3,5-octadienyl-ONN-azoxy) -2,2-propylenedioxybutane (V). 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.00 (3H, t, 8′-CH 3 ), 1.13, 1.
16 (3H, d, 4- CH 3), 1.46 (3H, s,
1-CH 3), 2.10 ( 2H, m, 7'-CH
2- ), 4.10 to 4.40 (2H, m), 4.52
4.70 (1H, m, 3-CH-), 5.46-6.4
8 (4H, m, olefinic H)
【0126】(2)前記(1)で得られたヒドロキシ化
合物(V)362mgをピリジン0.8mlに溶かし、
メタンスルホニウムクロリド0.15mlを加え、室温
で30分間攪拌した。次いで反応液を0℃に冷却し、
1,8−ジアザビシクロ〔5.4.0〕−7−ウンデセ
ン0.9mlを加え、さらに30分間攪拌した。反応
後、反応液をジエチルエーテル20mlと水10mlの
混合液にあけ、ジエチルエーテルで抽出した。エーテル
層は0.4規定硫酸水素カリウム溶液、水、飽和炭酸水
素ナトリウム溶液、水、飽和食塩水で順次洗浄し、芒硝
で乾燥した後、減圧下で濃縮した。残渣をシリカゲルの
カラムクロマトグラフィーで精製し、3−(1,3,5
−オクタトリエニル−ONN−アゾキシ)−2,2−プ
ロピレンジオキシブタン(III)225mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.04(3H,t,8′−CH3 )、1.18(3
H,d,4−CH3 )1.48(3H,s,1−C
H3 )、2.16(2H,m,7′−CH2 −)、4.
68(2H,m,3−CH−)、5.99(1H,d
t,6′−CH=)、6.18(1H,dd,5′=C
H−)、6.29(1H,dd,4′−CH=)、6.
60(1H,dd,3′=CH−)、7.15(1H,
d,1′=CH−)、7.40(1H,dd,2′−C
H=)(2) 362 mg of the hydroxy compound (V) obtained in (1) above was dissolved in 0.8 ml of pyridine,
0.15 ml of methanesulfonium chloride was added, and the mixture was stirred at room temperature for 30 minutes. The reaction is then cooled to 0 ° C,
0.9 ml of 1,8-diazabicyclo [5.4.0] -7-undecene was added, and the mixture was further stirred for 30 minutes. After the reaction, the reaction solution was poured into a mixed solution of 20 ml of diethyl ether and 10 ml of water and extracted with diethyl ether. The ether layer was washed successively with 0.4N potassium hydrogensulfate solution, water, saturated sodium hydrogencarbonate solution, water and saturated brine, dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- (1,3,5
225 mg of -octatrienyl-ONN-azoxy) -2,2-propylenedioxybutane (III) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.04 (3 H, t, 8′-CH 3 ), 1.18 (3
H, d, 4-CH 3 ) 1.48 (3H, s, 1-C
H 3), 2.16 (2H, m, 7'-CH 2 -), 4.
68 (2H, m, 3-CH-), 5.99 (1H, d
t, 6'-CH =), 6.18 (1H, dd, 5 '= C
H-), 6.29 (1H, dd, 4'-CH =), 6.
60 (1H, dd, 3 '= CH-), 7.15 (1H,
d, 1 '= CH-), 7.40 (1H, dd, 2'-C
H =)
【0127】(3)前記(2)で得られたプロピレンジ
オキシ化合物(III)58mgをアセトニトリル2mlに
溶かし、塩化第二鉄−シリカゲル115mgを加え、室
温で5分間攪拌した。反応後、ジエチルエーテルで希釈
し、エーテル層を水洗後、芒硝で乾燥し、減圧下で濃縮
した。残渣47mgをメタノール2mlに溶かし、ヒド
ロキシルアミン塩酸塩10mg、1規定ピリジン−メタ
ノール0.15mlを加え、室温で5分間攪拌した。反
応後、ジエチルエーテルで希釈し、エーテル層を水洗し
た。エーテル層は、芒硝で乾燥した後、減圧下で濃縮し
た。残渣21mgをシリカゲルの薄層クロマトグラフィ
ーで精製し、目的物(I)のアンチ−異性体10mgと
シン−異性体8mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm アンチ−異性体 1.04(3H,t,8′−CH3 )、1.38(3
H,d,4−CH3 )、1.95(3H,s,1−CH
3 )、2.18(2H,m,7′−CH2 −)、4.8
3(1H,q,3−CH−)、5.95〜6.30(3
H,m,オレフイン性H)、6.56(1H,dd,オ
レフイン性H)、7.09(1H,d,オレフイン性
H)、7.37(1H,dd,オレフイン性H) シン−異性体 1.04(3H,t,8′−CH3 )、1.42(3
H,d,4−CH3 )、1.76(3H,s,1−CH
3 )、2.18(2H,m,7′−CH2 −)、5.3
9(1H,q,3−CH−)、5.95〜6.30(3
H,m,オレフイン性H)、6.60(1H,dd,オ
レフイン性H)、7.11(1H,d,オレフイン性
H)、7.43(1H,dd,オレフイン性H)(3) 58 mg of the propylenedioxy compound (III) obtained in (2) above was dissolved in 2 ml of acetonitrile, 115 mg of ferric chloride-silica gel was added, and the mixture was stirred at room temperature for 5 minutes. After the reaction, the mixture was diluted with diethyl ether, the ether layer was washed with water, dried over sodium sulfate, and concentrated under reduced pressure. The residue (47 mg) was dissolved in methanol (2 ml), hydroxylamine hydrochloride (10 mg) and 1N pyridine-methanol (0.15 ml) were added, and the mixture was stirred at room temperature for 5 min. After the reaction, the mixture was diluted with diethyl ether, and the ether layer was washed with water. The ether layer was dried over sodium sulfate and then concentrated under reduced pressure. The residue (21 mg) was purified by silica gel thin layer chromatography to obtain the anti-isomer (10 mg) and the syn-isomer (8 mg) of the desired product (I). 1 H-NMR value: δ CDCl 3 , TMS, ppm anti-isomer 1.04 (3 H, t, 8′-CH 3 ), 1.38 (3
H, d, 4-CH 3 ), 1.95 (3H, s, 1-CH
3), 2.18 (2H, m , 7'-CH 2 -), 4.8
3 (1H, q, 3-CH-), 5.95 to 6.30 (3
H, m, olefinic H), 6.56 (1H, dd, olefinic H), 7.09 (1H, d, olefinic H), 7.37 (1H, dd, olefinic H) syn-isomer body 1.04 (3H, t, 8'- CH 3), 1.42 (3
H, d, 4-CH 3 ), 1.76 (3H, s, 1-CH
3), 2.18 (2H, m , 7'-CH 2 -), 5.3
9 (1H, q, 3-CH-), 5.95 to 6.30 (3
H, m, olefinic H), 6.60 (1H, dd, olefinic H), 7.11 (1H, d, olefinic H), 7.43 (1H, dd, olefinic H)
【0128】実施例19 3−(2−フエニル−1−プロペニル−ONN−アゾキ
シ)−2−ヒドロキシイミノブタン〔化合物(I):R
1 =フエニル基、R2 =メチル基、R3 =水素原子〕の
製造1: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)376
mgをテトラヒドロフラン5mlに溶かし、氷冷攪拌
下、リチウムジイソプロピルアミド(1.3当量)のヘ
キサン溶液を滴下した。30分間攪拌した後、これにア
セトフエノン300mg(1.5当量)のテトラヒドロ
フラン溶液5mlを滴下した。滴下後、さらに1時間攪
拌し、飽和塩化アンモニウム溶液5mlを加えて、反応
を停止した。反応液をジエチルエーテルで抽出し、エー
テル層は水、飽和食塩水で洗浄した後、芒硝で乾燥し
て、減圧下で濃縮した。残渣をシリカゲルのカラムクロ
マトグラフィーで精製し、3−(2−ヒドロキシ−2−
フエニルプロピル−ONN−アゾキシ)−2,2−プロ
ピレンジオキシブタン(V)403mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 0.70,1.05(3H,d,4−CH3 )、1.2
4,1.36(3H,s,1−CH3 )、1.55(3
H,s,3′−CH3 )、4.34〜4.45(1H,
m,3−CH−)、4.40〜4.60(2H,m,
1′−CH2 −)、7.20〜7.36(3H,m,芳
香核H)、7.45〜7.54(2H,m,芳香核H)Example 19 3- (2-Phenyl-1-propenyl-ONN-azoxy) -2-hydroxyiminobutane [Compound (I): R
1 = phenyl group, R 2 = methyl group, R 3 = hydrogen atom] 1: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI ) 376
mg was dissolved in 5 ml of tetrahydrofuran, and a hexane solution of lithium diisopropylamide (1.3 equivalents) was added dropwise under stirring with ice cooling. After stirring for 30 minutes, 5 ml of a tetrahydrofuran solution containing 300 mg (1.5 equivalents) of acetophenone was added dropwise. After the dropping, the mixture was further stirred for 1 hour, and 5 ml of a saturated ammonium chloride solution was added to stop the reaction. The reaction solution was extracted with diethyl ether, and the ether layer was washed with water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel to give 3- (2-hydroxy-2-
403 mg of phenylpropyl-ONN-azoxy) -2,2-propylenedioxybutane (V) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 0.70, 1.05 (3H, d, 4-CH 3 ), 1.2.
4,1.36 (3H, s, 1- CH 3), 1.55 (3
H, s, 3'-CH 3 ), 4.34~4.45 (1H,
m, 3-CH-), 4.40 to 4.60 (2H, m,
1'-CH 2 -), 7.20~7.36 (3H, m, arom H), 7.45~7.54 (2H, m , arom H)
【0129】(2)前記(1)で得られたヒドロキシ化
合物(V)403mgをピリジン2mlに溶かし、チオ
ニルクロリド0.29mlを加え、氷冷下、2時間攪拌
した。反応後、氷水にあけ、ジエチルエーテルで抽出し
た。エーテル層は飽和炭酸水素ナトリウム溶液、飽和食
塩水で洗浄した後、芒硝で乾燥して、減圧下で濃縮し
た。残渣300mgをベンゼン2mlに溶かし、1,8
−ジアザビシクロ〔5.4.0〕−7−ウンデセン0.
27mlを加え、室温で1時間攪拌した。反応後、反応
液をシリカゲルのカラムクロマトグラフィーにかけて精
製し、3−(2−フエニル−1−プロペニル−ONN−
アゾキシ)−2,2−プロピレンジオキシブタン(III)
104mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.23(3H,d,4−CH3 )、1.51(3H,
s,1−CH3 )、2.48(3H,d,3′−C
H3 )、4.71(1H,q,3−CH−)、7.12
(1H,q,1′=CH−)、7.36〜7.46(5
H,m,芳香核H)(2) 403 mg of the hydroxy compound (V) obtained in (1) above was dissolved in 2 ml of pyridine, 0.29 ml of thionyl chloride was added, and the mixture was stirred for 2 hours under ice cooling. After the reaction, the mixture was poured into ice water and extracted with diethyl ether. The ether layer was washed with a saturated sodium hydrogen carbonate solution and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure. Dissolve 300 mg of the residue in 2 ml of benzene, and add 1,8
-Diazabicyclo [5.4.0] -7-undecene 0.
27 ml was added, and the mixture was stirred at room temperature for 1 hour. After the reaction, the reaction solution was purified by subjecting it to column chromatography on silica gel to give 3- (2-phenyl-1-propenyl-ONN-).
Azoxy) -2,2-propylenedioxybutane (III)
104 mg was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.23 (3H, d, 4-CH 3 ), 1.51 (3H,
s, 1-CH 3), 2.48 (3H, d, 3'-C
H 3), 4.71 (1H, q, 3-CH -), 7.12
(1H, q, 1 '= CH-), 7.36 to 7.46 (5
H, m, aromatic nucleus H)
【0130】(3)前記(2)で得られたプロピレンジ
オキシ化合物(III)40mgをアセトニトリル2mlに
溶かし、塩化第二鉄−シリカゲル40mgを加え、室温
で1時間攪拌する。反応後、シリカゲルを除き、溶媒を
減圧下で濃縮した後、メタノール2mlに溶かし、ヒド
ロキシルアミン塩酸塩14mgとピリジン0.02ml
を加え、室温で1時間攪拌した。反応後、溶媒を減圧下
で濃縮し、シリカゲルの薄層クロマトグラフィーにかけ
て精製し、目的物(I)のアンチ−異性体24mgとシ
ン−異性体8mgを得た。1H−NMR値:δ CDC
l3 ,TMS,ppm アンチ−異性体 1.42(3H,d,4−CH3 )、1.98(3H,
s,1−CH3 )、2.49(3H,d,3′−C
H3 )、4.83(1H,q,3−CH)、7.13
(1H,q,1′=CH−)、7.36〜7.45(5
H,m,芳香核H) シン−異性体 1.46(3H,d,4−CH3 )、1.82(3H,
s,1−CH3 )、2.53(3H,d,3′−C
H3 )、5.41(1H,q,3−CH)、7.16
(1H,q,1′=CH−)、7.37〜7.45(5
H,m,芳香核H)(3) 40 mg of the propylenedioxy compound (III) obtained in (2) above is dissolved in 2 ml of acetonitrile, 40 mg of ferric chloride-silica gel is added, and the mixture is stirred at room temperature for 1 hour. After the reaction, the silica gel was removed, the solvent was concentrated under reduced pressure, the residue was dissolved in 2 ml of methanol, and 14 mg of hydroxylamine hydrochloride and 0.02 ml of pyridine were added.
Was added and stirred at room temperature for 1 hour. After the reaction, the solvent was concentrated under reduced pressure and purified by silica gel thin layer chromatography to obtain 24 mg of the anti-isomer and 8 mg of the syn-isomer of the target product (I). 1 H-NMR value: δ CDC
l 3, TMS, ppm anti - isomer 1.42 (3H, d, 4- CH 3), 1.98 (3H,
s, 1-CH 3), 2.49 (3H, d, 3'-C
H 3), 4.83 (1H, q, 3-CH), 7.13
(1H, q, 1 '= CH-), 7.36 to 7.45 (5
H, m, arom H) syn - isomer 1.46 (3H, d, 4- CH 3), 1.82 (3H,
s, 1-CH 3), 2.53 (3H, d, 3'-C
H 3), 5.41 (1H, q, 3-CH), 7.16
(1H, q, 1 '= CH-), 7.37 to 7.45 (5
H, m, aromatic nucleus H)
【0131】実施例20 3−(2−フエニル−1−プロペニル−ONN−アゾキ
シ)−2−(3−ヨードプロパルギルオキシイミノ)−
ブタン〔化合物(I):R1 =フエニル基、R2 =メチ
ル基、R3 =3−ヨードプロパルギル基〕の製造:実施
例19(2)で得られた3−(2−フエニル−1−プロ
ペニル−ONN−アゾキシ)−2,2−プロピレンジオ
キシブタン(III)26.3mgをアセトニトリル2ml
に溶かし、塩化第二鉄−シリカゲル90mgを加えて室
温で45分間攪拌した。反応後、酢酸エチルで希釈し、
不溶物を濾去し、濾液の酢酸エチル層を水、飽和食塩水
で洗浄し、芒硝で乾燥後、減圧下で濃縮した。これを1
mlのエタノールに溶かし、実施例8と同様に調製した
ヒドロキシルアミンの溶液に、室温で攪拌下滴下した。
1夜反応後、水で希釈し、酢酸エチルで抽出し、酢酸エ
チル層を水、飽和食塩水で洗浄し、芒硝で乾燥後、減圧
下で濃縮した。残渣35.9mgをプレパラティブ薄層
クロマトグラフィーにより精製し、目的物(I)(アン
チ−異性体:シン−異性体 5:1の混合物)14.5
mg(収率38.9%)を得た。1 H−NMR値:δ CDCl3 ,TMS,ppm(チ
ヤート上で判別可能)アンチ−異性体 1.42(3H,d,4−CH3 )、1.96(3H,
s,1−CH3 )、2.50(3H,d,3′−C
H3 )、4.80(2H,s,−CH2 −)、4.82
(1H,q,−CH−)、7.11(1H,d,オレフ
イン性H)、7.42(5H,m,芳香核H) シン−異性体 1.43(3H,d,4−CH3 )、1.85(3H,
s,1−CH3 )、2.52(3H,d,3′−C
H3 )、4.81(2H,s,−CH2 −)、5.30
(1H,q,−CH−)、7.14(1H,d,オレフ
イン性H)、7.42(5H,m,芳香核H)Example 20 3- (2-Phenyl-1-propenyl-ONN-azoxy) -2- (3-iodopropargyloxyimino)-
Production of butane [compound (I): R 1 = phenyl group, R 2 = methyl group, R 3 = 3-iodopropargyl group]: 3- (2-phenyl-1-) obtained in Example 19 (2) 26.3 mg of propenyl-ONN-azoxy) -2,2-propylenedioxybutane (III) was added to 2 ml of acetonitrile.
, Ferric chloride-silica gel 90 mg, and the mixture was stirred at room temperature for 45 minutes. After the reaction, dilute with ethyl acetate,
The insoluble material was filtered off, the ethyl acetate layer of the filtrate was washed with water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. This one
It was dissolved in ethanol (ml) and added dropwise to a solution of hydroxylamine prepared in the same manner as in Example 8 at room temperature with stirring.
After reacting overnight, the mixture was diluted with water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue (35.9 mg) was purified by preparative thin layer chromatography, and the target compound (I) (anti-isomer: syn-isomer 5: 1 mixture) 14.5 was used.
mg (yield 38.9%) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm (identifiable on chart) anti-isomer 1.42 (3H, d, 4-CH 3 ), 1.96 (3H,
s, 1-CH 3), 2.50 (3H, d, 3'-C
H 3), 4.80 (2H, s, -CH 2 -), 4.82
(1H, q, -CH-), 7.11 (1H, d, olefinic H), 7.42 (5H, m, aromatic nucleus H) syn-isomer 1.43 (3H, d, 4-CH) 3 ) 1.85 (3H,
s, 1-CH 3), 2.52 (3H, d, 3'-C
H 3), 4.81 (2H, s, -CH 2 -), 5.30
(1H, q, -CH-), 7.14 (1H, d, olefinic H), 7.42 (5H, m, aromatic nucleus H)
【0132】実施例21 3−〔2−(4−クロロフエニル)−1−プロペニル−
ONN−アゾキシ〕−2−ヒドロキシイミノブタン〔化
合物(I):R1 =4−クロロフエニル,R2=メチル
基、R3 =水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)376
mgをテトラヒドロフラン5mlに溶かし、氷冷攪拌
下、リチウムジイソプロピルアミド(1.3当量)のヘ
キサン溶液を滴下した。30分間攪拌した後、これにp
−クロロアセトフエノン464mg(1.5当量)のテ
トラヒドロフラン溶液3mlを滴下した。滴下後、さら
に1時間攪拌し、飽和塩化アンモニウム溶液5mlを加
えて、反応を停止した。反応液をジエチルエーテルで抽
出し、エーテル層は水、飽和食塩水で洗浄した後、芒硝
で乾燥して、減圧下で濃縮した。残渣をシリカゲルのカ
ラムクロマトグラフィーで精製し、3−〔2−ヒドロキ
シ−2−(4−クロロフエニル)プロピル−ONN−ア
ゾキシ〕−2,2−プロピレンジオキシブタン(V)の
ジアステレオマー436mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 0.74,1.05(3H,d,4−CH3 )、1.2
4,1.36(3H,s,1−CH3 )、1.55(3
H,s,3′−CH3 )、4.20〜4.44(1H,
m,3−CH−)、4.46(2H,dd,1′−CH
2 −)、7.20〜7.32(2H,m,芳香核H)、
7.34〜7.44(2H,m,芳香核H)Example 21 3- [2- (4-chlorophenyl) -1-propenyl-
Production of ONN-azoxy] -2-hydroxyiminobutane [Compound (I): R 1 = 4-chlorophenyl, R 2 = methyl group, R 3 = hydrogen atom]: (1) 3- ( Methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) 376
mg was dissolved in 5 ml of tetrahydrofuran, and a hexane solution of lithium diisopropylamide (1.3 equivalents) was added dropwise under stirring with ice cooling. After stirring for 30 minutes, p
3 ml of a tetrahydrofuran solution containing 464 mg (1.5 equivalents) of -chloroacetophenone was added dropwise. After the dropping, the mixture was further stirred for 1 hour, and 5 ml of a saturated ammonium chloride solution was added to stop the reaction. The reaction solution was extracted with diethyl ether, and the ether layer was washed with water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain 436 mg of diastereomers of 3- [2-hydroxy-2- (4-chlorophenyl) propyl-ONN-azoxy] -2,2-propylenedioxybutane (V). It was 1 H-NMR value: δ CDCl 3 , TMS, ppm 0.74, 1.05 (3 H, d, 4-CH 3 ), 1.2.
4,1.36 (3H, s, 1- CH 3), 1.55 (3
H, s, 3'-CH 3 ), 4.20~4.44 (1H,
m, 3-CH-), 4.46 (2H, dd, 1'-CH
2- ), 7.20 to 7.32 (2H, m, aromatic nucleus H),
7.34 to 7.44 (2H, m, aromatic nucleus H)
【0133】(2)前記(1)で得られたヒドロキシ化
合物(V)436mgをピリジン2mlに溶かし、チオ
ニルクロリド0.29mlを加え、氷冷下、2時間攪拌
する。反応後、氷水にあけ、ジエチルエーテルで抽出し
た。エーテル層は飽和炭酸水素ナトリウム溶液、飽和食
塩水で洗浄した後、芒硝で乾燥して、減圧下で濃縮す
る。残渣342mgをベンゼン2mlに溶かし、1,8
−ジアザビシクロ〔5.4.0〕−7−ウンデセン0.
28mlを加え、室温で1時間攪拌する。反応後、反応
液をシリカゲルのカラムクロマトグラフィーにかけて精
製し、3−〔2−(4−クロロフエニル)−1−プロペ
ニル−ONN−アゾキシ〕−2,2−プロピレンジオキ
シブタン(III)84mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.22(3H,d,4−CH3 )、1.50(3H,
s,1−CH3 )、2.44(3H,d,3′−C
H3 )、4.68(1H,q,3−CH−)、7.07
(1H,q,1′=CH−)、7.24(4H,m,芳
香核H)(2) 436 mg of the hydroxy compound (V) obtained in (1) above is dissolved in 2 ml of pyridine, 0.29 ml of thionyl chloride is added, and the mixture is stirred under ice cooling for 2 hours. After the reaction, the mixture was poured into ice water and extracted with diethyl ether. The ether layer is washed with saturated sodium hydrogen carbonate solution and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure. 342 mg of the residue was dissolved in 2 ml of benzene, and 1,8
-Diazabicyclo [5.4.0] -7-undecene 0.
Add 28 ml and stir at room temperature for 1 hour. After the reaction, the reaction solution was purified by subjecting it to silica gel column chromatography to obtain 84 mg of 3- [2- (4-chlorophenyl) -1-propenyl-ONN-azoxy] -2,2-propylenedioxybutane (III). .. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.22 (3H, d, 4-CH 3 ), 1.50 (3H,
s, 1-CH 3), 2.44 (3H, d, 3'-C
H 3), 4.68 (1H, q, 3-CH -), 7.07
(1H, q, 1 '= CH-), 7.24 (4H, m, aromatic nucleus H)
【0134】(3)前記(2)で得られたプロピレンジ
オキシ化合物(III)40mgをアセトニトリル2mlに
溶かし、塩化第二鉄−シリカゲル40mgを加え、室温
で1時間攪拌した。反応後、シリカゲルを除き、溶媒を
減圧下で濃縮した後、メタノール2mlに溶かし、ヒド
ロキシルアミン塩酸塩14mgとピリジン0.02ml
を加え、室温で1時間攪拌した。反応後、溶媒を減圧下
で濃縮し、シリカゲルの薄層クロマトグラフィーにかけ
て精製し、目的物(I)のアンチ−異性体25mgとシ
ン−異性体9mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm アンチ−異性体 1.42(3H,d,4−CH3 )、1.96(3H,
s,1−CH3 )、2.43(3H,d,3′−C
H3 )、4.82(1H,q,3−CH−)、7.11
(1H,q,1′=CH−)、7.37(5H,br
s,芳香核H) シン−異性体 1.45(3H,d,4−CH3 )、1.82(3H,
s,1−CH3 )、2.50(3H,d,3′−C
H3 )、5.40(1H,q,3−CH−)、7.14
(1H,q,1′=CH−)、7.37(5H,br
s,芳香核H)(3) 40 mg of the propylenedioxy compound (III) obtained in (2) above was dissolved in 2 ml of acetonitrile, 40 mg of ferric chloride-silica gel was added, and the mixture was stirred at room temperature for 1 hour. After the reaction, the silica gel was removed, the solvent was concentrated under reduced pressure, the residue was dissolved in 2 ml of methanol, and 14 mg of hydroxylamine hydrochloride and 0.02 ml of pyridine were added.
Was added and stirred at room temperature for 1 hour. After the reaction, the solvent was concentrated under reduced pressure and purified by silica gel thin layer chromatography to obtain 25 mg of the anti-isomer and 9 mg of the syn-isomer of the target compound (I). 1 H-NMR value: δ CDCl 3 , TMS, ppm anti-isomer 1.42 (3H, d, 4-CH 3 ), 1.96 (3H,
s, 1-CH 3), 2.43 (3H, d, 3'-C
H 3), 4.82 (1H, q, 3-CH -), 7.11
(1H, q, 1 '= CH-), 7.37 (5H, br
s, arom H) syn - isomer 1.45 (3H, d, 4- CH 3), 1.82 (3H,
s, 1-CH 3), 2.50 (3H, d, 3'-C
H 3), 5.40 (1H, q, 3-CH -), 7.14
(1H, q, 1 '= CH-), 7.37 (5H, br
s, aromatic nucleus H)
【0135】実施例22 3−〔2−(4−メトキシフエニル)−1−プロペニル
−ONN−アゾキシ〕−2−ヒドロキシイミノブタン
〔化合物(I):R1 =4−メトキシフエニル基、R2
=メチル基、R3 =水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)567
mgをテトラヒドロフラン7mlに溶かし、氷冷攪拌
下、リチウムジイソプロピルアミド(1.3当量)のヘ
キサン溶液を滴下した。30分間攪拌した後、これにp
−メトキシアセトフエノン495mg(1.1当量)の
テトラヒドロフラン溶液5mlを滴下する。滴下後、さ
らに1時間攪拌し、飽和塩化アンモニウム溶液10ml
を加えて、反応を停止した。反応液を酢酸エチルで抽出
し、酢酸エチル層は0.4規定硫酸水素ナトリウム溶
液、飽和食塩水で洗浄した後、芒硝で乾燥して、減圧下
で濃縮した。残渣をシリカゲルのカラムクロマトグラフ
ィーで精製し、3−〔2−ヒドロキシ−2−(4−メト
キシフエニル)−プロピル−ONN−アゾキシ〕−2,
2−プロピレンジオキシブタン(V)のジアステレオマ
ー675mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 0.76,1.07(3H,d,4−CH3 )、1.2
7,1.28(H,s,1−CH3 )、1.55(3
H,s,3′−CH3 )、3.79(3H,s,−OC
H3 )、4.30〜4.60(3H,m,3−CH−a
nd1′−CH2−)、6.60〜6.92(2H,
m,芳香核H)、7.34〜7.44(2H,m,芳香
核H)Example 22 3- [2- (4-Methoxyphenyl) -1-propenyl-ONN-azoxy] -2-hydroxyiminobutane [Compound (I): R 1 = 4-methoxyphenyl group, R 2
= Methyl group, R 3 = hydrogen atom]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) 567 obtained in Reference Example
mg was dissolved in 7 ml of tetrahydrofuran, and a hexane solution of lithium diisopropylamide (1.3 equivalents) was added dropwise under stirring with ice cooling. After stirring for 30 minutes, p
5 ml of a tetrahydrofuran solution of 495 mg (1.1 eq) of methoxyacetophenone is added dropwise. After dropping, the mixture was stirred for 1 hour, and 10 ml of saturated ammonium chloride solution was added.
Was added to stop the reaction. The reaction solution was extracted with ethyl acetate, and the ethyl acetate layer was washed with 0.4 N sodium hydrogen sulfate solution and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- [2-hydroxy-2- (4-methoxyphenyl) -propyl-ONN-azoxy] -2,
675 mg of diastereomers of 2-propylenedioxybutane (V) were obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 0.76, 1.07 (3 H, d, 4-CH 3 ), 1.2.
7,1.28 (H, s, 1- CH 3), 1.55 (3
H, s, 3'-CH 3 ), 3.79 (3H, s, -OC
H 3), 4.30~4.60 (3H, m, 3-CH-a
nd1′-CH 2 —), 6.60 to 6.92 (2H,
m, aromatic nucleus H), 7.34 to 7.44 (2H, m, aromatic nucleus H)
【0136】(2)前記(1)で得られたヒドロキシ化
合物(V)202mgをピリジン6mlに溶かし、チオ
ニルクロリド1.2mgを加え、氷冷下、2時間攪拌し
た。反応後、氷水にあけ、ジエチルエーテルで抽出し
た。エーテル層は飽和炭酸水素ナトリウム溶液、飽和食
塩水で洗浄した後、芒硝で乾燥して、減圧下で濃縮し
た。残渣111mgをベンゼン に溶かし、1,
8−ジアザビシクロ〔5.4.0〕−7−ウンデセン
0.1mlを加え、室温で1時間攪拌した。反応後、反
応液をシリカゲルのカラムクロマトグラフィーにかけて
精製し、3−〔2−(4−メトキシフエニル)−1−プ
ロペニル−ONN−アゾキシ〕−2,2−プロピレンジ
オキシブタン(III)17mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.22(3H,d,4−CH3 )、1.51(3H,
s,1−CH3 )、2.46(3H,d,3′−C
H3 )、3.84(3H,s,−OCH3 )、4.74
(1H,q,3−CH−)、6.86〜6.98(2
H,m,芳香核H)、7.15(1H,q,1′=CH
−)、7.34〜7.46(2H,m,芳香核H)(2) 202 mg of the hydroxy compound (V) obtained in (1) above was dissolved in 6 ml of pyridine, 1.2 mg of thionyl chloride was added, and the mixture was stirred for 2 hours under ice cooling. After the reaction, the mixture was poured into ice water and extracted with diethyl ether. The ether layer was washed with a saturated sodium hydrogen carbonate solution and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure. 111 mg of the residue was dissolved in benzene,
0.1 ml of 8-diazabicyclo [5.4.0] -7-undecene was added, and the mixture was stirred at room temperature for 1 hour. After the reaction, the reaction solution was purified by subjecting to silica gel column chromatography to obtain 17 mg of 3- [2- (4-methoxyphenyl) -1-propenyl-ONN-azoxy] -2,2-propylenedioxybutane (III). Obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.22 (3H, d, 4-CH 3 ), 1.51 (3H,
s, 1-CH 3), 2.46 (3H, d, 3'-C
H 3), 3.84 (3H, s, -OCH 3), 4.74
(1H, q, 3-CH-), 6.86 to 6.98 (2
H, m, aromatic nucleus H), 7.15 (1H, q, 1 '= CH
-), 7.34 to 7.46 (2H, m, aromatic nucleus H)
【0137】(3)前記(2)で得られたプロピレンジ
オキシ化合物(III)30mgをアセトニトリル2mlに
溶かし、塩化第二鉄−シリカゲル3mgを加え、室温で
1時間攪拌した。反応後、反応液をジエチルエーテルで
希釈し、エーテル層を水洗した。エーテル層は減圧下で
濃縮した後、メタノール2mlに溶かし、ヒドロキシル
アミン塩酸塩10mgとピリジン0.02mlを加え、
室温で1時間攪拌した。反応後、溶媒を減圧下で濃縮
し、シリカゲルの薄層クロマトグラフィーにかけ精製
し、目的物(I)のアンチ−異性体15mgとシン−異
性体6mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm アンチ−異性体 1.42(3H,d,4−CH3 )、1.98(3H,
s,1−CH3 )、2.46(3H,d,3′−C
H3 )、4.83(1H,q,3−CH−)、6.86
〜6.95(2H,m,芳香核H)、7.13(1H,
q,1′=CH−)、7.35〜7.45(2H,m,
芳香核H) シン−異性体 1.45(3H,d,4−CH3 )、1.82(3H,
s,1−CH3 )、2.52(3H,d,3′−C
H3 )、5.41(1H,q,3−CH−)、6.88
(2H,m、芳香核H)、7.18(1H,q,1′=
CH−)、7.36〜7.44(2H,m,芳香核H)(3) 30 mg of the propylenedioxy compound (III) obtained in (2) above was dissolved in 2 ml of acetonitrile, 3 mg of ferric chloride-silica gel was added, and the mixture was stirred at room temperature for 1 hour. After the reaction, the reaction solution was diluted with diethyl ether, and the ether layer was washed with water. The ether layer was concentrated under reduced pressure, dissolved in 2 ml of methanol, and added with 10 mg of hydroxylamine hydrochloride and 0.02 ml of pyridine,
The mixture was stirred at room temperature for 1 hour. After the reaction, the solvent was concentrated under reduced pressure and purified by silica gel thin layer chromatography to obtain 15 mg of the anti-isomer and 6 mg of the syn-isomer of the target compound (I). 1 H-NMR value: δ CDCl 3 , TMS, ppm anti-isomer 1.42 (3H, d, 4-CH 3 ), 1.98 (3H,
s, 1-CH 3), 2.46 (3H, d, 3'-C
H 3), 4.83 (1H, q, 3-CH -), 6.86
~ 6.95 (2H, m, aromatic nucleus H), 7.13 (1H,
q, 1 '= CH-), 7.35 to 7.45 (2H, m,
Arom H) syn - isomer 1.45 (3H, d, 4- CH 3), 1.82 (3H,
s, 1-CH 3), 2.52 (3H, d, 3'-C
H 3), 5.41 (1H, q, 3-CH -), 6.88
(2H, m, aromatic nucleus H), 7.18 (1H, q, 1 '=
CH-), 7.36 to 7.44 (2H, m, aromatic nucleus H)
【0138】実施例23 3−(スチリル−ONN−アゾキシ)−2−(3−ヨー
ドプロパルギルオキシイミノ)−ブタン〔化合物
(I):R1 =フエニル基、R2 =水素原子、R3 =3
−ヨードプロパルギル基〕の製造: 実施例9(2)で得られた3−(スチリル−ONN−ア
ゾキシ)−2,2−プロピレンジオキシブタン90mg
をアセトニトリル6mlに 溶かし、塩化第二鉄−シリ
カゲル270mgを加え、室温で40分間攪拌した。反
応後、酢酸エチルで希釈して不溶物を濾去した後、酢酸
エチル層を水、飽和食塩水で洗浄し、芒硝で乾燥した
後、減圧下で濃縮した。この残渣をエタノール2mlに
溶かした。これを実施例20の後半と同様に処理して、
目的物(I)(アンチ−異性体:シン−異性体 4:1
の混合物)99.1mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm(チ
ヤート上で判別可能) アンチ−異性体 1.42(3H,d,4−CH3 )、1.96(3H,
s,1−CH3 )、4.80(2H,s,−CH
2 −)、4.87(1H,q,−CH−)、7.45
(5H,m,芳香核H)、7.69(2H,abq,オ
レフイン性H) シン−異性体 1.44(3H,d,4−CH3 )、1.83(3H,
s,1−CH3 )、4.79(2H,s,−CH
2 −)、5.35(1H,q,−CH−)、7.45
(5H,m,芳香核H)、7.69(2H,abq,オ
レフイン性H)Example 23 3- (Styryl-ONN-azoxy) -2- (3-iodopropargyloxyimino) -butane [Compound (I): R 1 = phenyl group, R 2 = hydrogen atom, R 3 = 3]
-Iodopropargyl group]: 3- (styryl-ONN-azoxy) -2,2-propylenedioxybutane 90 mg obtained in Example 9 (2)
Was dissolved in 6 ml of acetonitrile, 270 mg of ferric chloride-silica gel was added, and the mixture was stirred at room temperature for 40 minutes. After the reaction, the reaction mixture was diluted with ethyl acetate and the insoluble material was filtered off, the ethyl acetate layer was washed with water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. This residue was dissolved in 2 ml of ethanol. This is processed in the same manner as the latter half of Example 20,
Target compound (I) (anti-isomer: syn-isomer 4: 1)
99.1 mg) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm (identifiable on chart) Anti-isomer 1.42 (3H, d, 4-CH 3 ), 1.96 (3H,
s, 1-CH 3), 4.80 (2H, s, -CH
2- ), 4.87 (1H, q, -CH-), 7.45
(5H, m, arom H), 7.69 (2H, abq , olefinic H) syn - isomer 1.44 (3H, d, 4- CH 3), 1.83 (3H,
s, 1-CH 3), 4.79 (2H, s, -CH
2- ), 5.35 (1H, q, -CH-), 7.45
(5H, m, aromatic nucleus H), 7.69 (2H, abq, olefinic H)
【0139】実施例24 3−〔2′−(3−ヨードプロパルギルオキシ)スチリ
ル−ONN−アゾキシ〕−2−ヒドロキシイミノブタン
〔化合物(I):R1 =2−(3−ヨードプロパルギル
オキシ)フエニル基、R2 =R3 =水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)317
mgをテトラヒドロフラン3mlに溶かし、氷冷攪拌
下、リチウムジイソプロピルアミド(1.3当量)のヘ
キサン溶液を滴下した。30分間攪拌した後、−30℃
に冷却し、これにo−プロパルギルオキシベンズアルデ
ヒド404mg(1.5当量)のテトラヒドロフラン溶
液3mlを滴下した。滴下後、さらに50分間攪拌し、
飽和塩化アンモニウム溶液3mlを加えて、反応を停止
した。反応液をジエチルエーテルで抽出し、エーテル層
は水、飽和食塩水で洗浄した後、芒硝で乾燥して、減圧
下で濃縮した。残渣863mgをシリカゲルのカラムク
ロマトグラフィーで精製し、3−〔2−ヒドロキシ−2
−(2′−プロパルギルオキシ)フエニル−エチル−O
NN−アゾキシ〕−2,2−プロピレンジオキシブタン
(V)のジアステレオマー335mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.03,1.27(3H,d,4−CH3 )、1.4
6,1.47(3H,s,1−CH3 )、2.51(1
H,t,≡CH)、3.77〜4.05(4H,m,ケ
タール−OCH2 −×2)、4.45〜4.81(5
H,m)、6.98〜7.12(2H,m,芳香核
H)、7.32(1H,m,芳香核H)、7.62(1
H,m,芳香核H)Example 24 3- [2 '-(3-Iodopropargyloxy) styryl-ONN-azoxy] -2-hydroxyiminobutane [Compound (I): R 1 = 2- (3-iodopropargyloxy) phenyl] Group, R 2 = R 3 = hydrogen atom]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) 317 obtained in Reference Example
mg was dissolved in 3 ml of tetrahydrofuran, and a hexane solution of lithium diisopropylamide (1.3 equivalents) was added dropwise under stirring with ice cooling. After stirring for 30 minutes, -30 ° C
After cooling to 0 ° C, 3 ml of a tetrahydrofuran solution containing 404 mg (1.5 equivalents) of o-propargyloxybenzaldehyde was added dropwise. After dropping, stir for another 50 minutes,
The reaction was stopped by adding 3 ml of saturated ammonium chloride solution. The reaction solution was extracted with diethyl ether, and the ether layer was washed with water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue (863 mg) was purified by silica gel column chromatography to give 3- [2-hydroxy-2].
-(2'-Propargyloxy) phenyl-ethyl-O
335 mg of the diastereomer of NN-azoxy] -2,2-propylenedioxybutane (V) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.03, 1.27 (3H, d, 4-CH 3 ), 1.4
6, 1.47 (3H, s, 1-CH 3 ), 2.51 (1
H, t, ≡CH), 3.77~4.05 (4H, m, ketal -OCH 2 - × 2), 4.45~4.81 (5
H, m), 6.98 to 7.12 (2H, m, aromatic nucleus H), 7.32 (1H, m, aromatic nucleus H), 7.62 (1
H, m, aromatic nucleus H)
【0140】(2)前記(1)で得られたヒドロキシ化
合物(V)240mgをピリジン1.4mlに溶かし、
無水酢酸0.4ml(6当量)を加え、室温で4時間攪
拌した。反応後、反応液を減圧下で濃縮し、残渣をテト
ラヒドロフラン1mlに溶かした。これに1,8−ジア
ザビシクロ〔5.4.0〕−7−ウンデセン0.13m
l(5当量)を加え、40℃で3.5時間、加温攪拌し
た。反応後、反応液にジエチルエーテル10ml、1規
定塩酸4mlを加えエーテル抽出した。エーテル層は
水、飽和食塩水で洗浄し、芒硝で乾燥した後、減圧下で
濃縮した。残渣をシリカゲルのカラムクロマトグラフィ
ーで精製し、3−〔2′−プロパルギルオキシスチリル
−ONN−アゾキシ〕−2,2−プロピレンジオキシブ
タン(III ′)204mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.22(3H,d,4−CH3 )、1.51(3H,
s,1−CH3 )、2.53(1H,t,≡CH)、
4.73(1H,q,3−CH−)、4.82(2H,
d,OCH2 )、6.98〜7.09(2H,m,芳香
核H)、7.33〜7.47(2H,m,芳香核H)、
7.83(1H,d,=CH−)、8.00(1H,
d,−CH=)(2) 240 mg of the hydroxy compound (V) obtained in (1) above was dissolved in 1.4 ml of pyridine,
0.4 ml (6 equivalents) of acetic anhydride was added, and the mixture was stirred at room temperature for 4 hours. After the reaction, the reaction solution was concentrated under reduced pressure, and the residue was dissolved in 1 ml of tetrahydrofuran. 1,8-diazabicyclo [5.4.0] -7-undecene 0.13 m
1 (5 equivalents) was added, and the mixture was heated and stirred at 40 ° C. for 3.5 hours. After the reaction, 10 ml of diethyl ether and 4 ml of 1N hydrochloric acid were added to the reaction solution, and the mixture was extracted with ether. The ether layer was washed with water and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain 204 mg of 3- [2'-propargyloxystyryl-ONN-azoxy] -2,2-propylenedioxybutane (III '). 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.22 (3H, d, 4-CH 3 ), 1.51 (3H,
s, 1-CH 3 ), 2.53 (1H, t, ≡CH),
4.73 (1H, q, 3-CH-), 4.82 (2H,
d, OCH 2), 6.98~7.09 ( 2H, m, arom H), 7.33~7.47 (2H, m , arom H),
7.83 (1H, d, = CH-), 8.00 (1H,
d, -CH =)
【0141】(3)前記(2)で得られたプロパルギル
オキシ化合物(III ′)48mgをメタノール1.5m
lに溶かし、氷冷下、ヨウ素74mg(2当量)と10
規定水酸化ナトリウム溶液0.058mlを加え、氷浴
をはずして20分間攪拌した。反応後、反応液に2規定
チオ硫酸ナトリウム溶液0.5mlを加え、ジエチルエ
ーテルで抽出した。エーテル層は1規定塩酸、飽和炭酸
水素ナトリウム溶液、飽和食塩水で洗浄し、芒硝で乾燥
後、減圧下で濃縮した。残渣をシリカゲルのカラムクロ
マトグラフィーで精製し、3−〔2′−(3−ヨードプ
ロパルギルオキシ)スチリル−ONN−アゾキシ〕−
2,2−プロピレンジオキシブタン(III)44mgを得
た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.22(3H,d,4−CH3 )、1.51(3H,
s,1−CH3 )、4.73(1H,q,3−CH
−)、4.95(2H,d,OCH2 )、6.09〜
7.07(2H,m,芳香核H)、7.33〜7.47
(2H,m,芳香核H)、7.82(1H,d,=CH
−)、7.98(1H,d,−CH=)(3) 48 mg of the propargyloxy compound (III ') obtained in the above (2) was added to 1.5 m of methanol.
Dissolve in 1 and under ice cooling, 74 mg (2 equivalents) of iodine and 10
0.058 ml of a normal sodium hydroxide solution was added, the ice bath was removed, and the mixture was stirred for 20 minutes. After the reaction, 0.5 ml of a 2N sodium thiosulfate solution was added to the reaction solution, and the mixture was extracted with diethyl ether. The ether layer was washed with 1N hydrochloric acid, saturated sodium hydrogen carbonate solution, and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- [2 '-(3-iodopropargyloxy) styryl-ONN-azoxy]-
44 mg of 2,2-propylenedioxybutane (III) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.22 (3H, d, 4-CH 3 ), 1.51 (3H,
s, 1-CH 3), 4.73 (1H, q, 3-CH
-), 4.95 (2H, d , OCH 2), 6.09~
7.07 (2H, m, aromatic nucleus H), 7.33 to 7.47
(2H, m, aromatic nucleus H), 7.82 (1H, d, = CH
-), 7.98 (1H, d, -CH =)
【0142】(4)前記(3)で得られたプロピレンジ
オキシ化合物(III)145mgをアセトン5mlに溶か
し、塩化第二鉄−シリカゲル290mgを加えて、室温
で2時間攪拌した。反応後、シリカゲルを除き、ジエチ
ルエーテルで希釈してエーテル層を水、飽和食塩水で洗
浄し、芒硝で乾燥した後、減圧下で濃縮した。残渣をジ
メチルホルムアミド−メタノール(1:5)3mlに溶
かし、ヒドロキシルアミン塩酸塩35mg(1.5当
量)、ピリジン0.05mlを加えて、室温で30分間
攪拌した。反応後、溶媒を減圧下で濃縮し、シリカゲル
のカラムクロマトグラフィーで精製し、目的物(I)の
アンチ−異性体94mgとシン−異性体20mgを得
た。1 H−NMR値:δ CDCl3 ,TMS,ppm アンチ−異性体 1.42(3H,d,4−CH3 )、1. 8(3H,
s,1−CH3 )、4. 0(1H,q,3−CH
−)、4.95(2H,s,OCH2 )、6.99〜
7.08(2H,m,芳香核H)、7.34〜7.48
(2H,m,芳香核H)、7.80(1H,d,1′=
CH−)、8.00(1H,d,2′−CH=) シン−異性体 1.47(3H,d,4−CH3 )、1.80(3H,
s,1−CH3 )、4.96(1H,q,3−CH
−)、5.44(2H,s,OCH2 )、7.00〜
7.09(2H,m,芳香核H)、7.34〜7.49
(2H,m,芳香核H)、7.82(1H,d,1′=
CH−)、8.00(1H,d,2′−CH=)(4) 145 mg of the propylenedioxy compound (III) obtained in (3) above was dissolved in 5 ml of acetone, 290 mg of ferric chloride-silica gel was added, and the mixture was stirred at room temperature for 2 hours. After the reaction, silica gel was removed, the mixture was diluted with diethyl ether, the ether layer was washed with water and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. The residue was dissolved in 3 ml of dimethylformamide-methanol (1: 5), 35 mg (1.5 equivalents) of hydroxylamine hydrochloride and 0.05 ml of pyridine were added, and the mixture was stirred at room temperature for 30 minutes. After the reaction, the solvent was concentrated under reduced pressure and purified by silica gel column chromatography to obtain 94 mg of the anti-isomer and 20 mg of the syn-isomer of the target product (I). 1 H-NMR value: δ CDCl 3 , TMS, ppm anti-isomer 1.42 (3H, d, 4-CH 3 ), 1. 8 (3H,
s, 1-CH 3), 4. 0 (1H, q, 3-CH
-), 4.95 (2H, s , OCH 2), 6.99~
7.08 (2H, m, aromatic nucleus H), 7.34 to 7.48
(2H, m, aromatic nucleus H), 7.80 (1H, d, 1 '=
CH -), 8.00 (1H, d, 2'-CH =) syn - isomer 1.47 (3H, d, 4- CH 3), 1.80 (3H,
s, 1-CH 3), 4.96 (1H, q, 3-CH
-), 5.44 (2H, s , OCH 2), 7.00~
7.09 (2H, m, aromatic nucleus H), 7.34 to 7.49
(2H, m, aromatic nucleus H), 7.82 (1H, d, 1 '=
CH-), 8.00 (1H, d, 2'-CH =)
【0143】実施例25 3−〔3′−(3−ヨードプロパルギルオキシ)スチリ
ル−ONN−アゾキシ〕−2−ヒドロキシイミノブタン
〔化合物(I):R1 =3−(3−ヨードプロパルギル
オキシ)フエニル基、R2 =R3 =水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)240
mgをテトラヒドロフラン3mlに溶かし、氷冷攪拌
下、リチウムジイソプロピルアミド(1.3当量)のヘ
キサン溶液を滴下した。30分間攪拌した後、−10℃
に冷却し、これにm−プロパルギルオキシベンズアルデ
ヒド305mg(1.5当量)のテトラヒドロフラン溶
液2.1mlを滴下した。滴下後、さらに30分間攪拌
し、飽和塩化アンモニウム溶液3mlを加えて、反応を
停止した。反応液をジエチルエーテルで抽出し、エーテ
ル層は水、飽和食塩水で洗浄した後、芒硝で乾燥して、
減圧下で濃縮した。残渣をシリカゲルのカラムクロマト
グラフィーで精製し、3−〔2−ヒドロキシ−2−
(2′−(3−プロパルギルオキシ)フエニル)エチル
−ONN−アゾキシ〕−2,2−プロピレンジオキシブ
タン(V)のジアステレオマー254mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.18,1.22(3H,d,4−CH3 )、1.4
7,1.48(3H,s,1−CH3 )、2.53,
2.54(1H,t,≡CH)、4.71,4.72
(2H,d,OCH2 )、6.92〜7.07(3H,
m,芳香核H)、7.32(1H,t,芳香核H)Example 25 3- [3 '-(3-Iodopropargyloxy) styryl-ONN-azoxy] -2-hydroxyiminobutane [Compound (I): R 1 = 3- (3-Iodopropargyloxy) phenyl] Group, R 2 = R 3 = hydrogen atom]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) 240 obtained in Reference Example
mg was dissolved in 3 ml of tetrahydrofuran, and a hexane solution of lithium diisopropylamide (1.3 equivalents) was added dropwise under stirring with ice cooling. After stirring for 30 minutes, -10 ° C
After cooling to 2.1 ml, 2.1 ml of a tetrahydrofuran solution containing 305 mg (1.5 equivalents) of m-propargyloxybenzaldehyde was added dropwise. After the dropping, the mixture was stirred for another 30 minutes, and 3 ml of a saturated ammonium chloride solution was added to stop the reaction. The reaction solution was extracted with diethyl ether, the ether layer was washed with water and saturated saline, and then dried with sodium sulfate,
Concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- [2-hydroxy-2-
254 mg of the diastereomer of (2 '-(3-propargyloxy) phenyl) ethyl-ONN-azoxy] -2,2-propylenedioxybutane (V) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.18, 1.22 (3H, d, 4-CH 3 ), 1.4
7,1.48 (3H, s, 1- CH 3), 2.53,
2.54 (1H, t, ≡CH), 4.71, 4.72
(2H, d, OCH 2 ), 6.92 to 7.07 (3H,
m, aromatic nucleus H), 7.32 (1H, t, aromatic nucleus H)
【0144】(2)前記(1)で得られたヒドロキシ化
合物(V)204mgをピリジン0.3mlに溶かし、
無水酢酸0.3ml(6当量)を加え、室温で3時間攪
拌した。反応後、反応液を減圧下で濃縮し、残渣をテト
ラヒドロフラン0.8mlに溶かした。これに1,8−
ジアザビシクロ〔5.4.0〕−7−ウンデセン0.4
3ml(5当量)を加え、40℃で3.5時間、加温攪
拌した。反応後、反応液にジエチルエーテル10ml、
1規定塩酸3mlを加え抽出した。エーテル層は水、飽
和食塩水で洗浄し、芒硝で乾燥した後、減圧下で濃縮し
た。残渣をシリカゲルのカラムクロマトグラフィーで精
製し、3−(3′−プロパルギルスチリル−ONN−ア
ゾキシ)−2,2−プロピレンジオキシブタン(III
′)130mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.22(3H,d,4−CH3 )、1.51(3H,
s,1−CH3 )、2.54(1H,t,≡CH)、
4.69(1H,q,3−CH−)、4.72(2H,
d,OCH2 )、6.99〜7.14(3H,m,芳香
核H)、7.33(1H,t,芳香核H)、7.63
(1H,d=CH−)、7.77(1H,d,−CH
=)(2) 204 mg of the hydroxy compound (V) obtained in (1) above was dissolved in 0.3 ml of pyridine,
0.3 ml (6 equivalents) of acetic anhydride was added, and the mixture was stirred at room temperature for 3 hours. After the reaction, the reaction solution was concentrated under reduced pressure and the residue was dissolved in 0.8 ml of tetrahydrofuran. 1,8-
Diazabicyclo [5.4.0] -7-undecene 0.4
3 ml (5 equivalents) was added, and the mixture was heated and stirred at 40 ° C. for 3.5 hours. After the reaction, 10 ml of diethyl ether was added to the reaction solution,
Extraction was performed by adding 3 ml of 1N hydrochloric acid. The ether layer was washed with water and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- (3'-propargylstyryl-ONN-azoxy) -2,2-propylenedioxybutane (III
′) 130 mg was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.22 (3H, d, 4-CH 3 ), 1.51 (3H,
s, 1-CH 3 ), 2.54 (1H, t, ≡CH),
4.69 (1H, q, 3-CH-), 4.72 (2H,
d, OCH 2), 6.99~7.14 ( 3H, m, arom H), 7.33 (1H, t , arom H), 7.63
(1H, d = CH-), 7.77 (1H, d, -CH
=)
【0145】(3)前記(2)で得られたプロパルギル
化合物(III ′)51mgをメタノール1.5mlに溶
かし、氷冷下、ヨウ素78mg(2当量)と10規定水
酸化ナトリウム溶液0.062mlを加え、氷浴をはず
して30分間攪拌した。反応後、反応液に2規定チオ硫
酸ナトリウム溶液0.5mlを加え、ジエチルエーテル
で抽出した。エーテル層は1規定塩酸、飽和炭酸水素ナ
トリウム溶液、飽和食塩水で洗浄し、芒硝で乾燥後、減
圧下で濃縮した。残渣をシリカゲルのカラムクロマトグ
ラフィーで精製し、3−〔3′−(3−ヨードプロパル
ギルオキシ)スチリル−ONN−アゾキシ〕−2,2−
プロピレンジオキシブタン(III)60mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.22(3H,d,4−CH3 )、1.51(3H,
s,1−CH3 )、4.70(1H,q,3−CH
−)、4.85(2H,d,OCH2 )、6.97〜
7.15(3H,m,芳香核H)、7.33(1H,
t,芳香核H)、7.63(1H,d,=CH−)、
7.77(1H,d,−CH=)(3) 51 mg of the propargyl compound (III ') obtained in (2) above was dissolved in 1.5 ml of methanol, and 78 mg (2 equivalents) of iodine and 0.062 ml of 10N sodium hydroxide solution were added under ice cooling. In addition, the ice bath was removed and the mixture was stirred for 30 minutes. After the reaction, 0.5 ml of a 2N sodium thiosulfate solution was added to the reaction solution, and the mixture was extracted with diethyl ether. The ether layer was washed with 1N hydrochloric acid, saturated sodium hydrogen carbonate solution, and saturated saline, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel to give 3- [3 '-(3-iodopropargyloxy) styryl-ONN-azoxy] -2,2-.
60 mg of propylenedioxybutane (III) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.22 (3H, d, 4-CH 3 ), 1.51 (3H,
s, 1-CH 3), 4.70 (1H, q, 3-CH
-), 4.85 (2H, d , OCH 2), 6.97~
7.15 (3H, m, aromatic nucleus H), 7.33 (1H,
t, aromatic nucleus H), 7.63 (1H, d, = CH-),
7.77 (1H, d, -CH =)
【0146】(4)前記(3)で得られたプロピレンジ
オキシ化合物(III)110mgをアセトン4mlに溶か
し、塩化第二鉄−シリカゲル220mgを加えて、室温
で2.5時間攪拌する。反応後、シリカゲルを除き、ジ
エチルエーテルで希釈してエーテル層を水、飽和食塩水
で洗浄し、芒硝で乾燥した後、減圧下で濃縮した。残渣
をジメチルホルムアミド−メタノール(1:5)3ml
に溶かし、ヒドロキシルアミン塩酸塩35mg(1.5
当量)、ピリジン0.05mlを加えて、室温で30分
間攪拌した。反応後、溶媒を減圧下で濃縮し、シリカゲ
ルのカラムクロマトグラフィーで精製し、目的物(I)
のアンチ−異性体52mgとシン−異性体14mgを得
た。1 H−NMR値:δ CDCl3 ,TMS,ppm アンチ−異性体 1.43(3H,d,4−CH3 )、1.98(3H,
s,1−CH3 )、4.85(1H,q,3−CH
−)、4.86(2H,s,OCH2 )、6.97〜
7.17(3H,m,芳香核H)、7.34(1H,
t,芳香核H)、7.57(1H,d,1′=CH
−)、7.79(1H,d,2′−CH=) シン−異性体 1.47(3H,d,4−CH3 )、1.81(3H,
s,1−CH3 )、4.86(1H,q,3−CH
−)、5.44(2H,s,OCH2 )、6.98〜
7.18(3H,m,芳香核H)、7.34(1H,
t,芳香核H)、7.58(1H,d,1′=CH
−)、7.80(1H,d,2′−CH=)(4) 110 mg of the propylenedioxy compound (III) obtained in (3) above is dissolved in 4 ml of acetone, 220 mg of ferric chloride-silica gel is added, and the mixture is stirred at room temperature for 2.5 hours. After the reaction, silica gel was removed, the mixture was diluted with diethyl ether, the ether layer was washed with water and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. 3 ml of the residue was added to dimethylformamide-methanol (1: 5).
35 mg of hydroxylamine hydrochloride (1.5 mg)
Equivalent) and 0.05 ml of pyridine were added, and the mixture was stirred at room temperature for 30 minutes. After the reaction, the solvent was concentrated under reduced pressure and purified by silica gel column chromatography to obtain the desired product (I).
52 mg of anti-isomer and 14 mg of syn-isomer were obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm anti-isomer 1.43 (3H, d, 4-CH 3 ), 1.98 (3H,
s, 1-CH 3), 4.85 (1H, q, 3-CH
-), 4.86 (2H, s , OCH 2), 6.97~
7.17 (3H, m, aromatic nucleus H), 7.34 (1H,
t, aromatic nucleus H), 7.57 (1H, d, 1 '= CH
-), 7.79 (1H, d , 2'-CH =) syn - isomer 1.47 (3H, d, 4- CH 3), 1.81 (3H,
s, 1-CH 3), 4.86 (1H, q, 3-CH
-), 5.44 (2H, s , OCH 2), 6.98~
7.18 (3H, m, aromatic nucleus H), 7.34 (1H,
t, aromatic nucleus H), 7.58 (1H, d, 1 '= CH
-), 7.80 (1H, d, 2'-CH =)
【0147】実施例26 3−(3−フエニル−1−プロペニル−ONN−アゾキ
シ)−2−ヒドロキシイミノブタン〔化合物(I):R
1 =ベンジル基、R2 =R3 =水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)376
mgをテトラヒドロフラン3mlに溶かし、−30℃に
冷却し攪拌下、リチウムジイソプロピルアミド(1.3
当量)のヘキサン溶液を滴下した。30分間攪拌した
後、これにフエニルアセトアルデヒド360mg(1.
5当量)のテトラヒドロフラン溶液3mlを滴下した。
滴下後、さらに50分間攪拌し、飽和塩化アンモニウム
溶液3mlを加えて、反応を停止した。反応液をジエチ
ルエーテルで抽出し、エーテル層は水、飽和食塩水で洗
浄した後、芒硝で乾燥して、減圧下で濃縮した。残渣を
シリカゲルのカラムクロマトグラフィーで精製し、3−
(2−ヒドロキシ−3−フエニルプロピル−ONN−ア
ゾキシ)−2,2−プロピレンジオキシブタン(V)の
ジアステレオマー420mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.15,1.34(3H,d,4−CH3 )、1.4
3,1.50(3H,s,1−CH3 )、1.90(1
H,m)、2.71〜2.85(1H,m)、2.92
〜3.05(1H,m)、3.48〜4.56(7H,
m)、7.21〜7.36(5H,m,芳香核H)Example 26 3- (3-Phenyl-1-propenyl-ONN-azoxy) -2-hydroxyiminobutane [Compound (I): R
1 = benzyl group, R 2 = R 3 = hydrogen atom]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) 376 obtained in Reference Example
mg was dissolved in 3 ml of tetrahydrofuran, cooled to −30 ° C., and stirred to obtain lithium diisopropylamide (1.3
Eq) hexane solution was added dropwise. After stirring for 30 minutes, 360 mg of phenylacetaldehyde (1.
3 ml of a tetrahydrofuran solution (5 equivalents) was added dropwise.
After the dropping, the mixture was stirred for another 50 minutes, and 3 ml of a saturated ammonium chloride solution was added to stop the reaction. The reaction solution was extracted with diethyl ether, and the ether layer was washed with water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography, 3-
420 mg of the diastereomer of (2-hydroxy-3-phenylpropyl-ONN-azoxy) -2,2-propylenedioxybutane (V) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.15, 1.34 (3H, d, 4-CH 3 ), 1.4
3,1.50 (3H, s, 1- CH 3), 1.90 (1
H, m), 2.71-2.85 (1H, m), 2.92
-3.05 (1H, m), 3.48-4.56 (7H,
m), 7.21 to 7.36 (5H, m, aromatic nucleus H)
【0148】(2)前記(1)で得られたヒドロキシ化
合物(V)278mgをピリジン3mlに溶かし、メタ
ンスルホニルクロリド0.12ml(2当量)を加え、
室温で2時間攪拌し、次いで40℃に加温して一夜攪拌
した。反応後、反応液を氷水にあけ、ジエチルエーテル
で抽出した。エーテル層は飽和炭酸水素ナトリウム溶
液、飽和食塩水で洗浄し、芒硝で乾燥した後、減圧下で
濃縮した。残渣をシリカゲルのカラムクロマトグラフィ
ーで精製し、3−(3−フエニル−1−プロペニル−O
NN−アゾキシ)−2,2−プロピレンジオキシブタン
(III)162mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.16(3H,d,4−CH3 )、1.45(3H,
s,1−CH3 )、3.53(2H,dd,3′−CH
2 −)、3.86〜3.98(4H,m)、4.62
(1H,m,3−CH−)、6.92(1H,ddd,
1′=CH−)、7.14(1H,dd,2′−CH
=)、7.16〜7.36(5H,m,芳香核H)(2) 278 mg of the hydroxy compound (V) obtained in (1) above was dissolved in 3 ml of pyridine, and 0.12 ml (2 equivalents) of methanesulfonyl chloride was added,
Stir at room temperature for 2 hours, then warm to 40 ° C. and stir overnight. After the reaction, the reaction solution was poured into ice water and extracted with diethyl ether. The ether layer was washed with a saturated sodium hydrogen carbonate solution and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- (3-phenyl-1-propenyl-O).
162 mg of NN-azoxy) -2,2-propylenedioxybutane (III) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.16 (3H, d, 4-CH 3 ), 1.45 (3H,
s, 1-CH 3), 3.53 (2H, dd, 3'-CH
2- ), 3.86 to 3.98 (4H, m), 4.62
(1H, m, 3-CH-), 6.92 (1H, ddd,
1 '= CH-), 7.14 (1H, dd, 2'-CH
=), 7.16 to 7.36 (5H, m, aromatic nucleus H)
【0149】(3)前記(2)で得られたプロピレンジ
オキシ化合物(III)30mgをアセトン2mlに溶か
し、塩化第二鉄−シリカゲル60mgを加えて、室温で
1時間攪拌した。反応後、シリカゲルを除き、ジエチル
エーテルで希釈してエーテル層を水、飽和食塩水で洗浄
し、芒硝で乾燥した後、減圧下で濃縮した。残渣をメタ
ノール1mlに溶かし、ヒドロキシルアミン塩酸塩1
1.5mg(1.5当量)とピリジン0.05mlを加
えて、室温で30分間攪拌した。反応後、溶媒を減圧下
で濃縮し、シリカゲルの薄層クロマトグラフィーで精製
し、目的物(I)のアンチ−異性体13mgおよびシン
−異性体7mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm アンチ−異性体(K−7489) 1.36(3H,d,4−CH3 )、1.91(3H,
s,1−CH3 )、3.53(2H,d,3′−CH2
−)、4.78(1H,q,3−CH−)、6.86
(1H,m,1′=CH−)、7.10〜7.38(5
H,m,芳香核Handオレフイン性H)、8.23
(1H,brs,OH) シン−異性体(K−7490) 1.10(3H,d,4−CH3 )、1.76(3H,
s,1−CH3 )、3.54(2H,d,3′−CH2
−)、5.36(1H,q,3−CH−)、6.90
(1H,m,1′−CH−)、7.11〜7.37(6
H,m,芳香核Handオレフイン性H)、8.06
(1H,brs,OH)(3) 30 mg of the propylenedioxy compound (III) obtained in (2) above was dissolved in 2 ml of acetone, 60 mg of ferric chloride-silica gel was added, and the mixture was stirred at room temperature for 1 hour. After the reaction, silica gel was removed, the mixture was diluted with diethyl ether, the ether layer was washed with water and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. The residue was dissolved in 1 ml of methanol and hydroxylamine hydrochloride 1
1.5 mg (1.5 equivalent) and 0.05 ml of pyridine were added, and the mixture was stirred at room temperature for 30 minutes. After the reaction, the solvent was concentrated under reduced pressure and purified by silica gel thin layer chromatography to obtain 13 mg of the anti-isomer and 7 mg of the syn-isomer of the target product (I). 1 H-NMR value: δ CDCl 3 , TMS, ppm Anti-isomer (K-7489) 1.36 (3H, d, 4-CH 3 ), 1.91 (3H,
s, 1-CH 3), 3.53 (2H, d, 3'-CH 2
-), 4.78 (1H, q, 3-CH-), 6.86
(1H, m, 1 '= CH-), 7.10 to 7.38 (5
H, m, aromatic nucleus Hand olefinic H), 8.23
(1H, brs, OH) syn - isomer (K-7490) 1.10 (3H , d, 4-CH 3), 1.76 (3H,
s, 1-CH 3), 3.54 (2H, d, 3'-CH 2
-), 5.36 (1H, q, 3-CH-), 6.90
(1H, m, 1'-CH-), 7.11 to 7.37 (6
H, m, aromatic nucleus Hand olefinic H), 8.06
(1H, brs, OH)
【0150】実施例27 3−〔3−(2−(3−ヨードプロパルギルオキシ)フ
エニル)−1−プロペニル−ONN−アゾキシ〕−2−
ヒドロキシイミノブタン〔化合物(I):R1=2−
(3−ヨードプロパルギルオキシ)−ベンジル基、R2
=R3 =水素原子〕の製造: (1)参考例で得られた3−(メチル−ONN−アゾキ
シ)−2,2−プロピレンジオキシブタン(VI)73m
gをテトラヒドロフラン1mlに溶かし、−30℃に冷
却し攪拌下、リチウムジイソプロピルアミド(1.3当
量)のヘキサン溶液を滴下した。30分間攪拌した後、
これにo−プロパルギルオキシベンズアルデヒド88m
g(1.3当量)のテトラヒドロフラン溶液1mlを滴
下した。滴下後、さらに50分間攪拌し、飽和塩化アン
モニウム溶液1mlを加えて、反応を停止した。反応液
をジエチルエーテルで抽出し、エーテル層は水、飽和食
塩水で洗浄した後、芒硝で乾燥して、減圧下で濃縮し
た。残渣をシリカゲルの薄層クロマトグラフィーで精製
し、3−〔2−ヒドロキシ−3−(2−プロパルギルフ
エニル)プロピル−ONN−アゾキシ〕−2,2−プロ
ピレンジオキシブタン(V)のジアステレオマー94m
gを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.13,1.23(3H,d,4−CH3 )、1.4
2,1.49(3H,s,1−CH3 )、1.72〜
2.03(1H,m)、2.53(1H,m)、2.8
6〜3.04(1H,m)、3.48〜4.56(7
H,m)、4.74(2H,d,OCH2 )、6.94
〜7.01(2H,m,芳香核H)、7.21〜7.2
8(2H,m,芳香核H)Example 27 3- [3- (2- (3-Iodopropargyloxy) phenyl) -1-propenyl-ONN-azoxy] -2-
Hydroxyiminobutane [Compound (I): R 1 = 2-
(3-Iodopropargyloxy) -benzyl group, R 2
= R 3 = hydrogen atom]: (1) 3- (methyl-ONN-azoxy) -2,2-propylenedioxybutane (VI) 73 m obtained in Reference Example
g was dissolved in 1 ml of tetrahydrofuran, cooled to −30 ° C., and a hexane solution of lithium diisopropylamide (1.3 equivalents) was added dropwise with stirring. After stirring for 30 minutes,
88m of o-propargyloxybenzaldehyde
1 ml of a tetrahydrofuran solution of g (1.3 equivalents) was added dropwise. After the dropping, the mixture was stirred for additional 50 minutes, and 1 ml of a saturated ammonium chloride solution was added to stop the reaction. The reaction solution was extracted with diethyl ether, and the ether layer was washed with water and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by thin layer chromatography on silica gel and the diastereomer of 3- [2-hydroxy-3- (2-propargylphenyl) propyl-ONN-azoxy] -2,2-propylenedioxybutane (V). 94m
g was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.13, 1.23 (3H, d, 4-CH 3 ), 1.4
2,1.49 (3H, s, 1- CH 3), 1.72~
2.03 (1H, m), 2.53 (1H, m), 2.8
6 to 3.04 (1H, m), 3.48 to 4.56 (7
H, m), 4.74 (2H , d, OCH 2), 6.94
~ 7.01 (2H, m, aromatic nucleus H), 7.21 to 7.2
8 (2H, m, aromatic nucleus H)
【0151】(2)前記(1)で得られたヒドロキシ化
合物(V)94mgをピリジン1mlに溶かし、メタン
スルホニルクロリド0.04ml(2当量)を加え、5
0℃で一夜攪拌した。反応後、反応液を氷水にあけ、ジ
エチルエーテルで抽出した。エーテル層は飽和炭酸水素
ナトリウム溶液、飽和食塩水で洗浄し、芒硝で乾燥した
後、減圧下で濃縮した。残渣をシリカゲルの薄層クロマ
トグラフィーで精製し、3−〔3−(2−プロパルギル
オキシフエニル)−1−プロペニル−ONN−アゾキ
シ〕−2,2−プロピレンジオキシブタン(III ′)5
0mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.14(3H,d,4−CH3 )、1.44(3H,
s,1−CH3 )、3.50(1H,t,≡CH)、
3.84〜4.01(4H,m)、4.62(1H,
m,3−CH−)、4.72(2H,d,1′=CH
−)、6.88(3H,m,2′−CH=and芳香核
H)、7.10〜7.28(3H,m,芳香核H)(2) The hydroxy compound (V) (94 mg) obtained in the above (1) was dissolved in pyridine (1 ml), and methanesulfonyl chloride (0.04 ml, 2 equivalents) was added.
Stir overnight at 0 ° C. After the reaction, the reaction solution was poured into ice water and extracted with diethyl ether. The ether layer was washed with a saturated sodium hydrogen carbonate solution and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel thin layer chromatography to give 3- [3- (2-propargyloxyphenyl) -1-propenyl-ONN-azoxy] -2,2-propylenedioxybutane (III ′) 5
0 mg was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.14 (3H, d, 4-CH 3 ), 1.44 (3H,
s, 1-CH 3 ), 3.50 (1H, t, ≡CH),
3.84 to 4.01 (4H, m), 4.62 (1H,
m, 3-CH-), 4.72 (2H, d, 1 '= CH
-), 6.88 (3H, m, 2'-CH = and aromatic nucleus H), 7.10 to 7.28 (3H, m, aromatic nucleus H)
【0152】(3)前記(2)で得られたプロパルギル
化合物(III ′)50mgをメタノールに溶かし、ヨウ
素90mg(2当量)と10規定水酸化ナトリウム溶液
0.07ml(4当量)を加え、室温で30分間攪拌し
た。反応後、反応液を水に希釈し、酢酸エチルで抽出し
た。酢酸エチル層は1規定チオ硫酸ナトリウム溶液、
水、飽和食塩水で洗浄し、芒硝で乾燥後、減圧下で濃縮
した。残渣をシリカゲルのカラムクロマトグラフィーで
精製し、3−〔3−(2−(3−ヨードプロパルギルオ
キシ)フエニル)−1−プロペニル−ONN−アゾキ
シ〕−2,2−プロピレンジオキシブタン(III)46m
gを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.15(3H,d,4−CH3 )、1.45(3H,
s,1−CH3 )、1.53〜1.68(1H,m)、
1.72〜1.87(1H,m)、3.52(2H,
d,3′−CH2 )、3.84〜4.01(4H,
m)、4.62(1H,q,3−CH−)、4.85
(2H,s,OCH2 )、6.89〜7.27(6H,
m,芳香核andオレフイン性H)(3) Dissolve 50 mg of the propargyl compound (III ') obtained in (2) above in methanol, add 90 mg (2 equivalents) of iodine and 0.07 ml (4 equivalents) of 10N sodium hydroxide solution, and add at room temperature. And stirred for 30 minutes. After the reaction, the reaction solution was diluted with water and extracted with ethyl acetate. The ethyl acetate layer is a 1N sodium thiosulfate solution,
The extract was washed with water and saturated saline, dried over Glauber's salt, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give 3- [3- (2- (3-iodopropargyloxy) phenyl) -1-propenyl-ONN-azoxy] -2,2-propylenedioxybutane (III) 46m.
g was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.15 (3H, d, 4-CH 3 ), 1.45 (3H,
s, 1-CH 3), 1.53~1.68 (1H, m),
1.72-1.87 (1H, m), 3.52 (2H,
d, 3'-CH 2), 3.84~4.01 (4H,
m), 4.62 (1H, q, 3-CH-), 4.85.
(2H, s, OCH 2 ), 6.89 to 7.27 (6H,
m, aromatic nucleus and olefinic H)
【0153】(4)前記(3)で得られたプロピレンジ
オキシ化合物(III)28mgをアセトン1mlに溶か
し、塩化第二鉄−シリカゲル50mgを加えて、室温で
4時間攪拌した。反応後、シリカゲルを除き、ジエチル
エーテルで希釈してエーテル層を水、飽和食塩水で洗浄
し、芒硝で乾燥した後、減圧下で濃縮した。残渣をメタ
ノール1mlに溶かし、ヒドロキシルアミン塩酸塩6.
5mg(1.5当量)とピリジン0.05mlを加え
て、室温で30分間攪拌した。反応後、溶媒を減圧下で
濃縮し、シリカゲルの薄層クロマトグラフィーで精製
し、目的物(I)のアンチ−異性体およびシン−異性体
の混合物10mgを得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 1.35,1.40(3H,d,4−CH3 )、1.7
5,1.93(3H,s,1−CH3 )、3.54(2
H,d,3′−CH2 −)、4.88,5.46(1
H,q,3−CH−)、4.95(2H,s,OC
H2 )、6.85〜7.09(3H,m,芳香核H)、
7.11〜7.29(3H,m,芳香核Handオレフ
イン性H)(4) 28 mg of the propylenedioxy compound (III) obtained in (3) above was dissolved in 1 ml of acetone, 50 mg of ferric chloride-silica gel was added, and the mixture was stirred at room temperature for 4 hours. After the reaction, silica gel was removed, the mixture was diluted with diethyl ether, the ether layer was washed with water and saturated saline, dried over sodium sulfate, and then concentrated under reduced pressure. The residue was dissolved in 1 ml of methanol, and hydroxylamine hydrochloride was added.
5 mg (1.5 equivalent) and 0.05 ml of pyridine were added, and the mixture was stirred at room temperature for 30 minutes. After the reaction, the solvent was concentrated under reduced pressure and purified by silica gel thin layer chromatography to obtain 10 mg of a mixture of the target (I) anti-isomer and syn-isomer. 1 H-NMR value: δ CDCl 3 , TMS, ppm 1.35, 1.40 (3H, d, 4-CH 3 ), 1.7
5,1.93 (3H, s, 1- CH 3), 3.54 (2
H, d, 3′-CH 2 —), 4.88, 5.46 (1
H, q, 3-CH-), 4.95 (2H, s, OC
H 2), 6.85~7.09 (3H, m, arom H),
7.11 to 7.29 (3H, m, aromatic nucleus Hand olefinic H)
【0154】実施例28 3−(1−ヘキセニル−ONN−アゾキシ)−2−〔2
−(3−ヨードプロパルギルオキシ)ベンゾイルオキシ
イミノ〕−ブタン〔化合物(I):R1 =n−ブチル
基、R2 =水素原子、R3 =2−(3−ヨードプロパル
ギシオキシ)ベンゾイル基〕の製造:2−(3−ヨード
プロパルギルオキシ)−安息香酸302mgをジメチル
ホルムアミド1mlに溶解し、1,1′−カルボニルジ
イミダゾール1当量を加えて室温で20分間攪拌した。
これに3−(1−ヘキセニル−ONN−アゾキシ)−2
−ヒドロキシイミノブタン(2−ヒドロキシイミノ−2
−デオクソ−KA−7367A:PCT/JP/010
82参照)219mgのジメチルホルムアミド2ml溶
液を加え、40℃で30分間攪拌した。次いで1,8−
ジアザビシクロ〔5.4.0〕−7−ウンデセン1.2
5当量を加え、さらに2時間攪拌した。反応後、ジエチ
ルエーテル150mlに希釈し、エーテル層を0.5規
定塩酸、飽和食塩水、飽和炭酸水素ナトリウム溶液、飽
和塩化アンモニウム溶液、飽和食塩水で順次洗浄した。
有機溶媒層は芒硝で乾燥後、減圧下で濃縮した。残渣を
シリカゲルのカラムクロマトグラフィーで精製し、目的
物(I)を得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 0.93(3H,t,6′−CH3 )、1.30〜1.
54(4H,m,CH2 −)、1.47(3H,d,4
−CH3 )、2.18(3H,s,1−CH3)、2.
22(2H,q,3′−CH2 −)、4.92(2H,
s,OCH2 )、5.06(1H,q,3−CH−)、
6.95(1H,d,1′=CH−)、7.01(1
H,q,2′−CH=)、7.08(1H,t,芳香核
H)、7.09(1H,d,芳香核H)、7.51(1
H,td,芳香核H)、7.87(1H,dd,芳香核
H)Example 28 3- (1-Hexenyl-ONN-azoxy) -2- [2
-(3-iodopropargyloxy) benzoyloxyimino] -butane [Compound (I): R 1 = n-butyl group, R 2 = hydrogen atom, R 3 = 2- (3-iodopropargyoxy) benzoyl group Preparation of 2- (3-iodopropargyloxy) -benzoic acid 302 mg was dissolved in 1 ml of dimethylformamide, 1 equivalent of 1,1′-carbonyldiimidazole was added, and the mixture was stirred at room temperature for 20 minutes.
Add to this 3- (1-hexenyl-ONN-azoxy) -2
-Hydroxyiminobutane (2-hydroxyimino-2
-Deoxo-KA-7366A: PCT / JP / 010
82) A solution of 219 mg of dimethylformamide in 2 ml was added, and the mixture was stirred at 40 ° C. for 30 minutes. Then 1,8-
Diazabicyclo [5.4.0] -7-undecene 1.2
5 equivalents were added and further stirred for 2 hours. After the reaction, the mixture was diluted with 150 ml of diethyl ether, and the ether layer was washed successively with 0.5 N hydrochloric acid, saturated saline, saturated sodium hydrogen carbonate solution, saturated ammonium chloride solution, and saturated saline.
The organic solvent layer was dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain the desired product (I). 1 H-NMR value: δ CDCl 3 , TMS, ppm 0.93 (3H, t, 6′-CH 3 ), 1.30 to 1.
54 (4H, m, CH 2 -), 1.47 (3H, d, 4
-CH 3), 2.18 (3H, s, 1-CH 3), 2.
22 (2H, q, 3'- CH 2 -), 4.92 (2H,
s, OCH 2), 5.06 ( 1H, q, 3-CH-),
6.95 (1H, d, 1 '= CH-), 7.01 (1
H, q, 2'-CH =), 7.08 (1H, t, aromatic nucleus H), 7.09 (1H, d, aromatic nucleus H), 7.51 (1
H, td, aromatic nucleus H), 7.87 (1H, dd, aromatic nucleus H)
【0155】実施例29 3−(1−ヘキセニル−ONN−アゾキシ)−2−〔3
−(3−ヨードプロパルギルオキシ)ベンゾイルオキシ
イミノ〕−ブタン〔化合物(I):R1 =n−ブチル
基、R2 =水素原子、R3 =3−(3−ヨードプロパル
ギルオキシ)ベンゾイル基〕の製造:3−(3−ヨード
プロパルギルオキシ)−安息香酸を用いて実施例28と
同様に反応処理して、目的物(I)を得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 0.93(3H,t,6′−CH3 )、1.31〜1.
54(4H,m,−CH2 −)、1.49(3H,d,
4−CH3 )、2.19(3H,s,1−CH3 )、
2.23(2H,q,3′−CH2 −)、4.89(2
H,s,OCH2)、5.06(1H,q,3−CH
−)、6.96(1H,d,1′=CH−)、7.02
(1H,q,2′−CH=)、7.19(1H,芳香核
H)、7.40(1H,芳香核H)、7.65(1H,
芳香核H)、7.77(1H,芳香核H)Example 29 3- (1-Hexenyl-ONN-azoxy) -2- [3
-(3-Iodopropargyloxy) benzoyloxyimino] -butane [Compound (I): R 1 = n-butyl group, R 2 = hydrogen atom, R 3 = 3- (3-iodopropargyloxy) benzoyl group] Production: 3- (3-iodopropargyloxy) -benzoic acid was used and treated in the same manner as in Example 28 to obtain the target product (I). 1 H-NMR value: δ CDCl 3 , TMS, ppm 0.93 (3H, t, 6′-CH 3 ), 1.31-1.
54 (4H, m, -CH 2 -), 1.49 (3H, d,
4-CH 3), 2.19 ( 3H, s, 1-CH 3),
2.23 (2H, q, 3'- CH 2 -), 4.89 (2
H, s, OCH 2), 5.06 (1H, q, 3-CH
-), 6.96 (1H, d, 1 '= CH-), 7.02
(1H, q, 2'-CH =), 7.19 (1H, aromatic nucleus H), 7.40 (1H, aromatic nucleus H), 7.65 (1H,
Aromatic nucleus H), 7.77 (1H, aromatic nucleus H)
【0156】実施例30 3−(1−ヘキセニル−ONN−アゾキシ)−2〔4−
(3−ヨードプロパルギルオキシ)ベンゾイルオキシイ
ミノ〕−ブタン〔化合物(I):R1 =n−ブチル基、
R2 =水素原子、R3 =4−(3−ヨードプロパルギル
オキシ)ベンゾイル基〕の製造:4−(3−ヨードプロ
パルギルオキシ)−安息香酸を用いて実施例28と同様
に反応処理して目的物(I)を得た。1 H−NMR値:δ CDCl3 ,TMS,ppm 0.98(3H,t,6′−CH3 )、1.30〜1.
54(4H,m,−CH2 −)、1.47(3H,d,
4−CH3 )、2.18(3H,s,1−CH3 )、
2.23(2H,q,3′−CH2 −)、4.89(2
H,s,OCH2)、5.06(1H,q,3−CH
−)、6.95(1H,d,1′=CH−)7.01
(2H,t,芳香核H)、7.03(1H,q,2′−
CH=)、8.04(2H,d,芳香核H)Example 30 3- (1-hexenyl-ONN-azoxy) -2 [4-
(3-iodopropargyloxy) benzoyloxyimino] -butane [Compound (I): R 1 = n-butyl group,
R 2 = hydrogen atom, R 3 = 4- (3-iodo-propargyloxy) preparation of a benzoyl group]: 4- (3-iodo-propargyloxy) - objects react in the same manner as in Example 28 using benzoic acid The product (I) was obtained. 1 H-NMR value: δ CDCl 3 , TMS, ppm 0.98 (3H, t, 6′-CH 3 ), 1.30 to 1.
54 (4H, m, -CH 2 -), 1.47 (3H, d,
4-CH 3), 2.18 ( 3H, s, 1-CH 3),
2.23 (2H, q, 3'- CH 2 -), 4.89 (2
H, s, OCH 2), 5.06 (1H, q, 3-CH
-), 6.95 (1H, d, 1 '= CH-) 7.01
(2H, t, aromatic nucleus H), 7.03 (1H, q, 2'-
CH =), 8.04 (2H, d, aromatic nucleus H)
───────────────────────────────────────────────────── フロントページの続き (72)発明者 石渡 博之 千葉県市川市菅野1−8−3 (72)発明者 奥野 之宏 東京都東村山市野口町2−17−43 (72)発明者 伊藤 久克 埼玉県川越市今福461 田園ハイツ川越2 −205 (72)発明者 白土 正三 東京都武蔵村山市残堀4−43−2 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Hiroyuki Ishiwata 1-8-3 Sugano, Ichikawa City, Chiba Prefecture (72) Inventor Yukihiro Okuno 2-17-43 Noguchi Town, Higashimurayama City, Tokyo Hisashi Ito 461 Imafuku, Kawagoe-shi, Saitama Prefecture 461 Denen Heights Kawagoe 2-205 (72) Inventor Shozo Shirato 4-43-2 Shimobori, Musashimurayama-shi, Tokyo
Claims (4)
原子、低級アルキル基、低級アルケニル基、低級アルキ
ニル基(ハロゲン原子で置換されていてもよい)、低級
アルコキシ基、低級アルケニルオキシ基、低級アルキニ
ルオキシ基(ハロゲン原子で置換されていてもよい)、
アリール基又はアラルキル基(アリール基及びアラルキ
ル基は1乃至2個のハロゲン原子、低級アルキル基、低
級アルコキシ基、ハロゲン化低級アルキニル基又はハロ
ゲン化低級アルキニルオキシ基で置換されていてもよ
い)を、R3は水素原子、低級アルキル基(カルボキシ
ル基で置換されていてもよい)、低級アルキニル基(ハ
ロゲン原子で置換されていてもよい)、低級アルキニル
オキシ基(ハロゲン原子で置換されていてもよい)、ベ
ンゾイル基(ハロゲン化低級アルキニルオキシ基で置換
されていてもよい)を示すが、R1がn−ブチル基を示
す場合はR3はハロゲン化低級アルキニル基、又はハロ
ゲン化アルキニルオキシ基で置換されたベンゾイル基を
示す〕で表される化合物。[Claim 1] [In the formula, R 1 and R 2 are the same or different and each is a hydrogen atom, a lower alkyl group, a lower alkenyl group or a lower alkynyl group (which may be substituted with a halogen atom). , A lower alkoxy group, a lower alkenyloxy group, a lower alkynyloxy group (which may be substituted with a halogen atom),
An aryl group or an aralkyl group (the aryl group and the aralkyl group may be substituted with 1 to 2 halogen atoms, a lower alkyl group, a lower alkoxy group, a halogenated lower alkynyl group or a halogenated lower alkynyloxy group), R 3 is a hydrogen atom, a lower alkyl group (which may be substituted with a carboxyl group), a lower alkynyl group (which may be substituted with a halogen atom), a lower alkynyloxy group (which may be substituted with a halogen atom) ), A benzoyl group (which may be substituted with a halogenated lower alkynyloxy group), but when R 1 represents an n-butyl group, R 3 represents a halogenated lower alkynyl group or a halogenated alkynyloxy group. A substituted benzoyl group].
る請求項1記載の化合物。2. A compound according to claim 1 which is an anti-isomer of a compound of general formula I.
請求項1記載の化合物。3. A compound according to claim 1, which is a syn-isomer of the compound of general formula I.
抗真菌剤。4. An antifungal agent containing the compound according to claim 1 as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24029491A JP3228533B2 (en) | 1990-10-01 | 1991-08-28 | Azoxy group-containing compounds |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2-260609 | 1990-10-01 | ||
JP26060990 | 1990-10-01 | ||
JP24029491A JP3228533B2 (en) | 1990-10-01 | 1991-08-28 | Azoxy group-containing compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05213852A true JPH05213852A (en) | 1993-08-24 |
JP3228533B2 JP3228533B2 (en) | 2001-11-12 |
Family
ID=26534660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP24029491A Expired - Fee Related JP3228533B2 (en) | 1990-10-01 | 1991-08-28 | Azoxy group-containing compounds |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3228533B2 (en) |
-
1991
- 1991-08-28 JP JP24029491A patent/JP3228533B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3228533B2 (en) | 2001-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5962575A (en) | Manufacture of triazolyl-alkanones and salts | |
FR2542315A1 (en) | NOVEL AZOLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIFUNGAL AND FUNGICIDES | |
FR2552431A1 (en) | NOVEL AZOLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIFUNGAL AND FUNGICIDES | |
JP3565878B2 (en) | Cyclopentane- and -pentene-β-amino acids | |
HU186752B (en) | Fungicide compositions containing triazolyl-gamma-fluoro-pinacolyl-derivatives as active agenta and process for producing the active agents | |
FR2649612A1 (en) | DRUGS BASED ON 1H-BENZOXADIAZINE DERIVATIVES-4.1.2 NOVEL DERIVATIVES AND METHODS FOR PREPARING THEM | |
EP0220947A2 (en) | Polyfluoroalkylisoxazolylamines, their preparation and use | |
IE922404A1 (en) | Cyclohexane and tetrahydropyran derivatives | |
JPH05213852A (en) | Azoxy group-containing compound | |
JPH05221938A (en) | Substituted aminopropane, preparation thereof and use thereof | |
JPH0348663A (en) | Hydroxyethyl-cyclopropyl-azoryl derivative | |
JPH07138214A (en) | Substituted amic acid derivative | |
JP4161331B2 (en) | Azolylmethylbicyclohexanol derivative, method for producing the same, agricultural chemicals, and use as pharmaceuticals | |
JP2630877B2 (en) | Optically active triazole derivatives and compositions | |
HU199437B (en) | Fungicides comprising hydroxyalkyl triazolyl derivatives as active ingredient and process for producing the active ingredients | |
US5541169A (en) | Azoxy compound | |
JPS63203670A (en) | 1-(2,4-difluorophenyl)-1-(1-fluorocyclopropyl)- 2-(1,2,4-triazol-1-yl)-ethan-1-ol | |
US5719291A (en) | Cyclohexane derivatives | |
EP0443513B1 (en) | Azoxy compounds | |
US8115019B2 (en) | Cis-2, 6-disubstituted tetrahydropyran derivatives and preparation method thereof | |
JPH03240766A (en) | Azoxy group-containing compound | |
JP3072397B2 (en) | Method for producing optically active bicycloalkenones | |
JPH0692927A (en) | New azoxy compound | |
JP2003327578A (en) | Method for producing optically active 2-phenyl-2,3- dihydroxypropylazole derivative | |
KR0119964B1 (en) | Novel heterocyclic vinyl sulfide and sulfone compounds, and process for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |